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Introduction 

Chapter Illltroductioll 
~fyocardial ischemia 
The heart is an organ that strongly depends on the supply of oxygen to preserve its 
viability and contractile function. Thus, even under optimal conditions anaerobic metabolism 
can only provide 7% of the A TP production that is required to maintain a normal contractile 
function. Since the oxygen storage capacity of the heart is minimal, a constant supply of 
oxygen by the arterial blood is mandatory. Under basal conditions, the extraction of oxygen 
from the blood is already 70-80% (compared to 20-40% in most organs), so that an increase in 
oxygen demand (up to five-fold during heavy exercise) simply cannot be met by an increase in 
oxygen extraction. Consequently, the increased oxygen demand is principally accommodated 
by an increase in flow of oxygenated blood to the myocardium. In the nOl1nal heart the 
vasodilator capacity of the coronary bed allows sufficient increases in flow, so that increases in 
oxygen demand do not result in anaerobic metabolism, even during strenuous exercise} 
However, when an obstlUction of the coronaty at1ery impedes coron31Y blood flow and hence 
myocardial substrate and oxygen supply, the energy demand of the heart cannot be met and 
ischemia ensues. Acute myocardial ischemia results in anaerobic metabolism and loss of 
contractile function of the ischemic area and may lead to cardiac an-hythmias, including 
ventricular fibrillation, and loss of viability (myocardial necrosis) when left untreated.2 
In virtually all people who develop myocardial ischemia, the underlying cause is 
coronary artery disease, due to atherosclerosis, for which smoking, high cholesterol and 
hypertension are some of the imp0l1ant risk factors. Acute myocardial ischemia is often caused 
by thrombus fonnation at the site of a partially stenosed artery. Thus, platelet aggregation at 
the site of the stenosis (often induced by plaque I1Ipture) can occlude the coronary artery. 
\Vhen a thrombus (unstable angina pectoris) or vasospasm (Prinzmetal's angina pectoris) or a 
severe stenosis impairs blood flow so that the energy demand cannot be met at rest, ischemia 
results principally as a consequence of an impaired supply and is therefore termed supply 
ischemia. Conversely, a mild stenosis, which does not result in ischemia at rest, can become 
flow limiting during increased myocardial oxygen demand caused by exercise or positive 
chronotropic andlor inotropic stimulation of the heat1_ Since the resultant myocardial ischemia 
principally occurs during an increased oxygen demand, it is often refened to as demalld 
ischemia. 
Novel insights into the consequences of myocardial ischemia 
Already many centuries ago clinical symptoms of myocardial ischemia, like chest pain 
and pain in shoulders and stomach, were noted in patients. At that time, however, these 
symptoms were not associated with disease of the heart, but rather related to disease of the 
stomach3 It was not until the early years of the twentieth centllly that Herrick4 found a relation 
between persistent coronary occlusion and the pathological findings of myocardial necrosis. In 
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1935, Tennant and Wiggers' observed that following a short period «3 min) of occlusion, 
contractile function recovered almost immediately upon reperfhsion. The next 40 years 
researchers maintained the idea that myocardial ischemia, dependent on its duration, could 
only lead to nvo distinct consequences. If the ischemic period lasted only a few minutes, the 
damage was reversible and recovelY of function was immediate. If, on the other hand, the 
ischemic period was prolonged, myocardium became il1'eversible damaged, resulting in 
myocardial necrosis and sustained impaired function. In 1975, these straightforward ideas 
were overhauled by the findings of Heyndrickx et a16 , who found that after a 15 min period of 
myocardial ischemia in awake dogs contractile function remained depressed for several hours 
despite an immediate restoration of coronmy blood flow and a nonnal electrocardiogram 
within minutes after reperfusion. Similar observations of delayed recovery of fUllction in 
anesthetized dogs ,vere initially received with scepsis and even considered an artefact. 7 It was 
not until seven years later, ,vhen Braunwald and Kloner8 coined the tenn "Myocardial 
Stunning" to describe this phenomenon of "delayed recovery of regional myocardial 
contractile function after reperfusion despite the absence of il1'eversible damage and despite 
restoration of normal flow", that the idea that myocardial damage could be reversible and that 
impaired contractile function does not necessarily reflect necrosis became fully appreciated.9 
Three different patterns in the responses to total coronary artery occlusions are currently 
delineatedJ which depend on the duration of occlusion. First, a coron31Y artelY occlusion that 
lasts less than 2 min produces no damage at all, so that cardiac metabolism and contractile 
function return to normal almost immediately upon reperfusion.5 Second, an occlusion that 
lasts between 2 and approximately 20 min results in reversible damage characterized by a 
delayed recovery of function upon reperfusion despite nonnal supply of oxygen and nutrients. 
The degree of stunning depends on the ischemic burden, i.e. the duration and severity of 
ischemia. After 5 min of myocardial ischemia produced by a total coronalY artelY occlusion in 
dogs, contractile fUllction remained depressed for 3 hours, whereas after 15 min of myocardial 
ischemia stunning lasted up to 6 hours.6 The severity of ischemia comprises both energy 
supply during ischemia (residual flow) and energy demand of the myocardium at the onset of 
ischemia. Several studies showed an inverse relationship between collateral blood flow during 
ischemia and myocardial stunning after a 10-min coronaty al1elY occlusion occlusion in 
conscious dogs. 10,1l Moreover, in patients the presence of residual flow within jeopardized 
myocardium during ischemia correlates with the rapid functional recovelY from myocardial 
stunning. 12 In pigs, which lack a native collateral circulation, 15 min of total coronary artelY 
occlusion resulted in a complete loss of wall thickening,13 whereas a 70% flow reduction 
lasting I hour resulted in a decrease of only 50% loss of systolic wall thickening,l4 Thns, 
residual flow during ischemia either via collaterals or a subtotal coronalY artelY occlusion 
attenuates stunning, The importance of energy demand at the onset of ischemia (often 
represented by the rate-pressure product) was suggested by observations that postischemic 
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contractile dysfunction is more pronounced in pentobarbital-anesthetized open-chest dogs 
(with hem1 rates of 150-175 beatslmin) than in awake dogs (with heart dtes of 100-110 
beats/min).15 However, the effect of hem1 rate may be due to modification of collateral blood 
flow, as Bolli et aLII found that although the rate-pressure product was related to the degree of 
stunning, when collateral blood flow was taken into account the influence became 
insignificant, 
While in intact heat1s ischemia lasting no longer than about 20 min results only in 
reversible damage, an ischemic period lasting more than 20 min produces cell death and 
myocardial infarction develops, One of the most prominent features of cell death is membrane 
disl1lption, indicating that ischemic injury has entered the lethal phase, and may be caused by 
phase separation of the phospholipidbilayer and activity of either Ca'+-activated 
phospholipases and proteases and/or osmotic imbalance resulting in cell swelling,2 It has also 
been suggested that norepinephrine, which is extensively released in the myocardial 
interstitium during ischemia, may be cardiotoxic,16 Administration of high systemic doses of 
isoproterenol produced focal necrotic lesions in nonnal rat hearts,I7 In contrast, depletion of 
cardiac norepinephrine stores by reserpination, did not limit myocardial infarct size in rabbits 18 
and dogs,I9 This hypothesis, however, is still controversial. 
The fraction of the jeopardized myocardium that becomes infarcted depends on the 
duration of ischemia and the presence of collateral blood flow (fig. I). In guinea pigs the 
collateral system is so ,veil developed that proximal occlusion of a major coronary branch does 
not result in any myocardial necrosis, On the other hand, in rats, rabbits and pigs collaterals are 
virtually absent, resulting in complete infarction within 1-1 Y:z hours,2o In humans a moderate 
and variable number of collaterals (which have probably developed during adulthood) is found 
and infarct development is therefore more gradual. After 2 hours of ischemia 50% of the 
endangered area is infarcted and infarction is complete after 6 hours of ischemia,21 Myocardial 
oxygen demand at the onset of ischemia was originally thought to be an important detenuinant 
of infarct size, as some Shldics suggested that myocardial oxygen demand before ischemia 
influences infarct size,22-24 Nevertheless, most of these shldies are done in dogs and the results 
can be explained by the presence of collateral flow, which is affected by both heart rate and 
bloodpressure." Moreover, in studies by the group of Schaper the bradycardia-induced 
decrease in myocardial oxygen consumption was achieved by either cholinergic stimulation23 
or infusion of a synthetic opiate,24 which were later shown to be cardioprotective (see 
preconditioning). 
Body core temperature also exerts an important effect on myocardial infarct size, as in 
pigs an increase of the temperature of l"C increased infarct size by 20%.25 Although 
hypothermia produces significant decreases in heart rate in rodents, the decrease in myocardial 
oxygen demand is not related to the positive relation between infarct size and temperature.26•27 
The mechanism by which temperahue influences infarct size is uncertain, but occurs most 
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likely via reduction of the basal metabolism with consequent slowing of high energy 
phosphate depletion, as all reaction rates are highly sensitive to temperature. Other 
mechanisms that may be responsible for the hypothennia-mediated protection, include reduced 
acidosis, and/or maintenance of ion homeostasis during ischemia and reperfusion.25 
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Figure 1 Development of irre~'ersible myocardial damage during total coral/my artelY occlusioll ill different species 
(modified ji"om Schaper et al.20 and Arnold et al.21). 
It was long believed that sllstained periods of myocardial ischemia always resulted in 
irreversible myocardial damage. However, with the advent of revascularization therapy, 
evidence accumulated that chronically impaired contractile dysfunction was not always the 
consequence of infarction. Thus, restoration of blood flow by bypass grafting could restore 
myocardial function in patients with chronically depressed function due to coronary artery 
disease.28 This phenomenon of chronic left ventricular dysfunction in the absence of ongoing 
metabolic evidence of ischemia may represent a self-protective downregulation in myocardial 
function and metabolism in order to ab0l1 evolution toward cell death despite chronic 
hypoperfusion. Diamond et a!." introduced this concept and Rahimtoola et al.30 later 
popularized this as myocardial ilibel'l/alioll. During the first few minutes of ischemia the 
energy supply-demand imbalance results in a decrease of CrP contents, lactate consumption 
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and myocardial contractile function. Myocardial contraction decreases slightly further which 
then in turn downregulates the energy demand, leading to a gradual recovery of erP content 
and lactate consumption to preischemic levels while contractile function remains depressed 
and necrosis does not occur.31 ,32 Hibemating myocardium retains its responsiveness to 
inotropic stimulation, however, at the expense of metabolic recovery, resulting in a new 
supply-demand imbalance.33 In the experimental setting hibernation can be achieved by severe 
flow reduction for several hours, for example 50% flow reduction for 5 hours results in a 40% 
decrease in contractile function and delayed but complete recovery of function within 1 week 
of reperfusion. 31 This short-term hibernation can be distinguished from stunning by measuring 
blood flow, which is reduced in hibemation and nonnal in stunning, or measuring metabolic 
changes associated with inotropic stimulation, which is at the expense of metabolic recovery in 
hibemation, while in stullning no metabolic deterioration occurS.34 Long-tenn hibernation can 
only be inferred from clinical shldies and is associated with ultrastmchlral alteration in 
cardiomyocytes, including loss of contractile material within the remaining cardiomyocytes, 
glycogen deposits, depletion of sarcoplasmic reticulum and increased interstitial fibrosis and 
possibly loss of cardiomyocytes.35 Until now, an experimental model for chronic hibemation 
has not been found because of the difficulty of excluding repetitive episodes of exercise-
induced ischemia providing an altemative explanation for the observed chronic contractile 
dysfunction during persistent coronary stenosis.34 On the other hand, it should be questipned 
whether a model of pure chronic hibemation is neceSS31Y as in patients coexistence of 
hibemation and shmning often occurs. It is more likely that coronary blood flow will fluctuate, 
because severe coronary artery stenosis causes loss of coron31Y autoregulation, which will 
result in brief periods of ischemia.36 At the present time, the mechanisms responsible for the 
development of short-term hibemation are not clear. Alterations in fi-adrenoceptor density or 
affinity, activation of ATP-sensitive K+ channels or endogenous adenosine have all been 
excluded.37,38 It has been suggested that Ca2+ transients are reduced39 or that the Ca2+ 
responsiveness of the myofilaments is decreased, due to a decrease in maximal developed 
force.4o 
Patients with angina pectoris who develop myocardial infarction often experience 
ischemia in the preceding hours to days. It was initially believed that these preceding periods 
of ischemia added to the ischemic burden possibly resulting in a larger infhrct size. 
Paradoxically, however, Murry et al.41 observed that when dogs were subjected to a 40 min 
coronary artery occlusion 29% of the ischemic area was infhrcted, but only 7% when the 
sustained period of ischemia was preceded by four cycles of 5 minutes of coronary artery 
occlusion and 5 min of reperfusion. This cardioprotective effect of short periods of ischemia 
was termed ischemic preconditioning, which also explains earlier findings of attenuated 
metabolic ischemia during a second flow reduction in the swine heart. Not also has the 
discovery of this phenomenon revived interest in the development of novel cardioprotective 
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strategies, but also shows that brief periods of myocardial ischemia can be either detrimental 
(stmllling) or protective (ischemic preconditioning) to the heart. In this thesis both stunning 
and ischemic preconditioning are studied. 
Stunning 
Shmning, although originally described in a conscious animal model, has been the focus 
of_numerous studies in particular in intact anesthetized animal models and isolated (rat) heart 
studies. Evidence for the OCCUlTence of stunning in man has been found in a variety of 
conditions. For example, using positive inotropic agents, myocardial dysfunction was 
succesfully restored in patients after open heart surgery.42.43 With the elllTent knowledge on 
the pathogenesis of dysfunction it is logical to assume that stunning may be the underlying 
cause, because stimulation with positive inotropic agents in the presence of ischemia would 
more often lead to irreversible damage and to chronic impainllent of function. In addition, 
after unstable angina Wijns et al.44 found that flow values are normal and identical between 
nonnally contracting and dysfunctional segments. Shmning also coexists with myocardial 
inL'lrction as thrombolysis or coronary angioplasty in patients with myocardial infarction 
salvaged a significant amount ofmyocardium.45 Therefore, despite a lower sensitivity of blood 
flow and contractile function measurements in man compared to animal modelsJ there is 
sufficient evidence that stunning does occur in humans. Several clinical investigators consider 
shmning not as a serious clinical problem, as the postischemic myocardial dysfunction 
evenhtally restores without phannacological intervention. However, it has also been suggested 
that repeated episodes of ischemia with subsequent reCUlTent stmming can induce myocardial 
hibernation46 and hence shmning does appear to be of clinical importance. 
Pathogellesis a/myocardial stunlling 
The observations by Heyndriekx et al.6 triggered tremendous research effOlts to unravel 
the mechanisms of shlIlning which have greatly contributed to our current knowledge about 
the role of many of the cellular processes during and after ischemia. Over the years a number 
of mechanisms have been fonvarded to explain stunning, including loss of and reduced ability 
to synthesize highMenergy phosphatesJ impairment of microvascular perfusion, impainnent of 
sympathetic neural responsiveness, generation of oxygen derived free radicalsJ activation of 
leukocytes, reduction in the activity of creatine kinaseJ and disturbances in Ca2+ homeostasis.47 
At the present timeJ the release of oxygen free radicals and Ca2+ overload are considered to be 
key events in the pathogenesis of stunning. HoweverJ there are several controversies regarding 
these triggers and modulators that remain to be solved. 
During ischemia metabolites such as lactate accumulateJ resulting in a decrease ill pH. 
Under nonnal conditions the michondria neutralize the increase in intracellular 11+. HoweverJ 
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during ischemia the Na + ~ exchanger. is the primary mechanism to restore intracellular pH, 
resulting in high intracellular Na+. Because less intracellular ATP is available during ischemia, 
the Na+/K+ pump is unable to adequately eliminate the increased Na+, Consequently, the 
Na+ICa+ exchanger reverses its function and exchanges Na+ for Ca2+, resulting in increased 
intracellular Ca2+. This mechanism, however, is of short duration as massive amounts of 
extracellular It inhibit the Na'/ft exchanger. At the onset of reperfusion, the extracellular 
fluid is replaced by a more alkalotic media, resulting in a decreased extracellular H' 
concentration and inhibition of the Na+~ exchanger is no longer occuning.48 The role of the 
Na+ICa+ exchanger is supported by the finding that Na+/H+ antipOlters given only during 
reperfusion can attenuate contractile dysfunction.49,50 Thus, upon reperfusion the Ca2+ levels 
do not immediately recover, but even increase further via the above mentioned mechanism of 
restoration of intracellular H+ concentration. 
The role of voltage dependent Ca" channels for the Ca" overload at the onset of 
reperfusion is studied using Ca2+ antagonists mainly before ischemia and at the onset of 
reperfusion. Ca2+ antagonists administered either before ischemia or prior to reperfusion 
attenuate myocardial stunning in isolated perfused hearts.51 In vivo shldies also support a role 
for Ca2+ in myocardial stunning since numerous stlidies have shown a beneficial effect of Ca2+ 
antagonists.51 ,52 However, in vivo studies could not show a beneficial effect when Ca2+ 
antagonists were administered just prior to or at the onset of reperfusion, questioning the 
importance of an increase in cytosolic Ca2+ during early reperfusion.52 Explanations for these 
findings could be that the residual flow via collaterals is not sufficient enough to get adequate 
levels of Ca2+ antagonists in the myocardium, or that the voltage dependent Ca2+ channels are 
less important for an increase in Ca2+ during early reperfllsion than Na+/Ca2 ... exchanger. 
During the initial minutes of reperfusion, not only the intracellular free Ca2+ 
concentration increase further but also oxygen free radicals are produced. Administration of 
anti-oxidants during occlusion or just prior to reperfusion diminishes myocardial stmming, 
whereas anti-oxidants administered 1 min after the onset of reperfusion have no effect on 
myocardial dysfunction.53 Direct measurement by spin trap and electron paramagnetic 
resonance spectroscopy has also shown production of oxygen free radicals in the initial 
minutes of reperfusion.54 \Vith these teclmiques a linear positive relation was noted between 
the magnitude of free radical production and the severity of stunning, dependent on the 
duration of ischemia and the amount of collateral blood flow. In dogs xanthine oxidase may be 
a source of oxygen free radicals, but its role in rabbits, swine and humans has been questioned 
as these species reportedly have negligible levels of this enzyme. 55 The role of oxygen free 
radicals is also confil1ned by the observation that ACE inhibitors may attenuate stunning by 
direct scavenging of oxygen derived free radicals and bradykinin-mediated release of 
prostacyclin.56 The exact mechanism whereby oxygen free radicals cause stunning is still in 
debate, but is thought to be mainly targeted on proteins and lipids, leading eventually to a 
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decrease in the Ca2+ responsiveness of myofilaments by two distinct mechanisms. First, 
directly by oxidative modification of contractile proteins. Secondly, indirectly by damage to 
the sarcolemma and sarcoplasmic reticulum which results in transient Ca2+ overload.57 
Sarcolemmal damage results in loss of selective permeability, impaitment of Ca2+ -stimulated 
ATPase activity and Ca2+ transport out of the cell, and impainnent of Na + IK+ ATPase activity 
with consequently Na + overload and Ca2+ overload. In the sarcoplasmic reticulum, impairment 
of the Ca2+ -stimulated ATPase activity and Ca2+ uptake results in decreased Ca2+ sequestration 
and Ca2+ overload (for detailed references see Bolli and Marban58). 
The consequences of oxygen free radicals and Ca2+ overload are still in debate and 
involve disturbance in Ca2+ homeostasis and decreased responsiveness of the myofilaments to 
Ca2+. Evidence for a decreased availability of Ca2+ is controversial as ill vitro studies showed 
either decreased59, unchanged60,6! or increased62,63 Ca2+ transients. Studies on reduced Ca2+ 
responsiveness are more conclusive. The increase in intracellular Ca2+, either caused by the 
Na+ overload or the oxygen free radicals, activates Ca2+-activated proteases (calpains), which 
damages the contractile proteins, resulting in a decrease in myofilament Ca2+ responsiveness. 
This was supp0l1ed by the study of Gao et al.64, who SUbjected skinned trabeculae 20 minutes 
to CaJpain I. Force-[Ca2+] relations showed a reduced Froax and an increased Caso after 
exposure, which could be prevented by calpastatin, a specific calpain inhibitor. Other ill vitro 
studies also showed a decrease in maximal force of stunned myocardium60,61 and additionally 
a decrease in the Ca2+ sensitivity.60 Thus, ill vitro studies show a decreased Ca2+ 
responsiveness ofthe myofilaments, however ill vivo evidence is stilllacking.40 
Tl'eatmeut of stu1lning 
Although contractile function of stunned myocardium eventually recovers completely, it 
may temporarily produce critical impairment of global left ventricular function when the 
shmned area encompasses a large region of the heart or when the heart is already £1iling. 
Considering the role of oxygen free radicals, it is not surprising that agents exhibiting free 
radical scavenging properties attenuate stunning.53 Also agents that limit Ca2+ overload during 
ischemia and early reperfusion, such as Ca2+ antagonists and Na + /H+ exchange inhibitors, can 
diminish postischemic dysfunction.49-s2 These agents, however, should ideally be adminstered 
before ischemia, but always before reperfusion. Once stmming has been established only 
positive inotropic agents (p-adrenoceptor agonists, phosphodiesterase (PDE)-II1 inhibitors, 
Ca2+ and Ca2+ agonists) result in complete recruitment of contractile function. However, after 
infhsion of these positive inotropic agents stops, contractile function retUInS to pre-infusion 
levels, indicating that contractility is increased without modifying the mechanism that 
underlies stunning, but also indicating that p~agonists are capable of reclUiting contractile 
reserve of stUlmed myocardium without deleterious effects.65 
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Conventional inotropic agents, however, also possess some disadvantages. The increase 
in Ca2+ transients after treatment with PDE-III inhibitors, Ca2+ or Ca2+ agonists may lead to 
arrhythmias. Moreover, the positive inotropic capacity of PDE-III inhibitors is diminished in 
heart failure, probably due to reduced cAMP production by the adenylyl cyclase.66•67 Because 
of this negative outcome, Ca2+ sensitizers which should be devoid of the risk of Ca2+ overload-
induced arrhythmias have received increasing interest. As it is thought that stunning is caused 
by a decrease in the Ca2+ sensitivity of the myofilaments, restoration of the contractile function 
of stunned myocardium by Ca" sensitizers seemed a logical approach. The advantage of Ca2+ 
sensitizers over conventional agents is that Ca2+ sensitizers increase force without an increase 
in the Ca2+ transients, thereby avoiding Ca2+ overload-induced alThythmias. In addition, Ca2+ 
sensitizers do not increase energy consumption, because the rate of Ca2+ uptake into the 
sarcoplasmic reticulum and myofibrillar ATPase, two processes that use ATP, are unchanged. 
Conversely, a concern is that an increase in the Ca2+ sensitivity could adversely affect diastolic 
function, including slowed relaxation and increased end-diastolic stiffness, which results in 
impairment of left ventricular filling and hence cardiac pump function. Addition of mild PDE 
inhibition could therefore be favorable as an increase in cAMP improves relaxation by 
facilitating the release of Ca2+ from troponin C and stimulation of Ca2+ uptake by the 
sarcoplasmic reticulum. 
Until now, numerous Ca2+ sensitizers have been developed, which all have different sites 
of action. Ca2+ sensitizers can modify the binding of Ca2+ to troponin C by increasing the 
affinity or prolong the duration of the Ca2+-induced conformation (pimobendan, levosimendan, 
MCI-154 and EMD 60263), modify the interaction between the various components of the 
myofilaments (pimobendan, MCI-154) or alter actin-myosin cross-bridge kinetics (EMD 
57033). Next to the Ca2+ sensitizing properties, most of these agents also have other properties, 
like PDE-III inhibition (pimobendan, levosimendan and MCI-154) or inhibition of the delayed 
inward rectifier K+ current (EMD 60263). 
Preconditioning 
Ischemic preconditioning 
Following the experimental discovery of ischemic preconditioning the existence of this 
phenomenon has been verified in several animal species including the pig6S, rat69,70 and 
rabbit71 . Direct evidence for the occurrence of ischemic preconditioning in patients is not 
available, because of the inability to accurately detennine the different occlusion and 
reperfusion phases and the extent of collateralization. Also, infarct size cannot be measured 
directly, but is assessed by indirect parameters such as enzyme leakage, survival or left 
ventricular function.72 Although the existence of ischemic preconditioning in humans is 
difficult to demonstrate several in vitJ'0 73,74 and in V;\l0 75,76 studies have confinned this 
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ischemic syndrome in humans. Based on total enzyme release, improved left ventricular 
function and a lower in-hospital mortality rate, it has been shown that patients who experience 
angina before acute myocardial infarction have smaller illh'lrct sizes.77-79 Ischemic 
preconditioning can be a confounding factor in clinical studies assessing the effectiveness of 
reperfusion therapy on infarct size, as the infarct size can be influenced by previous periods of 
ischemia. Moreover, insights into the mechanisms underlying ischemic preconditioning could 
potentially help to develop pharmacological agents which mimic preconditioning," 
Initially, it was thought that shmning was involved in the mechanism underlying 
preconditioning. Because of the depressed contractile function, the energy requirements were 
decreased. which would result in a reduced rate of energy untilization. However, the study by 
Murry et al.80 showed that in dogs aOer 15 min coronary artery occlusion followed by 120 min 
reperfusion, myocardial shlllning still persisted despite attenuation of preconditioning. 
Downey et al. 81 were the first to propose that adenosine plays a role in cardioprotection, 
after which a lot of studies were done focussing on cellular mechanisms. For example 
adenosine, bradykinin and norepinephrine, which are released during myocm:dial ischemia, all 
have their actions via activation of G-protein coupled receptors, leading to activation of protein 
kinase C. The latter is thought to playa central role in ischemic preconditioning. However, the 
role of protein kinase C is still in debate as controversial evidence is found in several species. 
Activation of protein kinase C is believed to lead to opening of the ATP-sensitive K+ channels 
in the sarcolemma and mitochondria that protects the heart against a subsequent ischemic 
period. Opening of the sarcolemmal ATP-sensitive K+ chamwls result in shortening of the 
action potential duration and consequently less Ca2+ overload.82 Opening of the ATP-sensitive 
K+ channels in the iImer mitochondrial membrane leads to membrane depolarization, matrix 
swelling, slowing of the ATP synthesis and accelerated respiration,S) The role of ATP-
sensitive K+ channels in ischemic preconditioning is supported by several studies in which 
ischemic preconditioning was abolished after administration of glibencJamide or 5-
hydroxydecanoate, which block the ATP-sensitive K+ channels in several species.84-89 
In experimental models. cardioprotection ,vas afforded by total corollmy occlusion 
follmved by an abrupt repcrfusiol1, a rare feature in patients. Ovize et al.90 detennined whether 
moderate ischemia by partial occlusion could also protect the heart and found that a flow 
reduction of 50% for 15 min could reduce infarct size, provided that complete reperfusion was 
given between the partial occlusion and the subsequent sustained occlusion. Based on the two-
stage Harris model, Koning et al.91 showed that 30 or 90 min of severe (70%), but not mild 
(30%) flow reduction protected against myocardial infarction without intermittent reperfusion. 
Thus, the degree of ischemia has to be severe enough to induce cardioprotection. The 
hypothesis of a threshold to protect the heaI1 was proposed by the group of Downey92, They 
suggested that during one cycle of ischemic preconditioning several metabolites are released 
such as adenosine and bradykinin, which playa major role in triggering protection by having 
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additive effects on protein kinase C stimulation. Blockade of bradykinin results in a 
subthreshold for cardioprotection, which can be overmled by more preconditioning stimuli 
resulting in additional release of adenosine and other metabolites. 
Non~ischelJlic preconditioning 
Besides brief myocardial ischemia, several stimuli that are not associated with ischemia 
have been shown to afford cardioprotection. For example, stretching the heart by volume 
overload protects the heart against sustained myocardial ischemia via activation of stretched 
activated channels, likely through a mechanism that involves downstream activation of protein 
kinase C, adenosine receptors, and/or ATP sensitive K+ channels.93,94 Also, in pigs increasing 
the heart rate to 200 bpm for a period of 30 minntes without myocardial ischemia protected the 
heart, and conld be blocked by glibenclamide, suggesting a mechanism via opening of the ATP 
sensitive K+ channels95. Domenech et a1.96 could mimic preconditioning by 5 brief periods of 
tachycardia in dogs, which was not due to changes in collateral flow nor activity or 
translocation of protein kinase C, but mediated by adenosine. Additionally, the role of ATP-
sensitive K+ channels has also been confirmed in cardioprotection by heat stress.97-99 Thus, the 
mechanism by which nonischemic stimuli give cardioprotection is comparable to -the 
mechanism of ischemic preconditioning. 
Not surprisingly phanllacological agents that stimulate one or more of the cellular 
components involved in the mechanism of ischemic preconditioning can also produce 
cardioprotection. Infusion of the ATP sensitive K+ channel opener before the sustained 
ischemic period decreased infarct size in anesthetized pigs, whereas infusion after the onset of 
ischemia and during reperfusion had no effect.87,IOO Other phanllacological agents that can 
protect the heart are protein kinase C activators lOl ,102, norepinephrine lO3 and adenosine.104,I05 
The role of the latter has been confilllled ill several species like pigs and rabbits, but its role in 
rats is still controversial. 
Remote preconditioning 
In the above mentioned studies the preconditioning stimulus and the sustained period of 
ischemia involved the same region of the hem1. However, cardioprotection can also be 
provoked by ischemia in other regions of the heart or even other organs, which is known as 
remote preconditioning. Przyklenk et a1. 106 reported that ischemia in the area perfused by the 
left circumflex coronary artery could also protect the adjacent area perfused by the left anterior 
descending coronary artery. This call be explained by activation of stretch-activated channels, 
because severe myocardial dysfunction leads to stretching of the adjacent non-ischemia 
myocardium.93 Also, ischemia in other organs such as kidneys, intestines (abdominal angina) 
or skeletal muscles prior to a sustained occlusion of the coronary artelY also limited infarct 
development, most likely via a neurogenic pathway activated during reperfusion, but also 
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involving adenosine and ATP-sensitive K+ channels. 107-109 Moreover, the combination of flow 
restriction in the femoral artery and stimulation of the gastrocnemius muscle, a clinical 
analogue in patients with claudicatio intennittens, resulted in demand ischemia and 
consequently cardioprotection in the heali. llo 
Studies on the interaction between the brain and the heart are also available and has 
shown that brain ischemia, induced by subarachnoidal hemolThage or transient ischemic 
attacks (TIA), causes a transient decrease in myocardial contractile function,111.112 also known 
as neurogenic stunning. However, the effect of brain ischemia on the development of 
myocardial infarct size during coronary artery occlusion has not yet been detennined. 
Aim and outline of the thesis 
The general aim of this thesis is to study the various aspects of brief periods of 
myocardial ischemia on the hemi muscle. Several animal models for the study of myocardial 
ischemia are available. Therefore, in chapter 2 the models that can be used to study 
myocardial ischemia are extensively discussed: ischemia versus hypoxia, global versus 
regional, ill vitro versus ill vivo. Also, in this review the three different ischemic syndromes 
stunning, preconditioning and hibernation are outlined in more detail. 
Rational therapy of established myocardial stunning consists of administration of 
inotropic agents, in particular Ca2+ sensitizers. However, several ill vitro studies reported a 
Ca2+ sensitization induced impairment of relaxation in nonnaJl13-1l5 or shilliled116 
myocardium. Importantly, in in vivo shldies showing no adverse effect of D.?'· sensitizing 
agents on diastolic function, the agents used not only possess Ca2+ sensitizing but also 
phosphodiesterase III (PDE-III) inhibitory properties. Currently, there are no ill vivo studies in 
which the effect of Ca'+ sensitizing agents without PDE-III inhibitory properties on diastolic 
function of regionally stunned myocardium has been evaluated. Consequently, in chapter 3 we 
describe the effects of the Ca'+ sensitizer EMD 60263, which is devoid of PDE-III inhibitOlY 
properties, on diastolic function of stunned myocardium. The study focuses mainly on early 
diastolic changes in regional myocardial segment dynamics. However, since EMD 60263 
decreases heart rate via blockade of the delayed inward rectifier K+ current, experiments were 
perfonned at spontaneous sinus rhythm, but also after restoration of heart rate via atrial pacing. 
Moreover, since disturbances in diastolic function are more likely to be aggravated at 
decreased diastolic intervals we also studied the effects of EMD 60263 after a further increase 
in heart rate. 
It has been suggested that the inotropic response to Ca2+ sensitizers may differ between 
stunned and normal myocardium. For instance, it has been shown that after infusion of EMD 
60263 the increase in regional systolic shortening iu stunned myocardium of anesthetized pigs 
was much more pronounced than that in nonnal myocardium. Il7 However, systolic shortening 
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is strongly load-dependent, even more so in stunned myocardium, and does not necessarily 
reflect myocardial contractilityll8 Therefore, in chapler 4, we employed the regional LV 
pressure-segment length relationship in analogy to the time varying elastance concept to 
examine both systolic and diastolic function in a load-independent manner. In chapter 3 we 
observed that the inhibition of the delayed inward rectifier current by EMD 60263 via 
prolongation of the action potential duration modified systolic and diastolic responses. 
Therefore, we used the Ca'+ sensitizer EMD 57033, which is devoid of the delayed inward 
rectifier K+ current blocking properties. However, EMD 57033 does exert some PDE-III 
inhibitory actions in addition to its Ca2+ sensitizing effects. 
In several ill vitro and ill vivo studies (including the studies of chapter 3 and 4) the 
beneficial effects of Ca2+ sensitizing agents on stunned myocardium have been confinued, but 
in none of these studies it was actually shown that during stunning the myocardial 
responsiveness to added Ca2+ was altered and that subsequent administration of Ca2+ 
sensitizers restored the responsiveness to added Ca2+. Therefore, in chapter 5 we studied the 
effect of EMD 57033 on the responsiveness of nOlmal and stunned myocardium to 
intracoronary Ca2+ infusions ill vivo. 
Brief periods of ischemia not only result in stunning, but also protects the heart against a 
subsequent long period of ischemia (ischemic preconditioning). In chapter 6 an overview is 
given of ischemic preconditioning. Several aspects are discussed like non-ischemic stimuli, 
remote preconditioning and the effect of temperature on cardioprotection. A possible trigger 
for preconditioning is adenosine, which is a breakdown product of A TP and released during 
ischemia. The role of adenosine in ischemic preconditioning has been confinued in several 
species like pigs, dogs and rabbits. 119 Three adenosine receptor subtypes (AI, A, and A,) have 
been characterized to date, of which Al and A3 receptors are thought to be involved in 
ischemic preconditioning.120-123 In rats, evidence on the role of adenosine and receptor 
subtypes is still controversial. 124,12S Therefore in chapter 7 the role of adenosine Al and A3 
receptors in ischemic preconditioning in anesthetized rats is studied. 
Norepinephrine, released during myocardial ischemia, is also one of the mediators 
involved in the signaling pathway leading to ischemic preconditioning. The release mechanism 
of catecholamines during regional ischemia was shtdied using a relatively new technique, 
called microdialysis. With this technique, based on diffusion of molecules through a semi-
penneable membrane, the local interstitial levels of norepinephrine can be measured. The 
advantage of this method above the conventional method of coronary venous sampling and 
biopsies is that coronary venous sampling is an indirect measurement and cannot be performed 
during total coronary occlusion and biopsies comprise not only interstitial fluid, but also 
cardiomyocytes and sympathetic nerve endings. Microdialysis measured within the 
myocardium is not dependent on blood flow and thus can be used during total coronary 
occlusion. In addition, this technique makes it possible to measure continuously and locally. 
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Using an ill vivo porcine model, the time course and magnitude of changes in interstitial 
concentrations of norepinephrine during severe myocardial ischemia and reperfllsion was 
investigated (chapter 8). 
Remote preconditioning of the heart has been observed to be induced by ischemia in the 
kidneys, small intestines and skeletal muscle. Brief periods of ischemia also occur in the brain, 
better known as transient ischemic attacks. As cerebral ischemia has been reported to cause an 
excessive release of catecholamines from sympathetic nerve endings in nonnal myocardium) 
the question can be raised whether transient cerebral ischemia prior to a prolonged period of 
myocardial ischemia may also be cardioprotective. In chapter 9 the effect of cerebral ischemia 
on infarct development is tested with special focus on norepinephrine as possible mediator of 
this remote preconditioning. As the role of norepinephrine has not yet been investigated in 
pigs, it was also tested whether exogenous administration of norepinephrine can protect the 
healt. 
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Introduction 
Although myocardial ischemia has been one of the most extensively studied topics iu 
cardiovascular research, its defInition is still debated.! In the strictest sense 'ischemia' derived 
from the Greek words, ischO (to restrain) and haitna (blood), means insufficient blood, and if 
we would adhere to this definition, all animal models which lack blood (e.g. isolated heart 
models) should by defInition be tenned 'ischemic'. Most investigators prefer to defIne ischemia 
as an imbalance between the amount of oxygen and substrates supplied to the heart and the 
amount needed to perform nonnal function. 1,2 The rationale behind this definition is that the 
myocardium strongly depends on oxygen to sustain adequate oxidative phosphorylation, the 
only metabolic process that is capable of providing sufficient high energy phosphates to 
maintain nOl1nal myocardial contraction. \Vhen oxygen supply to the heart becomes impaired 
there will be inadequate production of high energy phosphates with a resultant decline in 
myocardial contractility. 'When this condition develops, the myocardium starts to produce 
some, but not sufficient, high energy phosphates by anaerobic glycolysis, and lactate which is 
the end~product of this process stat1s to accumulate in the myocardium. Myocardial ischemia is 
thus viewed as a condition in which an imbalance exists between oxygen~supply and oxygen~ 
demand, leading to anaerobic metabolism and reduced contractile function. Central to the 
definition of ischemia is that coronary flow is not only insufficient to allow adequate energy 
production, but that the impaired flow also results in impaired removal of metabolic waste 
products. In the large majority of cases in man myocardial ischemia is confined to specific 
regions of the myocardium (regional ischemia), because a stenosis in a coronmy at1elY 
prevents adequate perfusion of the artery's distribution area (supply ischemia). In its early stage 
of development, the stenosis can be sufficiently mild so that oxygen supply is adequate under 
resting conditions, but becomes flow~limiting during stress such as exercise. At the moment 
that ischemia develops during exercise, coronary blood flow may be higher than under resting 
conditions, but the increase is not sufficient to meet the increased oxygen demand (demand 
ischemia). The situations that the entire human heart becomes ischemic (global ischemia) are 
relatively rare, but may be seen during severe hypotension and during open~heart surgery when 
aortic~cross clamping is required. 
Ischemia versus hypoxia 
In man at high altitude myocardial oxygen supply may become impaired, not because of 
a reduced coronalY blood flow but because the oxygen content of the blood is decreased. 
Because coronary blood flow is not restricted, there is no accumulation of myocardial 
metabolic waste products. This condition of reduced oxygen delivCly in the presence of 
unrestricted coronary inflow, has been termed hypoxia (or anoxia when no oxygen is present). 
Important in the interpretation of the data from ischemia and hypoxia studies is that in the 
latter there is adequate removal of metabolic waste products. 
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Ischemia versus infarction 
Myocardial ischemia does not only lead to changes in (global and regional) 
cardiovascular function and metabolism, but also to changes in homeostasis of electrolytes, 
neurohOlmones and ulhoastmctural feahlres of the myocardium. These changes can be seen 
within the first few minutes of ischemia and are reversible ,vhen perfusion is promptly 
restored. However, when ischemia is maintained there is a gradual transition from reversible to 
in-eversible injury as infarction develops. The distinction between ischemia and infarction thus 
concems the reversibility of the changes. 
In this overview we will discuss some of the most frequently used animal models in the 
shldy of myocardial ischemia (and hypoxia) and ischemic syndromes, which are the 
consequence of prior ischemia. 
:Myocal'dial ischemia 
Regional ischemia 
Experimental animal 
In man, myocardial ischemia is most commonly regional in nature and this condition has 
been widely studied in intact animals. In ill vivo studies the dog has traditionally been the most 
fioequently used animal species, but because of cost and social pressure against the use of dogs, 
the pigs has become a more favoured animal only-in recent years.3,4 This is surprising because 
Leonardo da Vinci already used pigs to demonstrate the movement of the heart during the 
cardiac cycle nearly five cenhlries agoo5 However, the pig did not become a widely used 
animal in biomedical research because of problems with handling of the animal. For instance, 
Pavlov banned all pigs from the laboratory as he considered all pigs to be hysterical because of 
their shrieking.4 In most shldies young and thus growing domestic swine are used and the age-
dependency of cardiovascular responses should therefore be kept in mind. The age of domestic 
pigs in acute studies usually ranges from 3 to 5 months, which is sufficiently old_ for 
mahuation of central nervous system regulation of cardiovascular functiollo6,7 An interesting 
feature is the relation between heart and body weight. In man this ratio is about 5 glkg, 
whereas it is twice as high in dogs. For pigs weighing between 25 and 30 kg the ratio is similar 
to that in man, but for animals exceeding 100 kg it is only half that value. The relative low 
heart weight in domestic pigs is probably the result of selective breeding during the last two 
centuries. Nowadays, one year old pigs reach body weights of 150 kg, whereas 200 years ago 
weights of only 40 kg were attained in twice that life span.8 
Smaller animals such as the rabbit and the rat have also been used to study regional 
myocardial ischemia,9 but instnnnentation of ill situ myocardium for measurement of regional 
metabolism and function is limited due to the small size of the heart and coronary vessels. An 
additional problem is that instantaneous reperfusion may not always occur when an occlusion 
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of a coronary artery is released and because quantitative assessment of phasic coronary blood 
flow is difficult, one must rely on visual inspection to verify reperfusion (disappearance of 
cyanosis). Nevertheless, the use of small animals has gained a large popularity in studies of 
ischemic preconditioning,IO,ll studies employing techniques such as microdialysis 12 and 
studies of post-infarction remodeling. 13.14 
Collateral circulatioll 
The early response to ischemia depends to a large extent on the existence of a collateral 
circulation. 15 Especially the group of Schaper has shown that major differences exist in the 
extent of collateralization of the various species. 16-18 Thus, it is important to realize that dogs 
may have a well-developed coronary collateral circulation (which may vary considerably 
among individual animals), while collateral blood flow in pigs and baboons is extremely low 
«5% of transmural blood flow).16.19.21 From the other species used in the study of myocardial 
ischemia, it has been well established that the collateral circulation of the rat is sparse and that 
the rabbit may show intraspecies differences.l 8,22 The guinea pig has such an extensive 
collateral network that normal perfusion is maintained after a coronary artery occlusion and 
infarction does not develop. Cats also have a well-developed collateral network, but this is not 
sufficient to prevent infarction.22,23 
In animals that do not have an extensive native collateral circulation, coronary collaterals 
can be induced by a variety of methods. These include permanent complete coronary artery 
occlusion, brief (2 min) repeated complete coronalY artelY occlusions at regular intervals for a 
number of weeks,24-26 progressive coronary artery occlusion by means of an ameroid 
constrict~r,16,27 partial coronary artery occlusion without or in combination with exercise28-31 
(exercise alone does not promote collateral growth,29,3o or embolization of the 
microvasculahue with non-radioactive microspheres with ~ diameter of 25 Jllll.32 In young 
growing pigs a mild fixed coronary stenosis becomes flow limiting as the animals grow older 
and collaterals develop.28 Bloor et al.33 have shown that in pigs collateral blood flow can 
evenhmlly account for 80% of the needed perfusion at baseline and 50% during exercise. 
It is quite obvious that when a coronaty at1ery is completely occluded in a species with a 
sizeable collateral network, detennination of residual coronary perfusion is mandatOlY to 
appreciate the severity of ischemia. Labeled (radioactiveJ4.35 or colouredJ6.37) microspheres are 
the first choice for measuring collateral blood flow, as this technique permits the detennination 
of both total collateral flow and its transmural distribution. The latter is important because 
from earlier shldies we know that, in p311icuiar, the subendocardial perfusion is a major 
determinant of regional function. 3S For species with a negligible collateral circulation regional 
perfusion data during ischemia are less mandatory. For a description of other methods to 
detelmine collateral blood flow and growth the reader is refelTed to reference 18. 
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Although pigs and baboons differ from dogs in their collateral blood flow, they both 
represent distinct groups of patients with coronaty atiery disease as a large number of these 
patients may have few collaterals during the early phase of their disease. On the other hand, in 
patients with a longstanding history of coronary artelY lesions, collaterals may develop and 
dogs may be a more appropriate model for their condition. 
Experimental conditions 
Because the pathophysiological responses to ischemia and also the response of 
phammcological agents may be influenced by the presence of anesthetic agents39.4' and acute 
surgical trauma,43 chronically instl11mented awake animal models are the first choice to mimic 
myocardial ischemia in man. In addition to the possibility of studying the animals without 
interference of anesthesia and acute surgical trauma, the awake animal model has the major 
advantage that it can be used in studies requiring long-term intelventiOJls or follow-up and 
during physiological stress as produced by exercise. Furthermore, if only used in short-tenn 
shldies, a number of different protocols can be perfonlled in the same animal, provided that 
sufficient time is (can be) taken to prevent interference from previous interventions. The 
elaborate surgery under sterile conditions, the high cost of the implanted transducers and 
probes (which have a limited life span due to chronic implantation), the cost of housing, the 
initial therapy to minimize the unavoidable discomfort related to the recovery from surgery and 
some of the interventions have limited the widespread use of awake animals. 
In the majority of studies, ischemia is therefore produced in anesthetized animals, either 
open- or closed-chest. The open-chest preparation has the advantage that regional function and 
metabolism can be studied in detail. In open-chest animals severe ischemia is almost invariably 
produced by complete occlusion of a coronary m1elY by inflation of a balloon placed around 
the vessel. If one wants to avoid thoracotomy, intracoronary devices have to be used to occlude 
a vessel. The closed-chest model has the advantage that tissue trauma is minimized, but the 
approach requires fluoroscopy for proper positioning of the obstruction. The most frequently 
employed method is inflation of a balloon placed at the tip of a catheter.44 
In order to produce mild or moderate ischemia, the flow in the coronary artery can be 
reduced to a fixed percentage of resting blood flow. In open-chest animals, this can be 
achieved by a hydraulic occluder positioned around the coronary atiery,45 tightening a J-
shaped screw clamp46 or other mechanical devices.47,48 These methods have the disadvantage 
that control of blood flow is difficult and requires continuous measurement of blood flow with 
flow probes or the use of microspheres at intervals. In order to circumvent large variations in 
flow (e.g. by changes in perfusion pressure or movement of the occlusion devices), more 
advanced methods may be used which control perfusion pressure49 or perfuse the coronary 
vascular bed by an extracol1)oreal system using the animal's own blood. 50S 1 Flow reductions 
can also be achieved by intracoronary placement of a hollow plug attached to a catheter.52,53 
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The lumen of a hole, drilled in the length of the plug, provides the limited perfusion when the 
catheter is so far advanced into the coronmy artery that the plug occludes the vessel. All 
advantage of this method is that it can also be used in closed chest animals and that the lumen 
of the catheter allows post-stenotic pressure measurements. A disadvantage is the risk that the 
lumen of the plug may become obstructed due to fonnation of blood clots, unless precautions 
are taken. Fm1hermore, the site of the obstI1lction in the artery cannot be determined in 
advance, which may lead to considerable variations in the size of the ischemic areas between 
individual animals. 
A disadvantage of all above described methods is that they produce concentric stenoses, 
while in man the majority (~70%) of stenoses are eccentric. At the site of obstruction, vessels 
with a fixed concentric constriction do not respond to vasodilators, ,vhile vessels with eccentric 
stenoses are capable to increase their nalTowed lumen, thereby enlarging coronary blood flow. 
There have been a few attempts to employ eccentric stenoses by pm1ial inflation of an 
intraluminal balloon. 54 The drawback of this approach is that it is velY difficult to keep the 
balloon (eccentric stenosis) in place. Movement of the balloon inside the artelY will cause 
variation in the geometry of the residual lumen and thereby in the severity of the obstI1lction. 
The left anterior descending coronaty artelY is most frequently used to produce regional 
myocardial ischemia, as it permits selective sampling of the regional coronary vein for 
metabolic studies. Nevertheless, left circumflex coronmy artery occlusions have also been 
used.55,56 It is well known that in man and pigs proximal occlusion of the left anterior 
descending coronary artery leads to a greater impaillnent of global left ventricular function 
than occlusion of the left circumflex coronalY 3l1elY, which is believed to be caused by the 
greater area at risk. Hoit and Lew57 have, however, shown that for the same areas at risk the 
compensatory increase in function in the adjacent non-ischemic area is different for the left 
anterior descending coronary artery than for the left circumflex coron31Y artely. This illustrates 
that not only the size of the area at risk, but also its location within the left ventricle determines 
the global functional consequences of ischemia. 
Blood samples collected from the coronary sinus are quite often used for metabolic 
studies. These samples are not only contaminated with blood from adjacent non-ischemic 
myocardium, but in pigs there is also contamination with blood from the left azygous vein, 
which drains into the coronary sinus. As a result of this, oxygen saturation in the coronary 
sinus of pigs may be around 65 to 70%, while in the local coron31Y vein it is usually around 
20% or even less. 58 However, the use of coronmy venous samples for studying metabolism is 
decreasing, because of recent developments in microdialysis, NMR spectroscopy and positron 
emission tomography.59-61 
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III l'ivo models of corOIlUlY arterial thrombosis 
In patients, myocardial ischemia develops quite often after fonllation of a thrombus at the 
site of a stenosis. Models mimicking this process have been developed in the past to study the 
process of thrombus fonnatioll, its prevention by phanllacological agents or the effectiveness 
of thrombolytic agents. These models are not velY useful for the study of well-defined 
ischemia and the evaluation of cardioprotective therapies, because of variation in time to 
occlusive thrombus fonnation and uncontrollable duration and severity of ischemia. These 
models are therefore not dealt with in this overview; for an extensive revie\v of these models 
the reader is referred to reference 62. 
Global ischemia (ill l'itro models) 
The consequences of acute myocardial ischemia can often be studied more easily under 
well-controlled conditions in isolated than in ill situ heart models. Lallgendorff has to be 
credited for being the first to devise a method to investigate the mechanical activity of an 
isolated heart.63 The principle has been described extensively64 and is based on forcing blood 
or an oxygenated fluid into the coronary arteries through a cannula implanted in the aorta. 
Initially, Langendorff used the model to study contractile function, but already before the tum 
of the century he reported on the relationship between phasic coronary blood flow and the 
rhythmic contraction of the heatt.65 Already very early, it was noted that coronary flow was 
considerably higher in hearts perfused with saline-like substances, than in hearts perfused with 
blood at the identical perfusion pressure; the reason being the higher viscosity of blood and 
consequently the higher coronal), vascular resistance. The original Langendorff preparation 
underwent many modifications, which penuitted studies under well-controlled conditions such 
as constant perfusion, perfusion at constant perfusion pressure or perfusion via a donor 
animal.66,67 
A critical point in setting lip the model remains the time interval between removing the 
heart from the animal and fixation in the perfusion system, as A TP and creatine phosphate start 
to decline within seconds after the heart is removed from the animal. After coronary perfusion 
with oxygenated blood has been re-established, a stabilization period of at least 15 to 30 
minutes must be allowed before baseline va,lues can be taken. The stability ofthe preparation is 
usually assessed from heart rate, left ventricular pressure and coronary blood flow (weaning of 
the reactive hyperemia after the period of ischemia). Since ill vivo experiments have revealed 
that brief periods of ischemia may already lead to ischemic syndromes such as stUlllling and 
preconditioning and as these phenomena are also studied in isolated heatt models, one must be 
aware that the period between removing the heart from the animal and ~he re-establishment of 
coronary perfusion and also the duration of the stabilization period could influence the 
outcome of such studies. 
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In comparison with the in vivo models, the perfusion pressures of the isolated hearts are 
lower. In in vivo experiments diastolic pressures are usually in the range of 70 to 85 mmHg. 
\Vhen saline-like solutions are used, such high pressures cannot be used in isolated hearts 
because tissue oedema will develop due to the lower coronary vascular resistance (leading to 
higher intracapillal), filtration pressures), in conjunction with the low colloid osmotic pressure 
of these solutions. The use of whole blood could circumvent these problems initially, but will 
lead to complications caused by foaming, clotting, hemolysis and thereby considerably 
shor1ens the period during which the preparation remains stable. Most investigators have 
therefore added substances to their perfusion medium, which increase the osmotic pressure or 
increase tissue pressure, by immersing the heart in an organ bath filled with perfusion medium. 
Interstitial oedema contributes to non-unifonn perfusion when perfusion is restored after 
ischemia, which is a limitation when recovery of post-ischemic fimction or ischemic 
preconditioning is studied. Microvascular compression does not only result from interstitial 
oedema hut may also result from the development of myocardial contracture.68,69 The ensuing 
vascular deformati0n can pat1ially be prevented by placing a fluid-filled balloon inside the left 
ventricular cavity.10 
The isolated heart model is well suited to study the effects of acute myocardial ischemia 
or hypoxia.7I Different degrees of ischemia can be produced by completely stopping or 
partially restricting perfusion, while different degrees of hypoxia can be produced by removing 
oxygen completely or pat1ially from the perfilsion medium. An advantage of the isolated heatt 
model is that one can Shldy in a very simple manner whether the consequences of ischemia are 
due to either lack of oxygen supply or accumulation of metabolites resulting from anaerobic 
metabolism.72 Depending on the hypothesis that is investigated it may either be an advantage 
or a disadvantage that the influence of the hemodynamic and neurohumoral factors, which are 
present in the intact animal, are eliminated. However, caution must be exerted when 
intelpreting the effects of phannacological interventions on acute 'ischemia. In such shldies 
quite often concentrations of phannacoiogical agents are used that are not tolerated by the 
intact animal. For instance, it has been concluded from isolated head studies that 
dihydropyridine derivatives protect the myocardium by a negative inotropic action,?3 while ill 
vivo experiments clearly demonstrate that the doses used in the isolated heat1 shldies cannot be 
used in the intact animal because of severe hypotension secondary to their vasodilator 
actions.?4 
The Langendorff preparation does not permit the left ventricle to eject the perfusate 
(cardiac output) and is therefore a non-working model. Some 30 years ago Neely et aJ.75 
developed a work performing isolated head model, which was capable of ejecting perfilsate. In 
order to do so, the perfusate is now supplied by a cannula inserted into the left atriulll and left 
ventricular outflow can be monitored, while left atrial pressure or aortic pressure can be 
controlled. The advantage of the working heart model is that it allows the constmction of 
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cardiac function curves using Windkessel like models under a wide variety of conditions such 
as during the post-ischemic recovery period. 
Although functional shldies can be perfonned in isolated hemi models, they are 
particularly useful for the study of metabolic pathways because the content of the substrates in 
the perfusion solution (usually Krebs-Henseleit bicarbonate buffer) can be altered, while the 
metabolic products can be detennined in the effluent. Finally, at the end of the experiment 
myocardial tissue is easily accessible for biochemical and histological analysis. Rat and rabbit 
healts are most frequently used in isolated heart studies, but the use of hearts from larger 
animals such as pigs is not uncommon.76 
In addition to using the whole heart, some models have employed only the 
intraventricular sephun.77 For a review of this and other simple models the reader is referred to 
reference 2. 
Finally, although isolated heart studies can provide useful information about the events 
that occurs during ischemia and early reperfusion, it should never be forgotten that 
extrapolation of the results to what is achml1y happening in regional ischemia in man should 
occur with extreme care. For instance, the perfusion medium of the isolated hearts lacks blood 
components such as leukocytes, which have been implicated in the development of myocardial 
injury associated with ischemia and reperfusion. Furthermore, with global ischemia one 
eliminates the interaction between the myocytes of different regions of the heart, which may 
have an impact on the ultimate function of regionally ischemic myocardium.78 
Isolated cal'diac lIlyocytes 
During the last 25 years isolated myocytes have emerged as a new experimental model 
and their applications are still evolving. Among them are shldies under anoxic or ischemic 
conditions, but routinely isolated myocytes are most frequently used in electrophysiological 
and biochemical experiments. Because the cells are free from surrounding tissue, all changes 
can be attributed to processes occurring within the cell. Cardiac myocytes are available as 
either cultured embryonic or adult cells or freshly isolated adults cells. Details of the differeut 
types and isolation procedures have been described extensively (see 79). An important 
detenninant of the quality of the preparation is the oxygen consumption, which must match 
that of the intact quiescent heart. 80.81 Contraction of the myocytes can be assessed by optical 
(e.g. laser diffraction, photodiode array edge detectors, and direct visual imaging) or 
mechanical detectors.82·84 Critical for all studies is the viability and stability of the preparation. 
It is therefore mandatory to detennine that the percentages of viable cells at the beginning and 
at the end of the Shldy do not differ when interventions are perfonned that do not produce 
irreversible injury. Membrane damage can be evaluated by release of cytoplasmic enzymes 
.such as lactate dehydrogenase and creatine phosphokinase.85 Another reason for concem is that 
functional changes may occur during the isolation procedures. For instance, Linden et al. 86 
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have shown that exposing myocytes to catecholamines leads to down-regulation of the number 
of receptors within minutes. 
Ischemic syndromes 
Stullnillg 
In 1975 Heyndrickx et alP repOlted that recovery of regional contractile function after a 
IO-minute coronary artery occlusion in conscious dogs was not immediate but took hours to 
days. In contrast, the electrocardiogram normalized almost instantaneously. This delayed 
recovelY of post-ischemic function, which initially received little attention and was even 
considered to be an experimental artefact,88 was later tenned stunning89 and the search for its 
mechanism has greatly contributed to our current knowledge of events occurring during 
ischemia and reperfusion. By definition, function of stunned myocardium ultimately recovers 
without intelvention. Shu1I1ing is therefore only clinically relevant for those patients in which 
global left ventricular function is already compromised through other cardiovascular 
conditions such as previous infarction. 
Because myocardial stunning is the consequence of a period of reversible ischemia, it 
follO\vs that every model that is used for the study of brief ischemia cmi serve as a model for 
stunning by merely showing that contractile function will recover when the period of 
reperfusion is extended sufficiently. 
III vivo models 
Shldies in chronically instrumented awake animals (dogs, pigs or baboons) arc most 
suitable for the study ofstullning, as the time course ofrecovelY of the post-ischemic function 
can be followed for periods up to weeks or months in the absence of complicating factors such 
as anesthesia, 8I1ificial ventilation and variations in temperature (see 90). Because the degree of 
sh111ning is detennined in part by the ischemic burden i.e. duration and severity of the flow 
(02) deficit,91,92 determination of residual perfusion during ischemia is mandatory in animal 
species with an extensive coronary collateral circulation such as the dog. Without collateral 
flow data, the effect of an intelvention on myocardial stunning cannot be properly interpreted. 
An additional advantage of the conscious animal model is that it can serve as its own control, 
provided that sufficient long periods are allowed between two successive stunning protocols. 
However, before pharmacological interventions are evaluated in such models, it is mandatOlY 
to establish that the successive occlusions produce the same degree of stunning. \Vith respect 
to this, one has to keep in mind that Shen and Vatner93 recently reported significant species 
differences for the same experimental protocols. Thus, while in pigs the degree of shllming 
was the same after two consecutive occlusions separated by 24 hours, it was less after the 
second occlusion in dogs, an obsetvation which might be related to recmitment of collateral 
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flow in the latter species. Because of cost and complexity of the awake animal models, most 
investigators use (open or closed chest) anesthetized animals, thereby accepting that full 
recovery of function cannot be achieved in the limited time span that is available. An important 
difference between the awake and anesthetized models involves the degree of stunning and the 
time course of recovery.42,91 Thus, when the same experimental protocols are used, post-
ischemic dysfunction is more severe in pentobarbital anesthetized dogs than in awake dogs,42 
to which the less significant production of oxygen derived free radicals in awake animals may 
contribute. An explanation might be that pentobarbital anesthesia, in part via altering 
hemodynamic conditions, results in higher oxygen demand at the onset of ischemia and thus 
increases the total ischemic burden.42 The effect of anesthesia on myocardial oxygen demand 
and its importance for the degree of stunning is supported by canine studies in which 
halothane94 and isoflurane95 anesthesia, were compared to fentanyl94 and mOlphine/(a-
chloralose/urethane anesthesia.95 Volatile anesthesia was found to result in better recovery of 
contractile function following a IS-minute coronary artelY occlusion. Another variable that 
influences functional recovery of stunned myocardium is temperature.42 Consequently, a 
rigorous control of body temperature is mandatory when studying myocardial stunning. Open-
chest animal preparations are more susceptible to temperature variations than closed chest 
animals. 
Most investigators have used a single coronalY artelY occlusion, which produces 
stunning, provided that its duration is sufficiently long,96 but multiple occlusions have also 
been used. Of interest is that when a large number of occlusions is used there is a progressive 
loss in the relation between the degree of shmning and residual perfusion during ischemiaJ97 a 
relation which is prominently present when a single lS-l11inute coronmy occlusion is used. 91 
Furthennore, partial coronary ariel)' occlusions of sufficient duration,98,99 or in the presence of 
exercise-induced ischemia lOO also produce shmning. Finally, rapid ventricular pacing for 24 to 
48 hours leads to post-pacing dysfunction which has all the characteristics of global 
myocardial stunning,IOI,I02 although pacing did not lead to demonstrable ischemia, Global 
stunning can also be produced by cardioplegia and sequential regional ischemia. To this endJ 
Heyndrickx et al.l03 applied one hour flow reductions of the left circumflex coronary artelY 
and the left anterior descending coronary artelY at 30 minute intervals. 
RecovelY of post-ischemic contractile function is sometimes also examined in models 
which employ periods of ischemia that are sufficiently long to produce a mixture of both 
reversible and hTeversible myocardial injury.t04+106 In these studies regional post-ischemic 
function will not retum to pre-ischemia values and functional data obtained during the first 
hours of reperfusion period do not reflect recovelY of shmned myocardium and are therefore 
difficult to interpret. 
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Isolated perfilsed hearts 
Even more so than the il1 situ anesthetized animal model, the isolated perfused heali 
model is limited by the relatively shOit period in which recovery of post-ischemic function can 
be studied. Because full recovelY of post-ischemic function is rarely observed in isolated heart 
studies, one must include other pertinent features of shmning such as absence of irreversible 
injmy, response to inotropic stimulation and the rebound in creatine phosphate to supranonnal 
levels 107, 108 to assure that one is dealing with models of pure shmning. With respect to this, it 
should be noted that durations of ischemia that do not result in myocardial necrosis under ill 
vivo conditions, may already produce irreversible damage in isolated perfused hemis. For 
instance, Borgers et a1. 109 observed that even a IS-minute period of global ischemia in isolated 
rabbit hearts ilTeversibly damaged a significant number of myocytes. 
In isolated he3lts, stunning has been produced by single or repeated brief periods of total 
global ischemia, by transient occlusion of a coronary mielY producing regional ischemia,11O 
and by pacing-induced tachycardia in the presence of a lowered coronary perfusion pressure 
thereby producing global demand ischemia. III In addition to hemis of rats, also hearts of 
rabbits, 109,112 ferrets I 13 and pigs76 have been used in isolated heart models to study shulIling. 
Limitations oifimctional parameters 
Understanding the limitations of the parameters that are used to describe contractile 
function is essential for proper assessment of the degree of stunning. Because ill vitro studies 
usually employ models of global myocardial ischemia, global cardiac function parameters such 
as left ventricular developed pressure (isovolumically beating hearts) and cardiac output 
(working hearts) are used to assess the degree of stunning. In ill vivo experiments regional 
sh1Tming is most commonly assessed by measurement of local contractile function, such as 
regional segment shortening or wall thickening. These parameters depend on pre- and 
afterload, which may be different from baseline during the post-ischemic period. In addition, 
the afler1oad~dependency is more pronounced in stullned compared to normal myocardium,114 
so that when the effect of an intervention on stunning is investigated, functional measurements 
should be made under identical or at least very similar loading conditions. One approach to 
COlTect for decreased afterload in ill vivo preparations is by partially clamping the aorta or by 
inflation of a balloon positioned in the aorta. Altemativeiy, changes in left ventricular pressure 
can be included in the assessment of contractile perfonnance by using parallleter~ derived from 
the left ventricular pressure-volume (time varying e1astance concept) or left ventricular 
pressure-segment length (or wall thickness) relations such as extemal work and end systolic 
elastance.114.116 
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Ischemic precollditiolling 
In 1985 Muny et al.l17 described that in nonllal dog myocardium the development of 
irreversible damage was delayed when a sustained coronaty at1ety occlusion was preceded by 
brief periods of reversible myocardial ischemia, a phenomenon which was tenned ischemic 
preconditioning. To date ischemic preconditioning is the most potent endogenous mechanism 
by which infarct size can be limited. Since the original description by Murry et a1.,117 
numerous shldies have been undertaken to elucidate the mechanism of ischemic 
preconditioning and to investigate whether the protection by ischemic preconditioning also 
applies to other endpoints than infarct size (e.g. arrhythmias and recovClY of function 
following reversible ischemia) and to demonstrate its existence and relevance in the clinical 
setting. 118,119 When infarct is taken as endpoint, the clinical importance of ischemic 
preconditioning has yet to be convincingly demonstrated. The lack of the definite proof for the 
OCCUlTence of ischemic preconditioning in man arises from the fact that in patients the accurate 
assessment of determinants of infarct size such as the area at risk, the residual (collateral) 
blood flow, the duration and completeness of the infarct producing coronary at1ery occlusion, 
and also the characteristics of the preceding ischemia that serves as preconditioning-stimulus, 
are extremely difficult. 120 Furthennore, patients have usually pre-existing lesions and a long 
histOlY of angina pectoris before infarction develops, which gives rise to further caution in 
extrapolating data obtained in nonnal animal hearts. Two important but unanswered questions 
regarding the clinical implication of ischemic preconditioning therefore are: 'does reCUlTent 
angina lead to a preconditioned state?' and 'can the as yet incompletely known mechanism of 
preconditioning be mimicked pharmacologically?' Cohen et a1. 121 have shown that awake 
rabbits become tolerant to multiple episodes of ischemic preconditioning. \Vith respect to this 
it is imp011ant to investigate if tolerance develops when pharmacological agents, that mimic 
ischemic preconditioning, are administered chronically. 
The choice of the experimental animal does not appear to matter because positive results 
have been obtained in each species investigated in which infarct size was chosen as endpoint. 
These species now include dogsll7, pigsl22, sheepl23, rabbits l !, rats lO, mannots124 and 
felTets,125 There is some evidence that the mechanism underlying ischemic preconditioning 
may not be the same in all species. 126 For instance, the role of activation of protein kinase C is 
still a velY much debated issne. 127,128 Similar controversies exist about the activation of ATP 
sensitive K+ channels and adenosine. However, such data should not playa decisive role in the 
choice of the experimental species as long as it has not been established whether such a 
mechanism could be operative in man. 
At variance with infarct size limitation, shldies using other endpoints such as ventricular 
atThythmias 01' attenuation of shmning have yielded less uniform results. Protection by 
ischemic preconditioning against alThythmias has conclusively been rep0l1ed in studies using 
rats, but its protective effect in large animals is controversial. 129,130 It also appears that in the 
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same species, the stimuli required to precondition tile heart against necrosis and arrhythmias 
may be different.!31 Presently, it is unclear if these different results are due to differences in 
species or to differences in experimental protocols. The age of the animal might need attention 
as Tani et al. 132 reported that in middle aged rats (50 weeks) the beneficial effects of ischemic 
preconditioning against reperfusion ventricular fibrillation and the rate of sarcoplasmic 
reticular Ca" uptake were reversed compared to young rats (12 weeks). Although it has been 
well established that senescent animals (and also patients) are more vulnerable to the 
consequences of ischemia than young animals, it should be taken into account that the 
observations by Tani et al.132 were made- in isolated healis, while using an endpoint of 
ischemic preconditioning that is still controversial. Attenuation of stunning by ischemic 
preconditioning is also still controversial. It now appears that classical preconditioning does 
not protect against stunning, but that tbe second window of protection, which occurs 24 to 72 
hours after the preconditioning stimulus has been applied, offers protection in large animals. 133 
Principally, all models used in the study of myocardial ischemia are suited to study 
ischemic preconditioning. In order to mimic the clinical situation as closely as possible awake 
animals are preferred, but producing myocardial infarction in animals without anesthesia meets 
almost insurmountable resistance from many ethical committees on animal experimentation. 
As a matter of fact there are only very few studies in awake animals in which ischemic 
preconditioning with infarct size as endpoint has been investigated. 121 ,133 
In ill vivo studies, a wide variety of anesthesia regimens have been used, quite often 
depending on the species. Because the precise mechanism of ischemic preconditioning is 
unknown, one should carefully describe the agents used to anesthetize animals as anesthetic 
agents may affect the magnitude of protection. This is suppOl1ed by studies of Haessler et a!. 134 
who showed that using identical experimental protocols, protection in pentobarbital 
anesthetized rabbits was significantly greater than in isoflurane- Of ketamine/xylazine-
anesthetized rabbits, which was not caused by differences in area at risk, temperature, heati 
rate or arterial blood pressure. Infarct sizes of the control groups were reported to be similar, 
but there was a clear tendency for the isoflurane-treated animals to have smaller infarcts, an 
observation, which has later been finnly established by Cope et al.135 A single 5-minute 
coronary artery occlusion, which was an effective preconditioning stimulus in pentobarbital 
anaesthetized dogs without premedication of the opioid analgesic butoll)hanol,136,137 was not 
sufficient to protect the myocardium after premedication of dogs with butorphanol,138 the 
threshold for preconditioning was increased as two episodes of 5-minute occlusions were 
required to provide an effective preconditioning stimulus. 
Ytrehus et al.139 have reported that infarct size development and the protection by 
ischemic preconditioning are velY similar for ill situ and isolated Krebs-Henseleit bicarbonate 
buffer-perfused rabbit heart. Downey and Yellon!40 have pointed out that this observation 
strongly supports the use of the isolated heart models, because in these models the 
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pharmacology of preconditioning can be better studied as administration of drugs can be 
prccisely controlled and dmgs that are not tolerated when administered systemically can be 
administered directly to the heart. However, of the rat heart, which is also used in ill situ 
experiments and isolated heart preparations, it is unknown whether the degree of protection is 
similar in these two models. 141 Isolated cardiomyocytes 142,143 also eliminate the interaction 
with non-cardiac tissue. The major attraction of this model is that it is very inexpensive and 
therefore pennits studies using agents and techniques, which cannot be afforded otherwise. 
However, the lack of innervation and extracardiac factors in isolated hearts and myocytes 
may be a shortcoming as evidence is now accumulating that brief supply or demand ischemia 
in other organs (kidney, small intestine and skeletal muscle) is capable of delaying myocardial 
infarct development produced by a coronary artery occlusioll. 144,145 Therefore, it appears that 
to fuBy appreciate the processes by which the myocardium can be protected, the intact animal 
is the most appropriate model. 
Experimental design 
The experimental protocol of an ischemic preconditioning stndy consists of five distinct 
phases (i) stabilization period after snrgelY, (ii) the preconditioning stimulus, (iii) a period of 
intemlittent reperfusion, (iv) a prolonged period of test ischemia during which in£1rctioll 
develops and (v) a period of reperfusion at the cnd of which the effect of the preconditioning 
stimulus 011 infarct size is assessed. Each of these phases require some conunent; 
(i) Sandhu et al. 146 observed in anesthetized rabbits that a single 5-minute coronmy miery 
occlusion limited infarct size development during a subsequent 30-minute occlusion when the 
preconditioning stimulus was given shortly (5 minutes) ailer the surgical procedures were 
completed, but was ineffective when the stabilization period was extended to 30 minutes. The 
reason for this observation is unknown but the authors speculated that the stress associated 
with surgery may have resulted in systemic release of catecholamines, a possible mechanism 
involved in ischemic preconditioning.'47 This observation may be impOliant for the design of 
experimental protocols, in which different groups of animals are studied (for instance 
comparison of the protective effect of a single versus multiple brief occlusions). Some 
investigators avoid differences in the duration of the experimental protocol by adjusting the 
duration of the stabilization period. But they should thus be aware that this could blur their 
data. 
(ii) In the vast majority of studies, the preconditioning stimulus consists of one or 
multiple brief periods of ischemia produced by abmpt occlusion and reperfusion of a coronary 
artely.132 The preconditioning stimulus should produce no or only negligible necrosis. 
Depending on the severity of the flow reduction, partial coronmy artery occlusions, alone l48 or 
in the prcsence of atrial pacing in order to produce demand ischemia,149 can be used to 
precondition the myocardium. 
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(iii) Intermittent reperfusion between the preconditioning stimulus and the period of test 
ischemia is required when complete occlusions are used to precondition the myocardium, but 
may not be necessary when a partial occlusion is used to either precondition the 
myocarditu1l 150,151 or during the test period of ischemia. 152 The duration of the intennittent 
reperfusion period is an imp0l1ant determinant for the outcome of preconditioning studies as, 
depending on the species, protection is lost after a few hours (classic preconditioning or first 
window of protection). However, in some species protection reappears after 24-48 hours 
(second window of protection), illustrating that ischemic preconditioning is, at least in some 
species, a biphasie phenomenon. 153,154 
(iv) As far as the duration of the infarct producing sustained coronary artelY occlusion is 
concemed, one should take into account that infarct size development is different in the various 
species. 155 Ischemic preconditioning has been shown in animals with l17 and without l22 a 
collateral circulation, implying that the extent of the collateral circulation is not cmcial for the 
occurrence of ischemic preconditioning. However, collateral blood flow is a major detenllinant 
of in£1l'ct size and in order to obtain a proper assessment of infarct size collateral blood flow 
should always be determined in species with a collateral circulation. Body temperahlre is 
another important detenllinant of infarct size development with the magnihlde of the effect 
depending on the duration of the coronary artery occlusion.156-158 The need for rigorous control 
of temperature also follows from the observation that protection by ischemic preconditioning is 
extended to longer occlusion durations when the experiments are perfonned at lower body 
temperahlre. 159 
Abmpt and complete reperfusion after the sustained occlusion has been a feahlre of all 
preconditioning studies except in the study by Kapadia et al. 160 The latter studied ischemic 
preconditioning in closed chest pigs by subjecting them to instlllmentation with a percutaneous 
transluminal angioplasty catheter on which an 311ificial stenosis (82% diameter reduction and 
30% flow reduction) was mounted just proximal to the ballo,on. Because the stenosis was left 
in place during the entire experimental protocol, reperfusion was incomplete. Although the 
stenosis was not severe enough to precondition the myocardium by itself, the presence of the 
stenosis did not prevent preconditioning by multiple balloon inflations. The presence of a 
stenosis during reperfusion has yielded conflicting reports on infarct size as no changes l61 ,I62 
as well as increases I63,164 have been rep0l1ed. In trying to explain these differences, one must 
keep in mind that the presence of a stenosis during reperfusion could lead to both persistent 
endocardial ischemia as well as a limitation of the reperfusion~induced damage by preventing 
an excessive burst of oxygen~derived free radicals. Nevel1heless, a nice feahlre of the model by 
Kapadia et a1. 160 is that it resembles a clinical condition (patients with a coronary artery 
stenosis which becomes totally obstmcted by thrombus and is treated with thrombolysis) more 
closely than any of the abmpt total occlusion - total reperfusionl11odels. 
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(v) The vast majority of studies use the ratio of infarcted area (IA) and the area at risk 
(AR) to assess infarct size limitation by ischemic preconditioning. In the further analysis it is 
then assumed that this ratio is independent of the area at risk i.e. the relation between AR and 
IA is proportional. Several groups of investigators have however shown that this is tme for 
rats,165 but not for pigs l51 and rabbits165 i.e. the linear regression line relating infarcted area 
and area at risk has a zero-intercept on the AR-axis. This implies that the mathematical 
description of this relationship is IA~a'AR + b or IA!AR~a + b/AR. Especially for small AR, 
IA! AR depends on AR. Thus unless AR exceeds 20% of the left ventricular mass, IA! AR 
should be used with care, in particular when studies are compared in which the areas at risk 
differ substantially. 
Hibernation 
·While myocardial shmning and ischemic preconditioning were originally laboratory 
observations, the concept of myocardial hi be Illation originates from clinical observations that 
in some patients with coronary artelY disease and chronic left ventricular dysfunction, wall 
function improved after coronary bypass surgely.166 The decreased wall motion before surgery 
was therefore viewed as a chronic adaptive response to a reduced coronary blood flow, with 
the reduction in contractility being reversible upon reinstatement of nonnal myocardial 
perfusion. The clinical importance of hibernation is that viability of myocardium is preserved 
due to restoration of aerobic metabolism, in the presence of a chronic blood flow reduction. 167 
In an earlier issue of this joumal, Hearse' made therefore a distinction between physiological 
and biochemical ischemia. In the latter condition the myocardium is metabolically distressed 
and cell death will evolve when this condition is maintained for a prolonged period of time. 
Hibernating myocardium can therefore be biochemical ischemic for only brief periods, while 
its function is depressed chronically because of subnol111ai flow i.e. the myocardium is 
chronically physiologically ischemic.'67 The most difficult modeling problem in hibemation is 
therefore how to achieve a state of reduced flow (function), which does not cause infarction. 
Hibemation should, by definition, be shtdied in chronic models, which implies the use of 
awake animals in which blood flow in a coronary artClY is chronically and sufficiently reduced 
such that the reduced coronary blood flow leads to a permanent regional dysfunction (which 
can be assessed continuously by sonomicrometry) but not to cell death. Regional metabolism 
should also be monitored continuously in the distribution area of the obstmcted coronary artelY 
and preferentially also in the 110l1nal myocardium to determine the nature of the metabolic 
adaptation. Essential for these models is that the function of the hibernating myocardium must 
recover after blood flow is nOl1nalized. Finally, at the end of the study the post-hibernating 
myocardium should be examined for the absence of cell death. None of the current models 
have met all these requirements, although in several shldies chronically instrumented animals 
(pigs and dogs) have been employed in which regional dysfunction was produced for several 
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days to months by partial narrowing ofa coronary m1ery.52,98,168-171 A further limitation of the 
existing models is that concentric stenoses have been applied, thereby excluding a potential 
role of the local intact endothelium as would have been possible if eccentric stenoses were 
used. Because of the lack of coronary collaterals the use of the pigs appears to be 
advantageous, when the flow restriction in the native coronary artery can be controlled. 
However, Millard et al,28 have shown that coronary collatcrals also develop in pigs with a 
fixed stenosis. 
Based on the results of some studies in manI71,l73 and in animals,I74 some investigators 
have hypothesized that chronic hibernation is nothing else than chronic stunning resulting from 
repetitive stress-induced ischemia, rather than a chronic downregulation of function secondary 
to a decreased coronary blood flow. If tme, flow might be nonnal or almost normal under 
resting conditions and even be increased during exercise-induced ischemia, while function 
should return to normal after a sufficiently long stress-free period. To test this hypothesis 
continuous assessment of regional myocardial function in patients with hibernating 
myocardium is required. If confinned, brief repetitive coronalY artery occlusions in the 
presence and possibly even in the absence of a mild stenosis, could produce hibernation. 
In several studies, hibernation has been produced by partially restricting coronary artery 
flow during periods ranging from only a few hours up to a few days.175-179 In these 'shorHenn 
hibernation modelsl the essential characteristics of chronic hibemation cannot be shldied. The 
usefulness of these short-term models is therefore limited, but they may provide some insight 
into the triggers leading to hibemation. However, for leach short-term hibernation model' it 
should be shown that chronic hibernation develops if the model is used in chronic studies. 
Otherwise the putative triggers identified in the short-tenll hibernation models' cannot be 
related to the development of hibernation. Isolated heart models using sequences of nOMflow 
and low-flow ischemia have also been employed to study metabolic adaptation as a possible 
trigger for hibernation. ISO This model is not only limited by the short time in which it can be 
studied, but has also the disadvantage that it produces global ischemia, and lacks the 
interaction with the other organs (neural reflexes) which may be vital in the development of 
hibemation. For these reasons isolated head models and other less well advanced models such 
as isolated cardiomyocytes appear not to be vmy useful in the Shldy of hibematiol1 at the 
present time. 
Future developments 
Molecular biologists have provided physiologists in recent years with new animal models 
of cardiovascular disease by altering the manm13lian genome through introduction or 
modification of genes. The mouse has become the animal of choice because their genome is 
well characterized, their cost is relatively low and a large series of animals can be obtained in a 
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shOlt period ofbreeding. 181 Assessment of cardiac function in these transgenic mice (e.g. gene-
targeted knock-out) is essential for understanding the functional consequences of the 
manipulation of the genome. Because in the past measurements of cardiovascular function in 
mice have been rare, the possibilities to detennine cardiac function in this species are just 
developing.182 In recent years, however, we have witnessed the development of miniaturized 
Langendorff preparations of isolated (work performing) mouse hearts for measurement of left 
ventricular contractility and relaxation,183,184 ill situ measurements of aortic and left ventricular 
pressure,185.186 the use of microsphere and dilution techniques for the detennination of blood 
flow and volumes,I87 the application of echocardiography for assessment of left ventricular 
dimensions, wall thickness, mass, circumferential fibre shortening and left ventricular wall 
stress-shortening relationships,ISS.190 and the application of Doppler echocardiography to 
obtain tracings from the left ventricular outflow tract for estimating peak blood velocity.l89 
Desai et al.,191 employing techniques, previously used in large animals, have described the 
feasibility of chronic monitoring hemodynamic and metabolic parameters in consciolls mice at 
rest and during exercise. 
The purpose of the aforementioned studies was to improve the ability to examine the 
phenotypic changes after gene targeted manipulations rather than the study of myocardial 
ischemia and ischemic syndromes. These transgenic models will, however, become useful for 
the study of processes involved in myocardial ischemia and ischemic syndromes, once we have 
leamed to apply our knowledge and techniques obtained in large animal studies. 
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CaHsensitization and diastolic function of normal and stunned porcine myocardium 
Ioe Kie Soei, Sandra de Zeeuw, Rob Krams, Dirk J Dtlncke}~ Pieter D Verdouw 
Background: Ca2-1- sensitizers prolong myofibrillar force development ill vitro and might therefore 
aggravate relaxation abnonnalities of stunned myocardium. This is the first in vivo study of 
the effects of the thiadiazinone derivative EMD 60263 «+)-5-(l-(alpha-ethylimino-3,4-
dimethoxybenzyl)-I ,2,3 ,4-tetrahydroquinoline-6-yl)-6-methyl-3,6-dihydro-2H -1,3,4-
thiadiazine-2-on), a Ca"-sensitizing agent with negligible phosphodiesterase III inhibitory 
activity, on diastolic function of regionally stunned myocardium. 
Methods and Results: After producing stulll1ing by two sequences of IO-min coronary artery 
occlusion and 30 min ofreperfusion, anesthetized pigs received either saline (n=7) or 1.5 and 
3.0 mglkg ofEMD 60263 (n~8) or its enantiomer EMD 60264 (n~6), which lacks the CaH _ 
sensitizing properties but shares the bradycardiac action via inhibition ofthe delayed inward 
rectifier K+ current. In stunned myocardium, systolic shortening was reduced to 46±4% of 
baseline (P<0.05) and mean rate of half end-diastolic segment lengthening, an index for 
diastolic function, to 35±4%; systolic shortening and mean rate of half end-diastolic 
lengthening of remote normal myocardium remained unchanged. Saline did not affect these 
parameters in shmned or 110nnal myocardium. Ei\1D 60264 did not affect systolic shortening 
but decreased mean rate of half end-diastolic lengthening in nonnal myocardium to 61±8% 
and in shmned myocardium to 16±5% of baseline. During saline and EMD 60264, nOllnal and 
stunned segments started to lengthen immediately after minimal segment length was reached 
(AT~ 0). Low dose EMD 60263 restored systolic shortening of the stunned region with no 
effect on AT. The high dose increased systolic shortening above baseline and", T to 21 0±30 ms 
in both regions. Consequently, mean rate of half end-diastolic lengthening increased to 
66±11 % in shlllned, while decreasing to 55±3% in nOl1nal myocardium. Aflerelimination of 
bradycardia, .I~.T and hence mean rate of half end-diastolic lengthening recovered in stUlllled 
myocardium, but in 11011nal myocardium the latter remained depressed because 6. T persisted. 
Conclusions: In conclusion, both doses of EMD 60263 improved systolic as well as diastolic 
function of shllllled myocardium. The high dose delayed relaxation of normal myocardium 
without adversely affecting systolic function. (EliI' J Pltol'lI/ocol. 1999;386:55-67) 
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Introduction 
In regionally stunned myocardium both systolic and diastolic function are depressed. I·) 
Since a decreased responsiveness ofthe myofilaments to Ca2+ is one ofthe plausible mechanisms 
underlying stunning3, it is not surprising that the effects of Ca2+ -sensitizing agents on regional 
systolic function of stunned myocardium have been investigated. Indeed, several studies in ill 
viv04,5 and ill vitro6-8 models have shown that this class of dmgs is capable of completely restoring 
systolic function. However, since Ca2+ -sensitizing agents may prolong force development of the 
myofibrils9,IO, there is some concem that an increase in the myofibrillar responsiveness to Ca2+ 
might delay the onset ofleft ventricular relaxation, thereby impairing early left ventricular filling 
and ultimately systolic function. This may be of particular impOliance under conditions in which 
diastolic Ca2+ concentrations are elevated such as heart failure ll and possibly myocardial 
stunningI2,13, although in the latter case this is not a ubiquitous finding. 14-18 Indeed, there are ill 
vitro studies that reported a Ca2+ sensitization-induced impainnent of relaxation in myocardium 
obtained from n0l1naI 19-21 , shmned8 and failing heal1s.21 However, in several studies no adverse 
effects ofCa2+-sensitizingagents on diastolic function of normal myocardium;1l vitro 6.22-24 and ill 
Viv025-27 or shulIlcd myocardium ill vitro6,7 could be demonstrated. ImpOliantIy, the agents used in 
these studies (EMD 53998, EMD 57033, CGP 48506, MCI-154 and levosimendan) do not only 
possess Cal+--sensitizing but also phosphodiesterase III inhibiting properties. to It can therefore not 
be excluded that a potentially adverse effect of increased Ca2+ sensitivity on diastolic function was 
bluuted by the positive lusitropic effect of phosphodiesterase 1II inhibition. 
Currently, there are no ill vivo studies in which the effect ofCaz+ -sensitizing agents without 
phosphodiesterase inhibiting propeliies on diastolic function of regional stullned myocardium has 
been evaluated. In the present study, we therefore assessed the effect of the thiadiazinone 
derivative EMD 60263 «+)-5· (1- (alpha·ethylimino-3,4·dimethoxybenzyl) - 1,2,3,4-
tetrahydroquinoline·6-yl)-6-methyl-3,6·dihydro - 2H-l,3,4 -thiadiazine-2-on), a Ca'+-sensitizing 
agent with negligible phosphodiesterase III inhibiting properties9,1O, on regional left ventricular 
diastolic fimction of shlllned and adjacent nomml myocardium. Since in vih"o experiments suggest 
that the nature ofthe response ofnonnal as well as shmned myocardium may be dose-dependent8 
two doses were chosen, one that is sufficient and one that is in excess of that required to restore 
systolic function.' As an index of regional left ventricular diastolic function the mean rate of half 
end-diastolic lengthening was employed.I.'s Since EMD 60263 produces profound bradycardia' 
that potentially could mask untoward effects on diastolic function, we also studied the actions of 
EMD 60263 after its bradycardic action was abolished by atrial pacing. In addition, we compared 
the actions ofEMD 60263 to those of its (-) enantiomer EMD 60264, a compound that lacks the 
Ca" -sensitizing propCIties ofEMD 60263 but shares its inhibitOlY action on the delayed rectifier 
inward K+ current, that is most likely responsible for the bradycardic action ofEMD 60263. 10 
EMD 60264 shows some weak phosphodiesterase III inhibitory activity with a concentration for 
half maximum inhibition ofthis enzyme (1.4 11M), which is approximately one twentieth ofthat of 
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EMD 60263 (see reference 10). Finally, disturbances in diastolic function are more likely to be 
aggravated and thereby to affect systolic function when the diastolic period is shortened. 
Therefore, we also studied whether adverse effects emerged or were aggravated after heart rate 
was increased above baseline levels in the presence of EMD 60263. 
Methods 
All experiments were perfonned in accordance with the "Guiding Principles in the Care and 
Use of Laboratory Animals" as approved by the Council of the American Physiological Society 
and with prior approval of the Animal Care Committee of the Erasmus University Rotterdam. 
Surgical preparation 
Cross-bred Landrace x Yorkshire pigs of either sex (n=21, 28-30 kg) were sedated with 
ketamine i.m. (20-30 mglkg, Apharmo, Huizen, The Netherlands) and anesthetized with 
pentobarbital i.v. (20 mglkg followed by 5-10 mglkg per hour, Sanofi, Paris, France) before they 
were inhlbated and connected to a respirator for intennittent positive pressure ventilation with a 
mix hIre of oxygen and nitrogen; arterial blood gas values were kept within the nonnal range by 
adjusting respiratory rate and tidal volume. Haemaccel (Behringwerke A.G., Marburg, FRG) was 
administered via an intravenous infusion to maintain fluid balance. A micromanometer-tipped 
catheter (B. Braun Medical B.V., Uden, The Netherlands) was inserted into the left carotid artery 
and advanced into the left ventricular cavity for recording of left ventricular blood pressure and its 
first derivative (L VdP/dt), while a fluid-filled cathetl'r was positioned in the descending aorta for 
monitoring arterial blood pressure.4,29 
After administration of 4 mg pancuronium bromide (Organon Teknika, ass, The 
Netherlands), a midstel1lal thoracotomy was performed and the heart was suspended in a 
pericardial cradle. An electromagnetic flow probe (Skalar, Delft, The Netherlands) was then 
positioned around the ascending aorta for measurement of aortic blood flow (cardiac output) and 
pacing leads were attached to the right atrial appendage and cOlmected to a pacemaker. A proximal 
segment of the left anterior descending coronary artery was dissected free for placement of an 
atraumatic clamp, while the anterior interventricular vein draining the left anterior descending 
coronary artery perfusion territory was cammlated for collection of local coronary venous blood.3o 
One pair of ultrasonic crystals was inserted inside the distribution territory ofthe left anterior 
descending coronary artery and another pair inside the distribution territory of the left circumflex 
coronary artery for measurement of regional myocardial function by sonomicrometry (Triton 
Tecllllology Inc., San Diego, CA, USA). Crystals were positioned in the midmyocardiallayer 
approximately 10 nun apart and parallel to fibre direction. 
Experimental protocol and groups 
Baseline values of systemic hemodynamics and regional myocardial function were recorded 
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after hemodynamic variables had been stable for at least 30 min following completion of 
instnllnentation. After arterial and coronary venous blood, samples were collected for 
detennination of hemoglobin, oxygen saturation and blood gas values, a batch (1-2xI0') of 
radioactive microspheres (15±1 ,.un (S.D.), labeled with either 46SC, 95Nb, IOJRu, 113Sn Of 14ICe 
(NEN Company; Dreieich, FRG), was injected into the left atrium, and a reference blood sample 
was withdrawn at a rate of 10 ml/min for determination of regional myocardial blood flow.29 
Subsequently, the distribution area ofthe left anterior descending coronary artery was stunned by 
two sequences of 10~min occlusion and 30 min ofreperfusion,31 At the end of the second 30~min 
reperfusion period, the animals received either two doses (1.5 and 3.0 mglkg administered 
intravenously over 3 min) ofEMD 60263 (n~8) or EMD 60264 (n~6) or two equivalent volumes 
of the vehicle (3 and 6 ml of saline, n~7), separated by 15 min. Since both EMD 60263 and EMD 
60264 produce bradycardia, measurements after the second dose of these compounds were 
repeated after heart rates were restored to pre-dmg levels observed following stunning (HR,,) and 
additionally after heart rate was raised to 30 beats/min above HR" (HR,,,,,). In the animals that 
received EMD 60264, regional myocardial blood flows were not determined. Furthermore, in 
these animals heart rate could not be raised to H~t+30 due to development of atrio~ventricular 
block during pacing. 
At the end of each experiment, normal and stunned myocardium were identified by a left 
atrial injection of patent blue violet (Sigma, st. Louis, MO, USA) after the left anterior descending 
coronaty artery had been reocc1uded. The animals were then killed with an overdose of 
pentobarbital, the heart excised and the left ventricle handled as described earlier to obtain regional 
myocardial blood flow data.29 
Data analysis 
Myocardial oxygen consumption of the perfusion territory of the left anterior descending 
coronaty artery was calculated as the product of local transmural myocardial blood flow 
(radioactive microsphere data) and the difference in the oxygen contents ofthe arterial and local 
coronalY venous blood, while the area inside the left ventricular pressure~segment length loop was 
taken as an index of extemal work.32,33 Mechanical efficiency \vas defined as the ratio of extemal 
work and myocardial oxygen consumption per beat. The area inside the left ventricular pressure~ 
segment length loop reflects mechanical work but does not have the dimensions of work and 
changes in mechanical efficiency have therefore been expressed as percentage of baseline.4 
Mechanical efficiency data are only presented for the distribution area of the left anterior 
descending coronalY artery, because myocardial oxygen consumption of the adjacent normal 
myocardium could not be calculated as local coronary venous blood was not sampled from that 
area. 
Systolic shortening was computed as 100%. (EDL-ESL)/EDL, in which EDL (end-diastolic 
length) and ESL (end-systolic length) are the segment length at the start and the end of left 
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ventricular ejection, respectively. Post-systolic shortening was calculated as 100% . (ESL-
Lmin)IEDL, in which Lmill is the minimum segment length after closure of the aortic valves. All 
segment length data were nonnalized to an EDL of 10 mm at baseline. Analogous to the studies by 
Tilton et af.28 and Charlat et aU, \ve used as index for early diastolic function the mean rate of 
half-end diastolic lengthening, which was defined as the slope ofthe line drawn from ESL to LlO, 
which is the point midway between ESL and the following EDL «LlO-ESL)/TlO, Fig. I). We also 
detennined the time interval (dT) between Lmill and the onset of segment lengthening (Lmin + 0.1 
mm) and calculated mean rate of half end-diastolic lengthening as the mean rate of segment 
lengthening during the time interval between Lmin + 0.1 mill and L5o• 
All data have been presented as means ± S.B.M .. Statistical significance of the changes 
produced by shll1ning were evaluated by paired t-test. The effects of the administered agents were 
assessed by two-way analysis of variance for repeated measures followed by paired t-test with 
Bonferroni adjustment. Statistical significance was accepted for P<0.05 (two-tailed). 
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Figure 1 Defillition a/the mean rate a/half elld-diastolic lellgthellillg (MRHEDL) during baseline conditions, stullning 
ami after the higher dose 0/ EMD 60263. Notice that at baselille alld during stunning the segment started to lengthen 
immediately after L"". (0) was reached, but tltat the ol/set o/lengthelling was delayed by liT after the higher dose 0/ 
Ei\lD 60263 (see results). liTis tlte lillie illterml in which Ihesegmellt length illcreasedfrolll L,...:. to Lmi• + 0.1 /1Im (0). Lso 
;s the poilltlllidli'ay be/lt.'een ESL and tlte following EDL. MRHEDL (--~) is tlte mean rate a/lengthening betweel/ ESL and 
LSf.> while MRHEDL' f·_·-) is defined as the meall rate o/lengthellillg between L,,:. + 0.1 JlIIII alld L51)- EDL and ESL are 
the end-diastolic and end-systolic lengtlt, respecti\'ely; L,.,;. = mil/imal segmelltlellgth; Tpss = duration a/post-systolic 
shortening; T..<o = the time inten'al betll'een ESL alld L51)-
Drugs 
EMD 60263 and EMD 60264 (E. Merck Darmstadt, Genuany) were dissolved in saline. 
Fresh solutions were prepared on the day of each experiment. 
- 62-
Chapter 3 EMD 60263 and Diastolic jllllCtiOIl 
Results 
Systemic hemodynamics 
At the end of the second occlusion-reperfusion cycle, mean arterial blood pressure (6±3%), 
cardiac output (l5±4%), stroke volume (11±6%), LVdP/dt=< (21±5%) and LVdP/dtm,o (l6±3%) 
had decreased from their respective baseline levels (all P<0.05, IF21), while heart rate, left 
ventricular systolic pressure and left ventricular end-diastolic pressure had remained unchanged 
(Table I). 
Infusion of saline did not produce any changes in global systemic hemodynamic variables of 
the control group, demonstrating the hemodynamic stability ofthe preparation. Increasing heart 
rate to H~ttJO via pacing decreased left ventricular end-diastolic pressure, stroke volume and 
LVdP/dtm,o (all P<0.05), while LVdPidtml< was not affected. Administration of EMD 60264 
produced dose-dependent decreases in mean mierial blood pressure, heart rate, LV dP/dtma~ and 
LVdP/dtmin . A decrease in systemic vascular resistance, most likely secondary to the 
phosphodiesterase III inhibitory activity ofEMD 60264, was responsible for the decrease in mean 
arterial blood pressure, as cardiac output was not altered. The lower dose ofEMD 60264 had no 
effect on stroke volume, but the higher dose produced an increase (2S±8%, P<O.OS), which was a 
direct effect ofthe bradycardia as stroke volume returned to pre-EMD 60264 values afterrestoring 
heart rate to HRst. 
Administration of EMD 60263 lowered heart rate (up to 46±3%), mean arterial blood 
pressure (l2±4%) and cardiac output (10±4%), but increased stroke volume (69±7%) and left 
ventricular end-diastolic pressure (from 10±1 to l4±1 mmHg) (all P<0.05). Despite the 
bradycardia, LVdP/dtmax was maintained but LVdP/dtmin showed a response similar to that 
obselved with EMD 60264. After elevating healt rate to HR"., left ventricular end-diastolic 
pressure, mean arterial blood pressure and stroke volume returned to pre-EMD 60263 values. 
LVdP/dtm,o recovered paltially, while the increase in LVdPldtml, did not reach levels of statistical 
significance. However, it is impOIiant that at cOlTesponding time points and heart rates, EMD 
60264 prodnced decreases in LVdP/dtm". The fhrther increase of heart rate to HR,,,JO resulted in a 
decrease in cardiac output due to a fmiher decrease in stroke volume from 2S±2 to 17±2 ml/min, 
while left ventricular end-diastolic pressure increased from 10±1 to l3±2 mmHg (P<0.05 vs 
saline). LVdPidtma, as well as LVdP/dtm,o did not change. 
A1yocardialoxygen consumptioll per beat and mechanical efficiency 
In stunlled myocardium transmural blood flow was decreased by 23±3% (n~2l) without 
affecting the endo-epi blood flow ratio. In the saline-treated animals no} changes were obselved 
during infusion of saline or after heart rate was increased to H~ttJo' Because the difference in 
atierial and coronary venous oxygen contents remained unchanged, myocardial oxygen 
consumption ofshmned myocardium decreased in parallel with transmural blood flow (Table 2). 
In nOll11al myocardium transmural blood flow and the endo-epi flow ratio were not significantly 
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affected. 
Administration ofEMD 60263 had no effect on myocardial blood flow or the difference in 
arterial and coronary venous oxygen content of stunned myocardium. Consequently, myocardial 
oxygen consumption also remained unchanged. Raising heart rate to ~t+30 had no effect on 
transmural myocardial blood flow, the endo-epi blood flow ratio or arterio-coronary venous 
oxygen content difference. In normal myocardium, the endo-epi blood flow ratio decreased from 
0.97±0.04 to O. 79±0.05 (P<0.05) due to a decrease in subendocardial blood flow, when the pacing 
rate was increased to H-Rtt 30' 
Table 1 Systemic hemodynamics during intravenous infusion of EMD 60263 and its (-) enantiomer EMD 60264 in 
anesthetized ~igs with stunned myocardium. 
Baseline StUlming DJ D, HR. H&l~l:l 
CO (I min·t) 
Saline 2.8±Q.2 2.4±O.P 2.4±O.2 2.4±0.1 2.3±Q.2 2.4±Q.2 
EMD 60264 2.6±Q.2 2.1±Q.2' 1.9±O.! b 1.9±0.2 1.8±Q.2 
EMD 60263 3.0±0.2 2.7±O.2 2.5±Q.2 2.4±O.2lx: 2.5±Q.2 2.2±O.3c 
HIt (beats min·t) 
Saline 107±2 104±7 105±6 102±6 106±4 \ 38±6b 
EMD60264 I08±4 lO9±4 91±3lx: 80±5lx: 108±4 
EMD 60263 I09±5 100±4 73±5lx: 54±5N:d 100±4 130±5b 
LVSP(mmHg) 
Saline 11!±3 I04±4 104±3 108±3 109±5 I04±3 
EMD60264 111±4 102±3 93±4 79±3lx: 74±5b 
EMD60263 113±2 108±3 106±3 I09±4d 103±8 6±6N: 
LVEDP (mmHg) 
Saline 9±1 9±1 9±1 IO±I 8±J 7±l b 
E~m 60264 7±1 6±1 7±J 8±J 7±J 
EMD60263 IO±I IO±! ll±l 14±1lx: IO±I 13±2c 
LVdP/dtll'--'-' (mmHg s·\) 
Saline 2110±190 1660±170' 1670±160 1700±150 1660±140 1790±160 
E~m 60264 2030±240 1560±120' 1470±140 l210±1OO" 1120±1lOb 
EMD 60263 2130±130 1640±120' 1620±J30 1720±130 1870±120 1670±160 
LVdP/dt.r"-,, (mmHg s'!) 
Saline -2120±150 -1780±21O' -1730±150 -1930±300 -2010±300 -2230±260~ 
EMD 60264 -2450±350 -2060±31O' -1240±140lx: -870±70lx: -870±90b 
EMD 60263 -2110±90 -1 740±80' -1140±120lx: _890±1IOlx: -1220±130t..: -1320±160' 
MAP (mmHg) 
Saline 89±3 84±4 83±2 86±2 89±3 87±3 
EMD 60264 92±5 85±3 75±4b 61±4lx: 61±5b 
E~m 60263 91±2 87±3 79±3b 77±3t.:d 84±7 73±6b 
SV (011) 
Saline 27±2 23±J 23±1 24±J 22±J l7±lb 
EMD60264 24±1 19±2 2J±1 24±lb 17±2 
EMD60263 27±! 27±J 34±2lx: 45±3N:d 25±2 17±2be 
SVR (dynes's CIll's) 
Saline 2640±240 2880±160 2800±160 2880±240 3200±400 3040±320 
EMD60264 2960±240 3360±160 3280±240 2640±240b 2880±240 
E~'fD 60263 2560±160 2720±240 2720±240 2720±240 2880±320 2960±320 
Dl and 0 1, 3 ml and 6 ml of saline for control and 1.5 mglkg and 3.0 mglkg for EMO 60264 and EMD 60263, respectively. HR,~ 
pacing at heart rate observed during stunning; HR,j')'l' pacing at 30 beats/min above HR.t. 'P<0.05 Stunning YS Uaseline; bp<O.05 \'s 
Stunning; <changes from Stunning are diOerent (P<O.05) YS changes from Stunning in the Saline group; dchanges from Stunning are 
different (P<0.05) \'s changes from Stunning in the EMD 60264 group; Cehanges from IIRst are dinerent (P<0.05) yschanges from 
HR,j in the Saline group (only for data at HR,ttJ(l)' Data are mean ± S.EJ\L; n""'7 (Saline); n=8 (EMO 60263) 
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External work (per beat) of the left anterior descending coronary aliery perfusion territory 
had decreased by as much as 50% after production of stmming. While infhsion of saline had no 
effect on external work, the latter recovered almost completely during administration of the lower 
dose of EMD 60263 and increased to 130% of baseline (P<0.05 vs baseline) following 
administration of the higher dose. In the left circumflex coronary al1ery perfusion territory, 
extemal work had decreased slightly at the end ofthe second ischemia-reperfusion cycle. Extemal 
work was not affected by the lower dose of EMD 60263, but showed a similar increase as in the 
stunned myocardium during the higher dose. Raising heart rate to HR,t+30 resulted in a significant 
fall of external work of both nOlIDal and stunned myocardium, which was accompanied by a 
smaller decrease in myocardial oxygen consumption pel' beat of stunned myocardium. 
In view of the larger decrease in external work than in myocardial oxygen consumption per 
beat, it follows that mechanical efficiency had decreased (to approximately 60% of baseline) in 
stunned myocardium. This decrease remained unchanged during infusion of saline, but 
administration of EMD 60263 completely restored mechanical efficiency. When heali rate was 
raised to HR,"JO mechanical efficiency tended to decrease (J'o=O.60). 
Segment shortening during systole and post-systole 
At the end of the occlusion-reperfusion sequences, systolic shortening had decreased to 
46±4% of baseline in stmmed myocardium, while systolic shOl1ening of nonllal myocardium 
remained unchanged. Infusion of saline had no effect on systolic shortening of either the stmmed 
or nornlal myocardium, while the increase in heart rate to HR,t+30 resulted in a decrease in systolic 
shortening of stunned myocardium (P<0.05) and tended to decrease systolic shortening ofnornlal 
myocardium. Infusion of EMD 60264 and subsequent restoration of heart rate to HR,t had no 
effect on systolic shortening in either the nonnal or stunned myocardium (Table 3, Figure 2 and 3). 
After infusion of 1.5 mglkg of EMD 60263, systolic shortening of stunned myocardium 
increased from 9±1% to 15±1%, while systolic shortening of the nOlmal myocardium increased 
from 14±1% to 17±l% (both P<0.05). Administration of3.0 mglkg ofEMD 60263 increased 
systolic shOl1ening of both the stunned and nonnal myocardium even fm1her to 24±2% and 
22±1%, respectively (both P<0.05 vs pre-stUlllling baseline). When heart rate was raised to HR", 
systolic shortening decreased to baseline values in both the stunned and nonllalmyocardium and 
to levels below baseline when heart rate was further increased to llR,;t+3o, 
Post-systolic shortening was negligible under baseline conditions, but became apparent 
during coronary artery occlusion (Figure 2) and persisted during reperfusion. Neither infhsion of 
saline nor that ofEMD 60264 affected post-systolic shortening. However, post-systolic shortening 
was markedly attenuated after infusion of the lower dose of EMD 60263 and was completely 
abolished after administration of the higher dose. Atrial pacing had no effect on post-systolic 
shortening in any of the three experimental groups. 
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Table 2 Myocardial perfusion and oxygen consumption of regionally stunned myocardium during intravenous infusion of 
EMD 60263 in anesthetized pigs with stunned myocardium. 
Baseline Stunning D, D, fiR-tHO 
Saline 
LADCA peifltsioll territory 
Transmural flow (mllmin lOOg·l) 156±6 121±1O' 111±1O 123±8 119±7 
EndolEpi 1.14±O.05 1.18±0.08 1.17±O.04 1.19±0.05 1.13±0.11 
il (a02 cont-evO) cont) (ftmol ml·l) 2.85±O.18 2.95±0.11 2.98±O.12 3.04±O.22 3.01±0.25 
MV02 (Jlmollmin 10Og·l) 441±26 353±26' 331±29 362±12 353±7 
MVOn",<l (~lmoIIOOg'\) 4.1±0.3 3.4±O.2 3.2±0.3 3.6±O.2 2.6±O.1 
EWbo<l (mmHglnuu) 90±17 95±20' 100±18 108±23 63±18b 
Mechanical efficiency (%) 100 57±9' 68±l1 60±10 53±13 
LCXCA pelfusion terrUm), 
148±8 146±9 Transmural flow (ml/min lOOg·l) 168±7 160±15 143±15 
Elldo/Epi 1.05±0.05 0.98±O.06 0.94±O.07 0.95±0.06 0.9l±0.04 
EWk>l (mmHglnun) 136±1O 120±14 115±l2 114±14 84±21b 
EMD 60263 
LADCA perfusion territory 
122±8' 118±1O 11O±17 Transmural flow (mVmin IOOg·l) 167±5 ll9±l! 
EndolEpi 1.07±O.09 1.16±0.09' 1. 13±0.09 1.17±O.08 1.07±O.07 
il(a02 cont-cv02 cont) (fllnol ml·l) 2.91±O.18 2.74±0.20 2.97±0.34 2.92±O.18 3.l0±0.22 
MV02 (~tll1oVmin IOOg·l) 484±27 328±19' 334±27 334±12 357±35 
t-.1VOnul (pmoIIOOg-t) 4.5±0.3 3.3±O.2' 4.7±OAt>. 6.4±O.5t>. 2.7±O.3
d 
185±21 84±lI' IS9±1t>. 243±21t>. 89±9d EWbo<l (nmlHglmm) 
100 64±9' 89±8t>. !OO±I4t>. 80±12 Mechanical eft1cicncy (%) 
LCXCA perfusion territory 180±7 164±lO' 138±13 I 29±lOb 116±l7b Transmural flow (mllmin IOOg·l) 
1.08±O.06 0.99±0.05' 0.99±O.04 0.97±0.04 O.79±O.OSb EndolEpi 
16l±16 145±17' 161±12 241±ISt>. 58±8bJ EWbut (mmHg'mm) 
LADCA lef! anterior descending coronary artery; LCXCA-Ieft circumflex coronary artery; D1 and D1 are 3 ml and 6 ml of saline for the 
saline group and 15 mglkg and 3.0 mglkg for the HMD 60263 group. HR,t+Jo""pacing at 30 beatsfmin above the heart rate observed 
during stunning; ).I(a02 cont-cv01 cont)=difference in the O2 contents of the arterial and coronary venolls blood; MV02= regional 
myocardial 01 consumption; EW = extemal work; 'P<0.05 Stunning vs Baseline; bp<0.05 \'s Stunning; <changes from stunning arc 
diflerent (P<0.05) from changes in saline group; dchanges from D2 are diflhent (P<O.OS) V5 changes from D2 in saline group (only for 
data at HR,H>O)' Data are expressed as mean~ S.E.M.; n=7 (Saline); 1l"'8 (EMD 60263) except for the measurements at HR<l.t>O which 
were for 6 and 7 animals, respectively. 
Rate of segment lengthening during diastole 
The sturuling protocol reduced the mean rate of half end-diastolic lengthening in the territory 
perfused by the left anterior descending coronary artery to 35±4% of baseline (n ~ 21), but had no 
effect on the mean rate of half end-diastolic lengthening of the adjacent nonnal myocardium 
(96±7% of baseline). Infusion of saline and the subsequent increase in heart rate to 30 bpm above 
baseline did neither affect the mean rate of half end-diastolic lengthening ofthe stunned nor that of 
the normal myocardium. Administration ofEMD 6~264 caused a dose-dependent decrease in the 
mean rate of half end-diastolic ieng1hening of both the stunned and nonnal myocardium to 16±5% 
and 61±8% of baseline, respectively (both P<0.05 vs stunning). During pacing at HR", mean rate 
of half end-diastolic lengthening remained unchanged in both stunned and normal myocardium 
(Figure 4). 
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Table 3 Ellects ofEMD 60263 and its (-) enantiomer E~ID 60264 on regional systolic shortening in anaesthetized pigs 
with stunned myocardium. 
Baseline Stunning D, D, HR" HR'I+lO 
LADCA perfusion territory 
End-diastolic length (mm) 
Saline 11.O±Q.7 12.O±Q.6' 11.8±O.7b 11.8±O.7 11.4±0.7b 10.9±O.7b 
EMD 60264 9.8±O.9 1O.7±1.l3 1O.8±1.l 1O.7±1.t 1O.4±l.Ib nm 
EMD 60263 12.0±1.2 13.0±1.4' 12.8±1.3 12.6±1.3b 11.7±1.2~ 1O.8±l.lb 
Systolic shortening (%) 
Saline 17±1 8±l" 8±1 9±2 9±2 6±2 
EMD 60264 19±1 8±1' 7±1 6±2 4±3 mn 
EMD 60263 17±1 9±1' 15±)",d 24±2!>:d 17±1h-.....J< 13±1 
Post systolic shortening (%) 
Saline 3.1±0.9 7.2±O.8' 6.2±O.8 5.6±1.I 5.1±O.7" 4.9±0.6b 
EMD60264 1.5±O.6 9.0±1.1' 9.0±1.2 7.3±1.l 7.2±1.4 nm 
EMD60263 1.3±0.4 7.0±0.8' 3.2±O.4!>:d O.5±O.2l>oJ 0.8±0.3lxd 0.3±O.2!>: 
LCXCA perfusion territo1)' 
End-diastolic length (mm) 
Saline 9.9±0.8 10.1±0.7 IO.0±0.7 10.1±0.8 9.5±O.6 9.2±O.6b 
EMD 60264 10.5±0.8 10.3±0.8 10.4±0.8 IO.7±0.8 IO.4±O.8 nm 
EMD60263 1l.4±1.1 11.6±1.2 1l.6±1.2 11.5±1.2 1O.2±O.9b 9.4±1.0bf 
Systolic shortening (%) 
Saline 12±1 11±2 11±2 11±1 1l±2 9±2 
EMD 60264 14±2 13±1 13±1 13±1 12±2 nm 
EMD 60263 14±1 14±\ 17±I!>:d 22±1lxJ t2±1~ 8±lbf 
Post systolic shortening (%) 
Saline 1.5±O.5 2.5±1.0 2.2±O.5 2.2±0.4 2.7±0.4 2.5±O.8 
EMD60264 0.4±O.2 0.6±O.3 O.6±O.3 1.0±0.4 0.4±0.3 nm 
EMD 60263 2.I±O.5 1.5±O.7 O.6±O.4b 0.5±0.3 0.8±O.4 O.6±O.2 
Dj and D2 are 3 Illl and 6 ml of saline for the saline group and 1.5 mglkg and 3.0 mglkg for the EMD 60264 and EMD 60263 groups, 
respectively. HR,,=pacing at heart rate observed during stunning; HR"'H=Pacing at 30 beats.imin above HR,!. ·P<O.OS Stunning vs 
Baseline; bp<O.OS vs Stunning; ~changes from Stunning are different (P<O.OS) vs changes from Stunning in saline group; dchanges from 
Stunning are difterent (P<0.05) \'s changes from Stunning in the EMD 60264 group; <changes from D2 are diftercnt (P<0.05) \'s changes 
from Dl in Saline group; fchanges from HR.! are different (P<O.OS) \"s changes from HR,! in Saline group, llm = not measured. Data are 
expressed as means ± S.E.M.; n=7 (Saline); n= 6 (EMD 60264); n=8 (EI\.m 60263). 
Administration of EMD 60263 caused a dose· dependent increase in the mean rate of half 
end-diastolic lengthening of the stunned myocardium (Figure 4). However, at variance with 
systolic shOliening, recovery of mean rate of half end-diastolic lengthening was only partial (to 
66±11% of baseline; P<O.05 vs baseline). The major reason was that, while under baseline 
conditions the segment started to lengthen immediately after Lmin had been reached (.6.T=O), there 
was a delay ("T~ 21 0±40 ms) in the onset of segment lenglhening during adminislmtion of the 
higher dose ofEMD 60263. Once Ihe segment started to lengthen, the rate oflengthening was not 
different from control. At HR", mean rate of half end· diastolic Icngthening increased to 92±16% 
of baseline predominantly because of a reduction in.6.T to 60±20 ms. The further increase in heart 
mte to HR"+30 did not affect mean rate of half end· diastolic lengthening (93±18% of baseline). In 
contrast to the stunned myocardium, mean rate of half end-diastolic lengthening of the normal 
myocardium decreased dose· dependently to 55±3% of baseline (P<O.05), due to a doubling ofT". 
The latter was again caused by an increase of.6.T to 210±40 ms. Increasing heart rate to ~1+30 
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increased mean rate of half end-diastolic lengthening to 77±ll % as aT decreased to l30±20 ms in 
the nonnal myocardium; this decrease in fiT of the nornial myocardium was, however, 
significantly less than in the stunned myocardium (P<0.05). 
B.ltr,~. St~"n!r'!1 t.S rng ~g_l 3,0 m9,~g , 
('""'fig) JfUtrffffjJUTJMftft '" 
lIoF ILml~'! 
St lAOCA 1m",) 
Sl lCXCA Imm) 
Figure 2 This recordillg of a represelltative e,periment with EMD 60263 sho\I's that systolic shortening already recQ)'ered 
during illjilsiollfhe lower of dose ofEMD 60263 alld that ill both stllllned (LADCA) alld normol (LCXCA) myocardillm/he 
oJ/set of segment lengthening was delayed after admillistration of the higher dose. ECG, electrocardiogram; AoP, aorlic 
pressure; LVP, left ~'elllric/flar pressure; LVdP/dt, left wlltriclIlar dP/dt; AoF, aortic bloodflow; SL, segmellt length, 
LADCA, left allferior descendillg coroJ/ory artery'; LCXCA, left circumflex corOl/ary' artery'. 
Discussion 
The use ofCa2+ -sensitizing agents in the treatment of cardiovascular conditions is still under 
debate. \Vhile there is a general consensus that Ca2+ sensitizers may be superior positive inotropic 
agents compared to beta sympathomimetic dmgs as they can increase force production with no (or 
negligible) increments in energy cost34-36, considerable concern has been expressed that the same 
characteristics could slow relaxation and elevate diastolic tension.8,19-21 Several studies have 
examined the effects of Ca" -sensitizing agents on diastolic function of myocardium (Table 4). 
These studies differ with respect to species, myocardial tissue localization (right vs left ventricle), 
state of tissue (nOlmal or diseased), type of agent used ("pure" Ca2+ sensitizer or mixed Ca2+ 
sensitizer / phosphodiesterase III inhibitor), doses used and the diastolic functional parameter that 
is studied. Studies in isolated intact or skinned muscle fibers obtained from right or left ventricle 
using EMD 53998, its (+) enantiomer EMD 57033, levosimendan, MCI-154 or CGP 48506 have 
yielded equivocal results with either no change or a reduction in the rate of relaxation (Table 4), 
while one study reported that the Ca2+-sensitizing substance caffeine improved relaxation.24 
Moreover. studies in isolated or ill situ hem1s have shown that compounds such as EMD 57033, 
MCI-154 and levosimendan do not exert a negative effect on diastolic function of both normal and 
globally stunned myocardium, while MCI-154 enhanced relaxation in failing humanl7,)' and 
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canine myocardium.26 However, these agents also possess phosphodiesterase III inhibiting 
properties and it has been argued that the beneficial effect of phosphodiesterase III inhibition on 
diastolic function may have counterbalanced any adverse effect ofthe increased Ca2+ sensitivity. 
This argument cannot be dismissed as in none of the aforementioned studies the agents were 
administered in the presence of adrenergic blockade. This is also corroborated by the observation 
that when levosimendan was administered in the presence of the selective bradycardic agent 
zatebradine to prevent the tachycardia by levosimendan, the increase in the maximum rate of fall 
of LV pressure and the decrease in the relaxation time constant tau were no longer observed, 
indicating that the improved relaxation depended entirely on the tachycardia which is a feature of 
phosphodiesterase III inhibition.J9 In a recent study in awake pigs, we observed that EMD 57033 
either in the absence or presence o[Jl-adrenoceptor blockade did not alter LVdP/dtm;, or LV end-
diastolic pressure." Those findings suggest that the lack of effect of EMD 57033 on diastolic 
function is not simply the result of simultaneous myocardial phosphodiesterase 111 inhibition. 
However, to allow the selective study of Ca2+~sensitization on diastolic function in the present 
study we employed EMD 60263, a compound that is devoid of phosphodiesterase III inhibitory 
actions.9,10 
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Figure 3 Systolic shortenillg (SS) al baseline (81.), during SIUllllillg (ST) alld after ill/IISioll 0/2 voillmes o/salille (3 1111 
[SJ alld 61111 (SJ) or 1lI'0 doseso/EMD 60263 (1.5 mg/kg [EJ alld 3.0 mglkg (EJ) or EMD 60264 (J.5I11g/kg [~EJ alld 
3.0 mglkg (~EJ). After administratioll o/the Itigh dose tlte heart rate was illcreased to heart rate at stulIlIillg (HR,J to 
elimillate the effect of bradycardia. *P <0.05 VS baseline,' tp<0.05 l'S stullning; LADCA = left anterior descellding 
coronal)' artery distribution area; LCXCA = left circumflex corol/ary arlery distribution area. 
In the present study, EMD 60263 produced a decrease in LVdP/dtm;, (Le., became less 
negative), suggesting that it slowed the early diastolic relaxation of the left ventricle as a whole. 
However, this decrease was at least in part mediated by the bradycardic effect ofEMD 60263, as it 
was partially restored when the hearts were paced at pre-dl1lg levels. In the EMD 60264 group 
elevating heart rate to pre-dl1lg levels did not increase LVdP/dt",;" furthermore suggesting an 
adverse effect of inhibition of delayed inward rectifier K'current on early relaxation. It must 
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therefore be assumed that the EMD 60263-iuduced decrease iu LVdP/dtmio is at least in part due to 
the effect on the delayed inward rectifier K+ CUlTent. 
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Figure" From top fo boltom are showlI tile effects of EUD 60263 on (LYrES!"). T50> meall rate of half end-diastolic 
lellgthellillg (MRHBDL) and meall rate o/half eud-diastolic lengthel/illg (MRHEDL'l at baseline (BL). during stllllllillg 
(ST) alld after illfllSioll 0/2 roll/mes o/salil/e(3 1111 [SJ alld 6ml [S]) or f1I'o doses ofEMD 60263 (1.5 mglkg [EJ alld 
3.0 mg/kg [E]) or EUD 60264 (1.5 mg/kg [-Ed alld 3.0 mglkg [-E]), Afteradmillisfratioll of the high dose the heart rale 
WaS lilcreased to heart rate at stflll1lillg (HRs) 10 eliminate Ihe ej)ect afbradycardia. Notice (hat 1Ja Ii/eludes TpM (grey 
bars) alld tlT(solid bars) (see Figllre I). ·P<0.05 \'s baseline; tp<0.05 vs stlll/Ilillg; LADCA = left allteriordescelldillg 
corollary' artery' distriblltion area; LCXCA = left circumflex coronm)' artery' distributioll area. 
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As index of uearly" regional diastolic function we used analogous to Tilton et aI.28 and 
Charlat et al.I the mean rate of half end-diastolic lengthening. The latter group of authors I has 
shown that in conscious dogs this index of early diastolic function is as severely depressed as 
systolic function. Moreover, the time course of rate of recovelY during the early hours of 
reperfusion was faster for systolic than for diastolic f\mction, although complete recovery of 
diastolic function preceded that of systolic f\mction. In the present study, the lower dose ofEMD 
60263 resulted in a complete recovery of systolic sholtening, but in only a pattial recovelY of the 
mean rate of half end-diastolic lengthening. With the higher dose of EMD 60263, systolic 
shortening of the post-ischemic myocardium exceeded baseline values, but the mean rate of half 
end-diastolic lengthening remained depressed at 66±ll % of baseline. 
The depressed mean rate of half end-diastolic lengthening associated with the high dose was 
the result of a delay in the onset of segment lengthening (AT # 0), because once the segment started 
to lengthen, the rate oflengthening was not different from baseline. To exclude that the effect of 
EMD 60263 on the delayed inward rectifier K+currentand on heart rate contributed to the increase 
in t!.T, we not only included a group of animals treated with Ei\1D 60264, but we also studied the 
actions ofEMD 60263 after eliminating its bradycardic action by atrial pacing. Since EMD 60264 
did not cause an increase in t!.T, this suggests that the increase int!.T with the higher dose ofEMD 
60263 was not the result of an effect on the delayed inward rectifier K+current. In addition, 
retrospective inspection of diastolic function ofnol1ual and stunned myocardium during infusion 
ofthe selective bradycardic agent zatebradine, which reduced heart rate to 55 bpm4, indicates that 
bradycardia per se can also not explain the delay in the onset ofrelaxation. Interestingly, pacing 
blunted the delay in onset of relaxation, but this effect was more pronounced in the stunned than in 
the nonualmyocardium. 
The EMD 60263-induced increase int!.T is consistent with ill vitro rep0l1s that thiadiazinone 
derivatives prolong the duration of force development by enhancing the crossbridge interaction 
between actin and myosin.9,10 This increase in t!.T may have an adverse effect on global left 
ventricular function, as it could impair left ventricular filling of which the largest fraction nonllally 
occurs during early diastole. Although after the higher dose ofEMD 60263 left ventricular end-
diastolic pressure increased, we failed to observe an impaiIment in left ventricular function as both 
the rate of segment lengthening and the end-diastolic segment length were not affected. 
Fmihennore, systolic fUllction was not impaired as stroke volume even increased to above baseline 
values. In a previous study using the same model, induction of bradycardia to similar heart rates 
with the specific bradycardic agent zatebradine increased left ventricular end-diastolic pressure to 
the same extent without affecting end-diastolic segment length (unpublished data). Similarly, 
zatebradine increased stroke volume although significantly less than EMD 60263.4 These 
observations suggest that left ventricular filling and global systolic left ventricular function were 
not adversely affected by an increase in myofibrillar sensitivity to Cao. during the EMD 60263-
induced bradycardia. 
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Autbors Model Myocardium CaI+ sensitizer Dose Relaxation-para.meteJ Remarks 
White etal. isolated ferret papillary muscle normal EMD57033 0.1·20 "M TlI2t at doses> 1 t.tM 
(1993) stimulated electrically 
Simnett et al. skinned fibers of guinae pig right normal EMD S7033 10 "M H-' 
(1993) ventricle 
Pagel etal. anesthetized dogs normal levosimcndan O.5-4J.lglkg min- l iv LVdP/d'tmin «-)" H ANS blockade 
(1994) awake dogs nonnal levosimendan O.5-4).lglkg min"! iv LVdP/dtmin 'H, 1: <-+ ANS blockade 
Korbmacher et al. isolated rabbit hearts normal EMD57033 30 "M LVdP/dt"". t,LVEDPH L VSP increased 
(1994) stunned EMD 57033 30 "M LVdP/dt"". t, LVEDP<-, LVSP increased 
Pagel etaL awake dogs nonnal levosimendan O.5-4).lglkg min-I iv LVdP/dt"". t" t HR held constant by 
(1995) awake dogs normal levosimendan O.5-4J.lglkg min-! iv LVdP/dtmin H. ,<-+ zatebradine 
Mori et al_ awake humans IHD MCI·l54 1.5Mg/kg+0.12 1:.J-, dV/dtlmru< <-+ 
(1995) ).lg/kg min-! iv 
Korbmacher et al. isolated rabbit hearts stunned EMD 57033 10-30 "M L YEDP «-), dP/dtmin l' 
(1995) LVSPt 
Hgashiyama et aL isolated ejecting rabbit hearts normal EMD57033 5-5.8 "M LVdP/dtmin<-}, Tv'2l'. 
(1995) LVEDPt 
Haika1a et al. paced guinae pig normal levosimendan 0.03·3"M "relaxation time" «-) 
(1995) papillary muscle EMD 53998 O.1-3).lM ''relaxation time"l' 
Hajjar et al. human LV trabeculae normal EMD57033 1-50 MM DFt,Tso%l' effect greater in failing 
(1997) failing than in normal hearts 
Palmer and Keotish rat skinned RV trabeculae nonnal Caffeine 20rnM ,t 
(1997) CGP48506 10 "M 1:<-} 
Takaoka et al. humans IHD MCI·154 1.5-3Mg/kg+ 16.6· PCWPt 
(1997) 33.2 ).lg/min iv 
Korbmacher et al. isolated rabbit hearts normal and EMD 60263 3 "M LVdP/dt"". t Detrimental effects less 
(1997) stunned 10 "M LVdP/dtmin<-+ in stunned than normal 
30 "M LVdP/dt"". t hearts 
T eramura et al. open-chest dogs normal MCI-1S4 lllg!kg min-l iv T1I2 «-) 
(1997) failing MCI·154 Illg/kgmin-! iv TII2 .J-
Stubenitsky et al. awake swine normal EMD57033 O.2-0.8mglkg min-I iv LVdP/dtmin H. Similar response after 
(1997) LVEDP<-} ~·b1ookade 
IHD _ ischemic heart disease: T 112 time to 50% peak tension or peak pressure; T 80";;' - time to 80% pe:lk tension; 1: time const:lnt of tension or pressure decay: L Y(SP) - left ventricular (systolic 
pressure); RV = right ventricular: DF: diastolic force; L YdP/dt",;n '" maximum rate of full ofL Y pressure: PCWP '" pulmonary capillary wedge pressure: ANS '" autonomic nervous system. 
Chapter 3 EMD 60263 aud Diastolic jimctioll 
In the present study restoration of heart rate to pre-drug levels (HR,,) in the presence ofEMD 
60263, decreased systolic shortening in both shmned and nonnal myocardium, while the effects on 
regional diastolic segment dynamics differed between stunned and Honnal myocardium. The 
different response of the delay of relaxation to pacing in stunned and nonnal myocardium was 
unexpected, particularly in view of evidence that pacing can induce an increase in intracellular 
Ca" concentration40,41 during both systole and diastole, which would tend to augment the EMD 
60263-induced diastolic relaxation abnonnalities. On the other hand, Kusuoka et al.42 repOlted that 
pacing increases intracellular inorganic phosphate levels, which could reduce the myofibrillar 
sensitivity to CaZ+. The latter observation may explain why despite an increased diastolic 
intracellular Ca2t concentration pacing improved relaxation in the stunned myocardium (Le., 
reduced the time delay to onset of segment lengthening). The persisting delay in segment 
lengthening in nonnal myocardium during pacing at a time when diastolic function of stunned 
myocardium was normal is supported by ill vitro observations of Korbmacher et al.8 in isolated 
rabbit hearts. This finding suggests that, despite the presencc of EMD 60263, a difference in 
myofibrillar Ca2+ sensitivity remains between stunned and normal myocardium. 
The prolonged development of force could be most detrimental when diastole is shortened, 
i.e., at higher heart rates. Thus, to study the physiological significance of the observed delay in 
diastolic lengthening, we paced the hearts at 30 beats/min above stu1llling level (HR".30)' Pacing at 
HRsttJo decreased the duration of diastole to below baseline value which in the saline-treated group 
decreased end-diastolic segment length and systolic shortening of both stunned and nonnal 
myocardium. The delay in diastolic lengthening produced by EMD 60263 further shOltened the 
period of diastolic lengthening and resulted in a decrease in end-diastolic length of both stunned 
and nOlmal myocardium and an impainnent of systolic shortening. However, only the changes in 
nonnal myocardium and not in stUlllled myocardium of the EMD 60263 treated group were 
statistically significant compared to the changes in the saline-treated group. This finding suggests 
that diastolic function ofnonnal myocardium is more susceptible to increases in myofibrillar Ca2t 
sensitivity than that of stunned myocardium, which is supported by observations in normal and 
post-ischemic isolated rabbit hearts.s 
Another important point to consider in the assessment of the effect of Ca2+ -sensitizers on 
diastolic function is the dose required to normalize systolic function relative to the dose at which 
Ca2t -sensitizers exert a negative effect on diastolic function. In the present study the higher dose 
(3.0 mglkg, iv) is in excess of that needed to restore systolic shortening of stunned myocardium.4 
Indeed, in the present study, 1.5 mglkg already nonualized systolic segment shortening but had no 
adverse effect on the onset of relaxation. Similarly, previous shldies have also indicated that the 
impairment of diastolic function by Ca'+-sensitizers is likely a dose-related fluding. Thus, Hajjar et 
al.21 reported that EMD 57033 exelted its negative lusitropic effects in nomlal human myocardium 
at doses higher than 10 11M. Korbmacher et al. 8 observed, however, that at 311M EMD 57033 
increased LVdP/dtm-n in post-ischemic isolated rabbit hearts by 50% while improving early 
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relaxation. A flirther increase to I 0 ~M had no additional effect on LV dP/dt"" but tended to 
decrease the maximum rate of relaxation. Finally, at 30 flM and consistent with the report of 
Hajjar et aPI, diastolic function was seriously impaired resulting in deterioration of systolic 
function. 
In conclusion, in the present study, both doses of EMD 60263 improved systolic function 
(shortening and mechanical efficiency) as well as diastolic function (mean rate of half end-
diastolic lengthening) of stunned myocardium. The high dose delayed relaxation of nomlal 
myocardium but without adversely affecting systolic function in the presence and absence of the 
EMD 60263 induced-bradycardia. 
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Cardiovascular profile of the calciulll sensitizer' EMD 57033 in open-chest 
anesthetized pigs with regionally stunned myocardium 
Salldra de Zeellll', Serge AlP Trilles, Rob Krall/s, Dirk J Dllllckel; Pieler D Verdollw 
Background Ca2+- sensitizers enhance systolic function, but impair relaxation ill vitro; these 
effects may differ in stunned and nonnal myocardium. We therefore studied the effect of 
EMD 57033 on systolic and diastolic function of nonnal and stunned porcine myocardium 
ill vivo. 
Methods and Results Myocardial stunning by 15 min coronary occlusion and 30 min 
reperfusion, abolished systolic shortening (SS) (baseline 13±I %) and decreased end-
systolic elastance (E,,) from 67±7 to 47±5 mmHg mm-' (both P<O.05). Maximum rate of 
fall of myocardial elastance (dE/dtm,,) decreased from -850±100 to -320±30 mmHg/mm s-
I, while the time constant 't;: of the decay of elastance increased from 58±3 to 6S±6 ms 
(both P<O.05). End-diastolic cIa stance (E,,) was unchanged although the zero pressure 
intercept (Lo.",) had increased. In the stunned region, EMD 57033 (0.2 mg/kg mit,-' for 60 
min, i.v., n~7) increased SS to 19±2 %, E" to 287±40 mmHg mm", dE/dtm," to -3630±640 
mmHglmm S-I and decreased 1;: to 50±3 ms, while Eed remained unchanged. In the nonnal 
region, EMD 57033 increased SS from 14±2 to 18±3 %, E" from 59±4 to 263±23 mmI-Ig 
nnn-', dE/dtm," limn -480±70 to -2280±700 mmHg l111n" ,-' and decreased t, from 9I±I2 
to 6I±3 ms (all P<0.05), while E,d remained unchanged. These responses were minimally 
affected by adrenoceptor blockade (n~7). Vehicle ('F7) had no effect on either region. 
EMD 57033 increased cardiac output (up to 27±8 %) and LVdP/dtrn" (86±19 %). Mean 
aortic pressure decreased (l9±7 %) due to systemic vasodilation that was not amenable to 
blockade of adrenoceptors or NO synthesis. 
Conclusions In conclusion, EMD 57033 restored systolic and diastolic function of stullned 
myocardium, and produced similar improvements in systolic and diastolic function in 
nonnal myocardium. (Br J Pharlllacol. 2000;129:1413-1422) 
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Introduction 
Shllmed myocardium is characterized by both a depressed systolic and diastolic 
function.'·3 Since a decreased responsiveness of the myofilaments to calcium (Ca") has been 
implicated in the mechanism underlying stullning, several groups of investigators have 
successfully employed "CaH -sensitizing agents" to restore systolic function of shmned 
myocardium in a variety of in v;,,04,5 and ill vi/r06-S models. It has been suggested that the 
inotropic response to Ca2+ -sensitizers may differ between shmned and nOl1l1al myocardium. 
For instance, we have shown that the EMD 60263-induced increase in regional systolic 
shortening in sh1l1ned myocardium of anesthetized pigs was much more pronounced than that 
in normal myocardium.4 However, systolic shortening is strongly load-dependent, even more 
so in stunned myocardium, and does not necessarily reflect myocardial contractility.9 That also 
the lusitropic response to Ca2+-sensitizers in shmned and normal myocardium may differ was 
suggested by Korbmacher et a1.8, who showed that in response to high doses of EMD 60263 
global diastolic function deteriorated more in normal than in globally stunned isolated rabbit 
hearts. However, data on diastolic functional responses of shull1ed myocardium to Ca2+_ 
sensitizing agents ill vivo are currently lacking_ 
In view of these considerations, we studied the effects of EMD 57033 on regional 
systolic and diastolic function in an ill vivo porcine model of shu1I1ed and normal myocardium. 
EMD 57033 was chosen because it is a thiadiazinone derivative, that lacks the inhibitory 
action on the delayed rectifier inward current that is exhibited by EMD 60263 and which may 
potentially modify systolic and diastolic responses by prolongation of the action potential 
duration. 10 However, EMD 57033 possesses phosphodiesterase III inhibiting properties (which 
EMD 60263 lacks) that could act to enhance systolic and diastolic function.1O Therefore, we 
also studied EMD 57033 in the presence of fl.. and p·adrenergic receptor blockade. To 
circumvent the problem of load-dependency of systolic shortening we employed, in analogy to 
the time-v31yil1g elastance concept, regional LV end-systolic pressure-segment length relations 
to obtain a more load-independent measure of regional myocardial contractility. I I Also based 
on the time-varying elastance concept we determined regional LV end-diastolic pressure-
segment length relations to describe diastolic function. Since the latter is a measure of late 
diastolic fUllction, we also determined the maximum rate of fall (dE/dtmin) and the time 
constant (T,) of the decay of myocardial elastance to describe early diastolic function. 
Methods 
Animal care 
All experiments were performed in accordance with the "Guiding Principles in the Care 
and Use of Laboratory Animals" as approved by the American Physiological Society and with 
prior approval of the Animal Care Committee of the Erasmus University Rotterdam. 
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Animal preparation 
Cross-bred Landrace x Yorkshire pigs of either sex (28-36 kg) were sedated with 
ketamine Lm. (20-30 mg kg-I, Apharmo, Huizen, The Netherlands) and anesthetized with 
sodium pentobarbital Lv. (20 mg kg-I, Sanofi, Paris, France), before they were intubated and 
cOIUlected to a respirator for intermittent positive pressure ventilation with a mixture (1:2 
vol%) of oxygen and nitrogen. Arterial blood gas values were kept within the normal range 
(pH: 7.35-7.45; pCO,: 35-45 mmHg; pO,: 100-150 IllmHg) by adjusting respiratory rate and 
tidal volume. Fluid-filled catheters were placed in the superior caval vein for administration of 
sodium pentobarbital (5-10 mglkg h-I) to keep a constant depth of anesthesia and for 
administration of Haemaccel (Behringwerke A.G., Marburg, Germany) to maintain fluid 
balance. A fluid-filled catheter was positioned in the descending aorta to monitor arterial blood 
pressure, while a micromanometer-tipped catheter (B. Braun Medical B.V., Udell, The 
Netherlands) was advanced into the left ventricle to measure LV blood pressure and its first 
derivative (LV dP/dt). In order to construct the LV pressure-segment length relations a balloon 
catheter was positioned in the inferior caval vein for varying LV preload. 
After administration of pancuronium bromide (4 mg, Organon Teknika, Oss, The 
Netherlands) a midsternal thoracotomy was perfonned and the heart suspended in a pericardia I 
cradle_ Then, an electromagnetic flow probe (Skalar, Delft, The Netherlands) was placed 
around the ascending aorta to measure ascending aortic blood flow (cardiac output). A 
proximal segment of the left anterior descending coronary artery (LADCA) was dissected free 
for placement of a Doppler flow probe (Clystal Biotech, Northboro, MA, USA) to measure 
coronary blood velocity and for placement of an atraumatic clamp for occlusion of the artery. 
The vein accompanying the LADCA was cannulated for collection of blood samples for 
detennination of coronary venous O2 content. 
Regional myocardial fimction was measured using sonomicrometry (Triton Technology 
Inc., San Diego, CA, USA) by placing one pair of ultrasonic crystals in the distribution area of 
the LADCA and one pair in the distribution area of the left circumflex coronary artery 
(LCXCA). Each pair was implanted in the midmyocardial layer approximately 10 mm apart 
and parallel to the fibre direction. 
Experimental protocols 
After a 30-45 min stabilization period, baseline data of systemic hemodynamics and 
regional myocardial function were recorded, while arterial and coronalY venous blood samples 
were collected. Preload was transiently reduced « 12 S)11 by inflation of the balloon in the 
inferior caval vein for determination of the LV pressure-segment length relations. 
Subsequently, the LADCA was occluded for IS min and after 15 min of reperfusion the 21 
animals were randomly allocated to one of three groups. The first two groups received either 
intravenous 0.5 ml min-I propylene glycol (n~7) or 0.2 mglkg min-I EMD 57033 (n~7) during 
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60 min. In 5 animals of the latter group blood samples were collected at 15 min intervals and 
the plasma stored at -25°C until detennination of plasma levels ofEMD 57033. Tissue samples 
were collected from various organs in two animals at the end of the experiment for 
detennination of EMD 57033 levels. The third group (n~7) received EMD 57033 after 
adrenoceptor blockade to eliminate the putative dependency on adrenergic activity of the EMD 
57033-induced changes. For this purpose, the u- and p-adrenoceptors were blocked after 15 
min of repel' fusion, Le. 15 min before administration ofEMD 57033 by intravenous infusion of 
I mg kg'l phentolamine and 0.5 mg kg'l propranolol (followed by 0.5 mglkg h'I), respectively. 
The adequacy of the doses of phentolamine and propranolol has been demonsu'ated 
previously.I,,13 Since we observed that the systemic vasodilation produced by EMD 57033 
was unmitigated in the presence of combined 0,- and J3-adrenoceptor blockade, we added a 
fomih group of pigs (n~4) in which EMD 57033 (0.2 mglkg min·1 i.v.) was infused after 30 
min of reperfusion in the presence of a.- and p-adrenoceptor blockade and blockade of NO 
synthesis, 14 NO synthesis was inhibited with N@- nitro-L-arginine (20 mg kg'l, Lv.). IS 
In the first three groups of animals, regional myocardial blood flows were detemlined by 
intra-atrial injection of 1-2xI0' radioactive microsphercs [l5±! ~Im (s.d.) in diameter] labelled 
with either 46SC, 95Nb, IOJRu, 113Sn or 141Ce (NEN Company, Dreieich, Gellnany), using the 
arterial reference sampling technique. 16 At the end of each experiment, the LADCA was 
ligated at the site' of occlusion and the area perfused by the LADCA was identified by 
intracoronary injection of patent blue violet (Sigma Chemical Co., St. Louis, USA). 
Immediately thereafter, the animals were killed with an overdose of pentobarbital and the heart 
excised and handled as described earlier in order to obtain regional myocardial blood flow data 
in the LADCA and non-LADCA regions)6,17 
Data acquisition alld allalys;s 
Systolic and post-systolic shortening. All segment length data were nOllllalized to an end-
diastolic length (EDL) of 10 nun at baseline to correct for variability in the implantation 
distance between the clystals. Systolic shOliening (SS) was computed as 100% '(EDL-
ESL)fEDL, in which EDL and ESL (end-systolic length) are the segment length at the onset of 
the rapid increase in LV pressure (LVdPfdt ~ 250 mmHg S'I) and at the end of LV ejection, 
respectively. Post-systolic segment shortening (PSS) was calculated as 100% '(ESL-Lm;o)fEDL, 
in which Lmin is the minimum segment length afler closure of the aortic valves. 
Reg;onal myocardial eiastance lIsing the LV pressure-segment length relatiolls. Regional 
myocardial end-systolic and end-diastolic elastance were detennined from the LV pressure-
segment length relations which were obtained by varying preload (Figure IA). Using linear 
regression analysis end-systolic elastance (E.;s) and the segment length at zero pressure 
intercept (Lo.,,) were obtained applying the iterative method described by Van der Velde et 
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al. 18, while end-diastolic elastance (E",) and the segment length at zero pressure intercept (Lo.oo) 
were detennined usiug the time point at which LVdP/dt had increased to 250 mmHg s-'. 
To describe early diastolic function in the LADCA and LCXCA regions we detennined 
the time course of instantaneous regional elastance using the cOlTesponding Lo,es of the 
LADCA and LCXCA regions, obtained during the preload reduction (Figure IB). From the 
time course of elastance (in analogy to the global LV indices of relaxation) we detennined the 
time constant (',) of the elastance decay between the occurrence of the maximum rate offall of 
regional myocardial elastance (dE/dtm;,) and the time point at which regional elastance had 
decreased to 20% of the peak systolic elastance at baseline. For this purpose the decay in 
elastance was fitted to E(t) = Eo e-tlte where E(t) is the instantaneous elastance at time point t, 
and Eo is the elastance at dE/dtmin• Finally, to study alterations in the onset of relaxation, we 
measured the duration of regional myocardial systole in the LADCA (Tsy:stok, LADCA) and 
LCXCA (Ts)'stole, LCXCA) perfused regions, which was defined as the time interval between the 
onset of the rapid increase in regional elastance and the OCCUlTence of dE/dtmin• in analogy to 
the detennination of the duration of global LV systole. 
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Figure 1 Left ventricular (LV) pressure-segmentlellgtll relations durillg transiellt decrease of preload (A). Extemal 
work (EW&.,,) was determilled by illtegrating the w-ea enclosed by the pressure-segment length loop m'er a filII 
cardiac cycle. Regional end-systolic (E.J and end-diastolic (E,J elastance were defined as the slopes (/al/ aand tall 
jJ; of the LV end-systolic pressure-segment length (LVESP-SL) alld LV end-diastolic presslIre-segment length 
(LVEDP-SL) relations, respeclh'ely. From the lime-elaslance curve (lie dllration of systole (1~),r<>!J alld (he maximum 
rate of fall of elastallce (dEltltu.iY) were determilled (B). The time cOllstallt (rJ of the elas/ance decay between the 
occllrrence of the maximllm rale of fall of regional I/lyocardial elaslallce (dEfdt",!) alld the time poillt at which 
regiollal elastallce !tad decreased to 20% of the peak systolic elastallce at baseline was determined by fitting the 
decay il/ elastance /0 E(t) = Eo e~/u where E is elastallce, t is tillie, alld Eo is fhe elas(allce at dE'Idt",b;' 
To complement these regional myocardial measurements we also determined the time 
constant of global LV pressure decay ('tLVP) during the time-interval between the occurence of 
LVdP/dtmi" and the timepoinl when LVP had reached 5 mmHg above LV end-diastolic 
pressure. 19 The duration of global LV systole (T ~;"". LV) lVas defined as the time interval 
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between the onset of the rapid increase in LV pressure (LVdP/dt ~ 250 mmHg s") and end-
ejection. 
Myocardial o.\J'gell consllmption, external work alld mechanical efficiency. Myocardial 
oxygen consumption (MVO,) of the perfusion telTitOlY of the LADCA was calculated as the 
product of local transmural myocardial blood flow and the difference in the oxygen contents of 
the arterial and local coronary venous blood. The area inside the LV pressure-segment length 
loop (Figure 1) was taken as an index of extel1lal work per beat (EWb.:.aJ,20-22 while mechanical 
efficiency was defined as the ratio of EWIx.at and MV02 be.at. Because EW reflects mechanical 
work but does not have the dimensions of work, the changes in mechanical efficiency have 
been expressed as percentage of baseline. 
Determination of plasma and tisslle concentrations of EMD 57033 
To 600 fll of plasma or homogenized tissue 500 fll of water saturated ethylether was 
added and mixed. After the organic and aqueous phases were separated in an Eppendorff table 
centrifuge, the organic top layer was removed and collected in an Eppendorff vial. This 
extraction procedure was repeated five times and the ether phases were collected separately. 
Thereafter the ether was evaporated in a speed vac centrifuge and the residuals were 
resuspended and dissolved in 300 fll acetonitri!. The amount of EMD 57033 in a given plasma 
or tissue sample was determined Oil a HPLC system. To this end 30 ~ll of the acetonitril 
solntions was injected on a LiChrosorb RP 8 (5flm) RT 125-4 column (Merck KGaA), which 
was equipped with a Hibar LiChroCart 4-4 precolumn (Merck KGaA). The column was 
equilibrated and developed in a buffer composed of 35% acetonitril and 65% 0.1 M sodium 
phosphate, pH 6.0 at a flow rate of I ml min-I. The elution was monitored at a wavelength of 
320 nm. The concentration of EMD 57033 was detennined from the area of the peaks eluting 
at the appropriate time from the column by comparison with the values detennined for 
identically treated standard samples. The plasma concentration of a given blood or tissue 
sample was determined by adding the peak areas of the ether extraction samples. 
Statistical Analysis 
All data have been presented as mean ± s.e. mean. Statistical significance (P<0.05, two-
tailed) of the changes within each group was tested using one-way analysis of variance for 
repeated measures followed by Dunnet's test. Comparison between the changes produced by 
the different interventions was assessed by two-way analysis of variance for repeated 
measures. 
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Drugs 
EMD 57033 (the (+) enantiomer of 5-[I-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-
quinolyl]-6-methyl-3,6-dihydro-2H-I,3,4-thiadiazin-2-one; E. Merck KGaA, Dannstadt, 
Germany) was dissolved in propylene glycol so that an infusion rate of 0.5 ml min·1 
corresponded to 0.2 mglkg min·1 EMD 57033. Propranolol hydrochloride (ICI-Phanna, 
Rotterdam, The Netherlands) and phentolamine-methanosulfonide (CIBA-Geigy, Basel, 
Switzerland) were dissolved in saline. N(J)_ nitro-L-arginine (Sigma Chemical Co., St Louis, 
USA) was dissolved in deionized water. Fresh solutions were prepared on the day of each 
experiment. 
Results 
Systemic hemodynamics 
During the 15 min LADCA occlusion, mean alierial pressure had decreased from IOO±2 
mmHg at baseline to 92±2 mmHg (n~21, P<0.05). Since the decrease in mean arterial pressure 
was accompanied by a similar fall in cardiac output it follows that systemic vascular resistance 
had remained unchanged. LVdP/dtmax decreased by 14±3 %, but TS)"5!O!e was not affected. 
However, LVdP/dtmlo decreased fi'om -2000±70 to -1590±70 mmHg Sl (P<0.05), while 'LVP 
and LV end-diastolic pressure increased (Table I). After 15 min of reperfusion there was no 
recovery in any of the hemodynamic variables, except for LV end-diastolic pressure which had 
rehmled to baseline values. In the following 15 min the changes were negligible in the 14 
animals which were left untreated, but in the other seven animals adrenergic blockade caused 
marked decreases in mean arterial pressure, heart rate, cardiac output, LVdP/dtmax and 
LVdP/dtmlo (to -1340±140 nmilig S-I, (P<0.05), and caused a further increase in 'LVP. while 
Tsysto!e was maintained. 
Infusion of the vehicle had minimal effects on systemic hemodynamics and global LV 
relaxatiou parameters (Table I). In contrast, infusiou of EMD 57033 caused a marked decrease 
ill mean arterial pressure due to a decrease in systemic vascular resistance. LV systolic 
pressure did not chauge duriug the first 30 min (l13±8 mmHg), but fell to 94±7 mmHg duriug 
the following 30 miu. There was a gradual increase in LVdP/dtm" up to 186±19 % of its 
stunning value (thereby exceeding the baseline value), which reflected an increase in global 
contractility as preload (LV end-diastolic pressure) and afterload (LV systolic pressure) both 
decreased. LVdP/dtmin and l'LVP remained unchanged initially, but after 60 min LVdP/dtmin 
became less negative by 430±190 mmHg S-I and 'LVP had increased by 19±4% (P<0.05 vs 
vehicle) at a time when heart rate had increased and LV systolic pressure had decreased 
slightly. The increase in heart rate was also likely to be responsible for the decrease in TS)'5!O!e' 
The effects of EMD 57033 did not depend on the activity of the adrenergic system, as the 
increases in heart rate and LV dP/dtma, and the decrease in systemic vascular resistance were 
not affected when EMD 57033 was administered in the presence of adrenoceptor blockade. 
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LVdP/dtm;" however, becamc more negative initially by -430±11O 1l1lnHg s" (P<0.05), but 
had retumed to stunning values at 60 min of infusion, possibly because LV systolic pressure 
was maintained during the infusion. Finally, 'tLVP remained unchanged. 
Table 1 Effect ofEMD 57033 on S~'stemic Hemod~namics in Anesthetized Pigs with Stunned Myocardium. 
Baseline IS min IS min Adrenergic 30 min A!~l by Infusion 
Occlusion Reperfusi Blockade Reperfusio Infusion 30 min 60 min 
on n 
(n=21) ~n=21) {n"'21} 
MAP 94±4 PG 5±3 1±3 
mmllg 100±2 92±2* 9l±3* EMD 2±6 _18±7U 
+ 68±6t EMD 11±3' -3±2 
CO 2.5±O.! PG 0.2±O.11 0.2±O.1' I min'! 2.7±O.1 2A±O.l * 2.S±O.1* EMD O.6±O.ln O.3±0.21 
+ 2.0±0.lt EMD O.9±O.l11 0.9±O.211! 
SVR 39±1 PG 1.1±\'S -2.8±1.2 
mmllg min 1_[ 37±1 393:1 37±2 EMD -7.5±3.0' -11.6±3.011 
+ 33±1 HID -S.9±O.811 -II.3±O.9n 
HR 119±6 PG ·7±2 -8±4 Dpm I 17±4 21±4 l24±S EMD 6±4' 16±81 
+ 89±7t EMO 11±2" 19±411 
LVSP 108±4 PG 7±3 3±3 
nnnHg 114±2 lOS±2* 104±3* EMD 5±7 _J4±6" 
+ 84±S E'ID 6±3 11 S±3 t 
LVdP/dt". ... , 1630±lOO PG -10±100 -130±90 
mmHgs'! 18S0±90 1620±80· 14703:70* E'ID 760±l40" 1230±200n 
+ lO60±80t EMO 880±11011 1380±21011 
T.}",!. 316±II PG 20±31 19±5I 
n" 306±7 308±8 30S±9 EMO -16±7" _27±1411 
+ 340±9t EMD _26±SI1 _3S±9" 
tl\'P S3±3 PG 2.3±O.7 2.3±1.4 
m, 49±2 S2±2* SOH· EMD 4.7±1.7 11.0±2.61t 
+ S7±4t E'ID 2.0±S.4 _6.3±S.lt 
LVEOP 7.2±O.8 PG .7±O.3 O.3±O.3 
mmHg 6.8±O.6 IO.l±O.7· 7.6±O.7· EMO 
_2.0±0.411 -L9±O.7" 
+ 9.0±1.2 E'ID -2.S±O.611 _3.9±O.7Il 
MAP, mean arterial pressure; HR, heart rate; CO, cardiac output; LVSP, left ventricular systolic pressure; LVdP/dt." ..... 
maximal rate of rise in left ventricular pressure; LVEOP, left ventricular end-diastolic pressure; SVR, systemic vascular 
resistance; PG, propylene glycol (n=7); EMD, El\ID S7033 (0.2 mglkg min· l , n=7 in each group); -, no (.{ and P blockade; +, (.{ 
and P blockade; Values are mean± s.c. mean; ·P<O.OS vs Baseline (only for IS min Occlusion and IS min Reperfusion); 
tp<O.05 vs corresponding 15 min Rep (only for 30 min Reperfusion); Ip<O.OS vs 30 min Reperfusion; 'P<O.OS \'s change in 
vehicle group; ~P<O.OS vs EMO S7033·induced change in animals without adrenoceptor blockade. 
Additional blockade of NO synthesis by N"'-nitro·L·arginine, resulted in an elevated 
systemic vascular resistence (52±8 mmHglmin ,") compared to adrenoceptor blockade alone 
(33±l nunHglmin I", P<0.05). However, NO was not involved in the vasodilating actions of 
EMD 57033 as the decrease in systemic vascular resistance (-14±5 mmHg/min I") was 
Ullllitigated at 60 min of infusion of EMD 57033. Similarly, additional blockade of NO also 
did not modify the responses ofthe other hemodynamic variables to EMD 57033 (not shown). 
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Figure 2 EBect of EMD 57033 (0.2 mg/kg mill·1, i.v.) 011 regiollal systolic shortening (SS) ill the area per/used by lite 
LADCA alld tlte area per/used by the LCXCA. Absolute values are shown at baseline (BL, 11=21), during ischemia 
(after 15 11Iill LADCA occlusion, n=21). alld durillg Stllllllillg (ST) ill the absence (11=14) alld ill tlte presence (1/=7) of 
a+jJ.adreliocepfor blockade. Tlte effects of the illfusions of vehicle (1/=7) alld EMD 57033 (11=7 ill both groups) hare 
been presented as absolute challges (n"J from their respeclive stullllillg values. Dala are mean ±s.e. mean; ·P<0.05 
StUllllillg vs baseline, fp<0.05 vs sl/lllllillg, Ip<0.05 vs challge ill vehicle group. ~P<0.05 vs EMD 57033-illduced 
change ill allimals without adrellocep/or blockade. 
Regional systolic fUllctioll 
Systolic shortening After production of stunning, there was a complete loss of SS, and 
the appearance of a pronounced PSS (9.0±0.5 % vs l.S±0.3 % at baseline) in the distribution 
area of the LADCA, while SS of the normal myocardium remained unchanged (Figure 2). 
Infusion of vehicle had a negligible effect on SS and PSS of both normal and stunned 
myocardium. During infusion of EMD 57033, SS in the stunned myocardium increased up to 
19±2 %, while PSS disappeared. In the normal myocardium, SS increased from 14±2 % to 
18±3 % (P<0.05). Adrenoceptor blockade did not modify the responses to EMD 57033 of 
regional wall motion in either shmned or normal myocardium. 
Elld-systolic elastallce Stunning produced a rightward shift of the LV end-systolic pressure-
segment length relation in the LADCA area with an 18±7 % decrease in Eo. (P<0.05, n~14; 
Figure 3; Table 2). Infusion of vehicle had no effect on this relation, but EMD 57033 produced 
a leftward shift with a progressive increase in Ee> to four times above its shmning values (both 
P<O.OS). Adrenoceptor blockade blunted the EMD 57033-induced increase in Eo;' 
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Figure 3 LV end-systolic pressure-segment length relations in the LADCA (left pallels) alld LCXCA (right pallels) 
petjusion territories at baseline, during Stllllllillg alld after 30 lIIil/ and 60 mill o/in/usion o/vehicle (A alld Bj, or 
EMD 57033 (0.2mglkg lIIill-1, Lv.) ill the absence (C alld D) alld ill the presellce (E alld F) o/adrelloceptor blockade. 
LVP :=; left ventricular pressure. For statistical analysis see Table 2. 
In the LCXCA area, stunning and the subsequent infusion of vehicle had no effect on the 
LV end-systolic pressure-segment length relation. Inftlsion of EMD 57033 caused a tripling of 
Ees without a change in Lo,e;;' Adrenoceptor blockade had no effect on the responses of E ... s and 
Lo.« to EMD 57033. 
Regional diastolic functioll 
Onset of relaxation Stunning did not alter the onset of relaxation as the duration of 
regional LV systole in either LADCA (Tsys!o!e, tAOCA) or LCXCA (Ts}'s!o!e, tCXCA) perfused 
myocardium remained unchanged (Figure 4), The small decrease in heart rate that occurred 
during infusion of the vehicle was associated with small increases in Tsys!o!e, lADCA and TS)·stok, 
LCXCA' Conversely, the EMD 57033-induced increase in heart rate resulted in reductions of 
T S),!ok, LAOCA and Ts}'stole, tCXCA, that reached levels of statistical significance in the presence of 
adrenoceptor blockade. 
- 87 -
Brief Ischemia: a double-edged sword 
Table 2 Effect of Er..m 57033 on Regional Left Ventricular End-Systolic E1astance in Anaesthetised Pigs with 
Stunned Mrocardium. 
Baseline Reperfusion di~i br Infusion 
(n~2!) Adrenergic 30 min 30min 60 min 
blockade 
LADCA perfusion territory 
E .. , mmHg mlll·1 46±5* PG -7±4 -8±4 67±7 EMD 100±52 239±41 fi 
+ 49±!! EMD 60±23H 126±29U1 
LD, .. ,mm 8.9±OA* PG ·O.2±O.3 ·O.7±O.3 7.0±0.2 EMD - 1.2±O.5f .1.0±0.5 
+ 9.7±O.3* EMD -1.3±OAf -1.4±OAt 
LCXCA perfusion territory 
E.,., mmHg mn}"1 
76±7 PG -18±7 ·!4±9 80±7 EMD 165±49H 204±28tt 
+ 52±6* EMD 119±26H 234±56tt 
LD ... ,mm 7.5±O.2* PG ·O.2±O.l ·O.2±O.2 7.4±O.! EMD O.!±O.l O.l±O.2 
+ 7.8±O.l EMD ·O.I±O.l O.I±O.l 
LADCA, left anterior descending coronary artery; LCXCA, left circumflex coronary artery; Bu. end-systolic elastance; Lo .... 
intercept at zero pressure of the LV end-systolic pressure-segmenllength relation; PG, propylene glycol (n=7); EMD, EMD 57033 
(0.2 mglkg min'l, L\'., n=7 in each group); -, in the absence of a-and P-blockade; +, in the presence of a-and P-blockade; Values 
are mean± s.e. mean; *P<O.05 vs Baseline (only for 30 min Repcrfusion); 'P<0.05 vs 30 min Rcperfusion; Ip<0.05 vs change in 
vehicle group; 'P<0.05 \'s EMD 57033-induced in animals without adrenoceptor blockade. 
Maximum rate of fall of elastallce alld time COl/stallt of decay of elastallce Stunning 
resulted in a less negative dE/dtm;, (from -S50±lOO tnmHglmm s" at baseline to -2S0±20 
mmHglmm s·') of the LADCA perfused area, but had no effect on dE/dtm;, of the LCXCA 
perfused area (-S90±SO mmHglmm " at baseline). Vehicle had no effect on dE/dtm;, in either 
region but in the presence of EMD 57033, dE/dtm;, became more negative by 33S0±640 
mmHglmm s·' and lS00±650 mmHglmm " in the LADCA and LCXCA areas, respectively. 
Allhough adrenoceplor blockade tended 10 blunt the effects of EMD 57033, this did not reach 
levels of statistical significance (not shown). 
In view of the dependency of dE/dtmin on maximum elastance (EeJ, we also detctmined 
the time constants ofregionai myocardial elastance decay (,re, Figure 5). Stunning increased 'Ie 
in the LADCA area, but had no effect on" in the LCXCA area. Vehicle had no effect on "of 
either area, while EMD 57033 decreased " in both areas (P<0.05). Adrenoceptor blockade 
blunted the EMD 57033·induced decrease in both stunned and nonnal myocardium. 
Elld-diastolic elaslallce In the LADCA area stullning had no effect on Eed , but increased 
Lo.", from S.7±0.3 to 9.9±0.4 mOl (Table 3, Figure 6). Vehicle had no effect on E" or Lo.",' In 
contrast, EMD 57033, which had also no effect on E"" tended to decrease LO.,d (P~0.09S). 
Adrenoceptor blockade had no significant effect on the responses of E", to EMD 57033, but 
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prevented the decrease in Lo,ed' 
In the adjacent LCXCA area, the stunning protocol and subsequent infusion of vehicle 
had no effect on the LV end-diastolic pressure-segment length relation (Table 3, Figure 6). 
Infusion ofEMD 57033 also had no effect on E"" but caused a leftward shift of the LV end-
diastolic pressure-segment relation. Adrenoceptor blockade did not modify the responses of EN 
to EMD 57033, but blunted the decrease in Lo.",' 
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Figllre 4 The effect ofEMD 57033 (0.2111g/kg min·1, i.~I.) 011 the duration of systole (T»"u) ill the LADCA (top) and 
tlte LCXCA (bottom) perfusion territories. Absolute \'alues are sltowJ/ at baseline (8L, 11=21), and during stunning 
(ST) ill the absence (n=14) alld ill the presence (1/=7) of a+jJ-adrelloceptor blockade. Tlte effects of the illfusions of 
~'ehic/e (1/=7) alld E'MD 57033 (11=7 in both groups) ha\'e been preseflled as absolute challges (!J.~tJ from tlleir 
respecti\'e stunnillg values. Data are mean ± s.e. meall; *P<O.05 stullnillg \'S baseline, fp<0.05 vs stllllllillg, Ip<0.05 
vs change ill \'ehic/e group, 1p<O.05 vs EMD 57033-illduced change ill animals withollt adrelloceplor blockade. 
Alechal1ical efficiency oflhe stullned myocardium 
Stunning caused a 68±5 % decrease (P<0.05) in EW",,, but only a 12±6 % decrease in the 
MVO, "", of the LADCA-pernlsed myocardium, so that mechanical efficiency (EWb,,/MVO, 
"',,) decreased by 66±6 % (Figure 7). Innlsion of vehicle had no effect on mechanical 
efficiency as both EWbe.1t and MVOl beat remained unchanged. However, during infusion of 
EMD 57033 both EW",,, and MVO, b", returned to baseline values and consequently also 
mechanical efficiency was nonnalized, The increase in MV02 was accompanied by an 
equivalent increase in myocardial blood flow, so that myocardial O2 extraction (62±6 % at 
shulI1ing and 62±6 % at 60 min of infusion) and coronary venous P02 (27±3 mmHg at 
shmning and 28±3 mmHg at 60 min of infusion) remained unchanged. In the pigs in which 
EMD 57033 was infused in the presence of adrenoceptor blockade, the responses of EW""" 
MV02 be.1" mechanical efficiency and coronary venous POl were not different from the 
esponses to EMD 57033 in the absence of adrenoceptor blockade. 
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Figure 5 From fop fa boltom are showllfhe time cOl/slollls 0/ decay a/regional elastance (rJ during early diastole 0/ 
the LADCA (~. L4DC) alld LCXCA (~. lcrc.J pel/llsioll territories. Absolute mllles are shown at baseline (EL, 11=2/) 
alld durillg stullning ill the absellce (n=14) alld ill the presence (1/=7) 0/ a+fJadrelloceptor blockade. The effects 0/ 
the il/jilsiolls o/whicle (11=7) alld EMD 57033 (0.2 mglkg mill", i.v., 1/=7 ill both groups) have been presented as 
absolute changes (LI~J fi"OlJl their respective stwllJing mlues. Data are meall ± s.e. meall; ·P<O.05 stul/llillg vs 
baselille, tp<O.05 liS stlil/ning, Ip<O.05 liS challge ill \'Chicle group, lp<O.05 vs EMD 57033·illdllced change ill 
al/imals witholt! adrelloceplor blockade. 
Plasma alld fiSSile levels ofEMD 57033 
EMD 57033 could not be detected in the pre-dntg samples. During EMD 57033 infusion, 
the plasma levels increased time-depcudenlly to 3.54±0.13, 5.03±0.63, 6.53±0.74 and 
7.23±0.67 jIg mi" at 15, 30,45 and 60 min, respectively. In two of these experiments it was 
shown Ihat at the end of the 60 min infusion EMD 57033 had accumulated in the left ventricle 
(26.6 and 29.5 jIg per g of wet weight) and Ihe liver (29.4 and 26.2 jIg g"), while tissue levels 
in the stomach (6.7 and 6.6 jIg g-') and skeletal muscle (13.5 and 5.3 jIg g-I) were in the range 
of the plasma concentrations. EMD 57033 concentrations in the cerebellum (4.3 and 4.2 ~g g") 
and cerebnnn (4.4 and 5.3 jIg g") were below plasma levels, possibly due to the blood-brain 
barrier. 
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Table 3 Effec( of EMD 57033 011 Regional Left Ventricular End-Diastolic Elastmlce in Anesthetized Pigs wit" 
Stwl1Ied Myocardillm. 
Baseline Reperfusion fi~! by Infusion 
(n~21) Adrenergic 30 min 30 min 60 min 
blockade 
LADCA perfusion territory 
Ee<!' mmHg mn}"l 3.9±0.4 PG -0.4±0.5 -0.7±O.5 4.2±O.4 EMD -0.7±0.6 -0.6±1.3 
+ 4.4±O.4 EMD -0.8±O.S -1.0±0.9 
Lo.e<!.nun 9.9±O.4* PG 0.0±0.1 -0.3±O.2 8.7±0.3 EMD -0.3±0.4 -1.9±1.4 
+ 9.8±O.9* EMD -0.4±0.2 -0.6±O.3 
LCXCA perfusion territory 
Ee<!. mmHg nUl}"1 4.6±O.4* PG 0.4±0.4 0.5±0.s 3.7±O.2 EMD -0.6±1.3 1.9±2.1 
+ 6.2±1.I EMD -1.9±O.8t -2.3±I.S 
Lo,tJ, nun 9.6±0.7* PG 0.2±0.2 0.I±O.2 9.l±O.4 EMD -2,3±1.8f -2,8±1.Sf 
+ lO.l±O.8* EMD -O.S±O.lfn -0.7±O.2tn 
LADCA, left allterior descending corOl/ary artery; LCXCA, left circllll1fle:r: corollary artery; E,u~ end·diastolic daslallce; L{).<.7 
illtercept 01 zero pressure of the LV end·diastolic pressure-segment length relation; PO, propylene glycol (n=7); EAlD, EAlD 
57033 (0.2 mglkg lIlill·1, i.v., 11=7 ill each grollp); -, ill the absence of a·and jJ.blockade; +, illihe presellce of a-and jJ.blockade; 
Values are //Ieol/± s.e. mean; ·P<0.05 ~'S Baseline (ollly for 30 mill Repetjilsioll); 'P<0.05 l'S 30 mil/ Reperfi1sioll; Ip<0.05 vs 
change ill ~'ehicle group; 1p<0.05 ~'S EMD 57033-illdrlced cho/Jge ill animals without adrel/ocep/or blockade. 
Discussion 
The major findings in this ill l'ivD porcine model of regional myocardial stunning are (i) 
EMD 57033 increased systolic shortening in stunned myocardium more than in the adjacent 
normal myocardium; (ii) EMD 57033 also increased end-systolic elastance in normal and 
stunned myocardium, but with similar responses in both regions; (iii) EMD 57033 did not 
delay the onset of relaxation, but improved the maximum rate of fall of regional myocardial 
elastance and decreased the time constant of early diastolic regional myocardial elastance 
decay; EMD 57033 had no effect on end-diastolic elastance in either normal and stunned 
myocardium; (iv) EMD 57033 restored mechanical efficiency of the stmmed myocardium; (v) 
the effects on regional systolic and diastolic function were only slightly modified by 
pretreatment with a- and p-adrenoceptor blockade, indicating that at the dose used 
phosphodiesterase III inhibition contributes only minimally to the actions ofEMD 57033; (vi) 
finally, the EMD-induced systemic vasodilation was not amenable to either adrenoceptor 
blockade or additional inhibition of NO synthesis. 
- 91 -
Brief Ischemia: a double-edged sword 
LADCA LCXCA 
T "j Vehicle 0; I 10 10 E .s /; , "- 5 5 :; 0 Baseline 0 0 
T "l 
• StunnIng 
0; • 30 min Infusion EMD 57033 I ~ 60 min InfusIon E 10 10 
.s ~ {ff "- 5 5 :; 0 0 
0; T T EMD 57033 I 10 10 E after a+p-bJockade .s ¥ 
" 
"- 5 5 
> 
--' 
0 0 
8 10 12 8 10 12 
Segment Length (mm) Segment Length (mm) 
Figure 6 LV end-diastolic pressure-segment length relatiol/s ill the LADCA (left panels) alld LCXCA (right panels) 
per/usiol/ territories at baselil/e, dllrillg stlll/ning alld after 30 mill alld 60 mill O/ill/IISioll o/veMcle (A alld B), or 
EMD 57033 (0.2 mglkg mill·I , i.v.) ill the absence (C alld D) and il/ presetlce (E and F) of adrelloceptor blockade. 
LVP = left wl/tricular pressure. For statistical analysis see Table 3. 
Systolic jimctioJl 
EMD 57033 resulted in a time-dependent (i.e. plasma concentration-dependent) 
restoration of SS in stunned myocardium, while producing only a small increase in SS in the 
remote normal region. This finding is in accordance with previous observations in our 
laboratOIY with EMD 60263 in a similar model of myocardial stunning in the ill vivo pig 
heart.4 These studies could be interpreted to suggest a relatively preferential effect of Ca'+-
sensitizing dmgs on systolic function of stunned myocardium. However, SS is a load-sensitive 
index of systolic fUllction and does not necessarily reflect the contractile state of the 
myocarditnn22, pal1icularly under conditions of stunning when its load-dependency is even 
greater.9 Indeed, EMD 57033 produced similar increments in EtS in stumled and nOimal 
myocardium. This suggests that the greater increase in SS in shmned myocardium resulted 
principally from a greater sensitivity of regions with a lower EtS for positive inotropic 
interventions. This is supported by the observation that the p-adrenoceptor agonist dobutamine 
also produces a preferential increase in systolic sh011ening of shmned myocardium, whereas 
E" responses were similar in nonnal and stumled region.9,23 Similar to the present study, 
Korbmacher ef al. 8 observed that EMD 60263 at an optimal dose of 3 ftM produced similar 
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increments in LVdP/dt=, innonnal (from 1415 to 1885 mmHg s·') and globally stmmed (from 
845 to 1300 mmHg s·') isolated rabbit hearts in which afierload was held constant. Also with 
EMD 57033, these authors reported similar increments in LV systolic pressure in stunned and 
normal isolated rabbit hearts at constant afierload. Interestingly, we observed that the increase 
in Ee, in the stunned myocardium was time-dependent whereas the Ec, in normal myocardium 
at 30 min of infusion of EMD 57033 had not increased further afier 60 min of infusion. In 
view of the progressive increase in plasma levels over time, this observation suggests that the 
maximum effect in normal myocardium was reached at a lower dose than that in stunned 
myocardium. Indeed, Korbmacher et al.8 observed in their ill vitro study that a further increase 
in dose ofEMD 57033 to 10 pM did not ftll1her increase LVdP/dt=, in stunned hearts, while it 
slightly decreased LVdP/dtm" in nonnal myocardium. These findings suggest that the nonnal 
myocardium is more sensitive to adverse effects on systolic function than shmned myocardium 
in which the Ca2+ responsiveness is lower.3 
It has been proposed that ill vitro ENID 57033 exerts, besides its Ca2+--sensitizing effects, 
phosphodiesterase inhibiting actions. IO•24 In the present study, blockade of a· and p. 
adrenoceptors did not modulate the inotropic responses to EMD 57033 in normal myocardium 
ill vivo. Thus, the increase in Ees produced by EMD 57033 in nonnal myocardium was not 
altered by adrenoceptor blockade, while the index of global LV contractility LVdP/dtm" was 
also unmitigated in the presence of adrenoceptor blockade. Hence the EMD·57033·induced 
actions appeared to be primarily the result of an increase in Ca2t responsiveness which is in 
accordance with previous shldies in awake pigs from our laboratory.2s However, there was a 
slight blunting of the increase in Ee; in stunned myocardium, which is difficult to explain by a 
phosphodiesterase III inhibitory action, as it seems unlikely that a pharmacological property 
such as phosphodiesterase III inhibition could differ in the stunned from normal myocardium. 
Moreover, the duration of global LV systole, and Tsystole, L\DCA and Tsy,tole, LCXCA which were not 
altered by EMD 57033 in the presence of intact adrenoceptor activity, were not increased but 
were slightly shortened by EMD 57033 in the presence of adrenoceptor blockade. Taken 
together the present study suggests that the EMD-57033-induced systolic actions ill vivo are 
not the result of phosphodiesterase III inhibition. 
Shmning reduced mechanical efficiency likely due to a decrease in Ees which not only 
decreases extemal work but also increases potential work, resulting in a relatively high 
MVO,." EMD 57033 restored external work while producing only a small increase in MVO" 
thereby restoring efficiency of stulmed myocardium. This favourable effect is most likely the 
result of positive inotropism, rather than a unique feature of EMD 57033, because we 
previously observed a similar restoration of mechanical efficiency of stunned myocardium 
during infusion of the p~adrenoceptor agonist dobutamine.23 
·93· 
Brief Ischemia: a double-edged sword 
150 
Adrenergic Blockade 
+ 
E 
E 
0> 
100 
I 
* E 
.s 50 1ii 
ill 
.0 
" 
W 0 
0> 4 0 
0 
* 
~ 
"6 
E 
2, 
1ii 
ill 
2 
.0 
N 
0 
> ::; 
0 
100 
* C 50 
w 
::; 
0 
BL Stunning 
t'o.abs by Infusion 
if 
o Vehicle 
II EMD 57033 
~ EMD 57033 after a+p-blockade 
30 60 
Infusion time (min) 
Figure 7 EWf.cu" MV01 f.c.o1 alld ME of the LADCA pelf used area. Absolute values are showJI al baseline (8L, n= 21), 
and dllring Slllllllillg ill the absence (11=14) alld ill the presellce (1/=7) of a- aI/(/ jJ-adrenoceptor blockade. The effects 
afvehicle (1/=7) alld EMD 57033 (0.2 mglkg mill,l, i.v.) illihe absence (11=7) or presellce (11=7) ofadrellaceptar 
blockade have been presemed as absolute changes (AdJ from their respective s/wJ/ling vailles. Data are mean ± s.e. 
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57033-il/d/fced chal/ge ill animals without adrellocep/or blockade. 
Diastolic jill/clioll 
It has been suggested that increased Ca2+ responsiveness can lead to maintaitied 
contraction at Ca2t levels at which nonnally relaxation occurs.26 In rat skinned right ventricular 
trabeculae these authors have shown that ENID 57033 can even cause contraction in the 
absence of Ca", Consequently, contraction could be prolonged thereby delaying the onset of 
relaxation lO,24, the rate of relaxation could be attenuated 8,27 and end-diastolic stiffness could 
be increased27,28 even when Ca2t concentrations are normal. 
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Early diastolic function appeared to be well preserved during EMD 57033 infusion in the 
present study. Ts)"stole slightly decreased in both nonnal and stunned myocardium and in the left 
ventricle as a whole, possibly due to the small increase in heart rate. Thus, the onset of 
relaxation was not delayed by EMD 57033 either in the presence or absence of intact 
adrenoceptor activity, indicating that phosphodiesterase III inhbition did not mask the potential 
contraction prolongation produced by the Ca'+-sensitizing actions of EMD 57033. LVdP/dtm;o 
is often used as an index of global early LV relaxation, despite its dependency 011, in particular, 
LV systolic pressure.'9.JO In the present study, LVdP/dtm;o improved slightly during the first 30 
min of EMD 57033 infusion but fell to 75% of the value at stunning during the following 30 
min. The decrease in LVdP/dtm;o may have been due to the 20% reduction of LV systolic 
pressure, and does not necessarily reflect an impairment of global LV relaxation. This is even 
more so, as in the adrenoceptor blocked animals, both LVdP/dtmin and LV systolic pressure 
were not affected by EMD 57033. This strongly suggests that phosphodiesterase IJI inhibition 
did not contribute significantly to the maintenance of LVdP/dtmio ' Inspection of the less load-
sensitive time constant 1'LVP supports this notion. Nevertheless, both indexes are global 
variables and do not discriminate between the effects of EMD 57033 on normal and stunned 
myocardium, which is also why regional indexes of ventricular relaxation were employed. In 
both stunned and normal myocardial regions, the maximum rate of fall of regional myocardial 
elastance (dE/dtmin) increased, which is not surprising in view of the marked increments in Ee;;. 
However, even after conection for the load-dependency of dE/dtminJ i.e. by calculating the time 
constants of elastance decay 'I<> the data indicated no untoward effects of EMD 57033 on early 
diastolic function. Imp0I1antly, even in the presence of adrenoceptor blockade, EMD 57033 
did not exert detrimental actions on dE/dtmin or the relaxation time constants, suggesting that 
the lack of adverse effects were not the result of masking of untoward effects of Ca2+_ 
sensitization by concomitant phosphodiesterase III inhibitOlY effects of the compound. In the 
present study we also failed to find evidence of a negative effect of EMD 57033 on late 
diastolic function, as Eed was maintained during EMD 57033 infusion, even in the presence of 
adrenoceptor blockade. 
The importance of abnonllalities in diastolic function is that these could compromise 
systolic pump function via reduced LV filling and via impairment of myocardial perfusion by 
reducing the effective diastolic perfusion time of the coronary bed. However, in the present 
study EMD 57033, either with or without adrenoceptor blockade, restored regional systolic 
shortening, external work and mechanical efficiency, while myocardial oxygen supply was 
unimpeded. 
Conclusions 
The Ca" -sensitizing agent EMD 57033, at a dose of 0.2 mglkg min", restored regional 
systolic and diastolic function of shmned myocardium in the in vivo porcine heart. In Honnal 
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myocardium, quantitatively similar improvements in systolic and diastolic function were 
observed. Phosphodiesterase IJ] inhibition contributed minimally to these actions. The results 
of the present study suggest that Ca"-sensitizing agents are prime candidates for 
complementing the cutTent inodilator therapeutic arsenal in the clinical setting for acute states 
of heart failure, because they are powerful enhancers of systolic perfonnance ill vivo at doses 
that do not appear to exert adverse effects on diastolic function. 
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III vivo evidence that EMD 57033 restores myocardial responsiveness 
to intra coronary eaH in stunued myocardium 
Sandra de Zeeuw, Serge AlP Trines, Rob Krams, Dirk J DUllckel', Pietel'D Verdouw 
Background Despite ample ill vitro evidence that myofilament Ca2+ -responsiveness of sh.ullled 
myocardium is decreased, in vivo data are inconclusive. Conversely, while Ca2+ -sensitizing 
agents increase myofilament Ca2+-responsiveness ill vitro, it has been questioned whether 
this also occurs bl vivo. We therefore tested in open-chest anesthetized pigs whether EJ\ID 
57033 (the (+) enantiomer of 5-[ 1-(3,4-dimethoxybenzoyl)-1 ,2,3,4-tetrahydro-6-quinolyl]-
6-methyl-3,6-dihydro-2H-l ,3,4-thiadiazin-2-one) increases responsiveness to Ca2+ of non-
stunned myocardium and restores function of stunned myocardium by nonnalizing the 
responsiveness to Ca2+. 
Methods and Results Studies were perfonned under Il-adrenoceptor blockade to minimize the 
contribution of the phosphodiesterase-III inhibitOlY actions of EMD 57033. Consecutive 
illtracoronary Ca2+ infusions were used to evaluate the contractile response (assessed by 
the left ventricular end-systolic elastance, Ee~) to added Ca2+ of non-srunned myocardium 
and myocardium srutuled by 15 min coron81Y ariery occlusion and 30 min reperfusion. In 
non-shmned propranolol-treated myocardium, the Ca2+ infusions doubled Ees (baseline 
6.9±0.9 mmHg 111n1"2, n=8). Following Ca2+-washout, subsequent ENID 57033 infusion 
(0.1 mglkg·min·1, Lv.) tripled E" (P<0.05) aud potentiated the Ca'+-induced increase in E" 
to 55.7±10.0 mmHg nm'-' (P<0.05). Stunning (n~7) decreased E" to 5.3±0.6 mmHg mm-' 
(P>0.10) and attenuated the Ca'+ -induced increase in E" (P<0.05). Subsequent infusion of 
EMD 57033, increased E" to 6.8±1.8 mmHg nun-' (P<0.05) and restored responsiveness 
to added Ca'+. 
Conclusions These in vivo findings are consistent with the ill vitro observations that 
myofilament Ca2+ -responsiveness of stunned myocardium is reduced and that EMD 57033 
increases contractility by enhancing myofilament Ca2+-responsiveness. (Eur J Pltarlllllcoi. 
2000 .. 403:99-109) 
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Introduction 
It has been shown in ill vitro models that a reduced responsiveness of the myofilaments 
to Ca2+ underlies the mechanism of myocardial shllllling,l but evidence that this mechanism is 
also operative ill vivo is lacking (see reference 2 and 25). For instance, Ito et al.3 observed that 
in an ill vivo canine model of regional myocardial shmning maximum systolic shortening 
attainable with intracoronalY Ca2+ infusions was not different for stunned and nonnal 
myocardium. In addition, Heusch et al.4 also £1iled to find evidence for a decreased Ca2+ 
responsiveness as assessed by the response of a regional work index to intracoron31Y Ca2+ in ill 
vivo porcine myocardium, shmned by a 90-min flow reduction that decreased the local 
myocardial work index by 60%, a protocol that produced shuming without necrosis. A 
complicating factor in explaining the discrepancies between the ill vitro and the ill vivo results, 
is that in the ill vivo studies contractile function was estimated using indices that display 
considerable load-dependency and of which it is known that their load-dependency increases 
with shlllning.5 Thus, Hofmallll et a1.6 showed under well controlled ill vitro conditions that 
pCa for half maximal activation of tension was decreased, compared to baseline, in single cell-
sized preparations from porcine myocardium shlllned ill vivo by a 45-l11in period of 60% 
coronary flow reduction and 30 min ofreperfusion. \Ve have shown earlier that EMD 60263, a 
thiadiazinone derivative, which has been demonstrated to possess Ca2+-sensitizing properties ill 
vitro/,8 is capable of restoring systolic shortening of regionally stunned myocardium ill vivo.9 
The beneficial effects of a number of Ca2+-sensitizing agents on systolic function of stunned 
myocardium have now been continued in several isolated and intact heart studies,IO-12 but in 
none of these shldies it was actually shown that during shmning, the responsiveness to Ca2+ 
was altered and that subsequent administration of the Ca2+-sensitizing agents restored the 
responsiveness to Calf. 
Therefore, the aims of the present ill vivo study were to detenuine whether administration 
of a Calf -sensitizing agent alters the myocardial responsiveness to added Ca2+ in uon-shlllued 
myocardium and whether this agent restores function of stmmed myocardium by normalization 
of the myocardial responsiveness to Ca2+. As a Ca2+-sensitizing agent we used EMD 57033 
(the (+) enantiomer of 5-[ 1-(3,4-dimethoxybenzoyl)-1 ,2,3,4-tetrahydro-6-quinolyIJ-6-methyl-
3,6-dihydro-2H-l,3,4-thiadiazin-2-one), because we have shown that this agent, in a dose of 
0.2 mg/kg.milrl, is capable of restoring systolic function of regionally stunlled myocardium, 
without adversely affecting diastolic function,I2 a potential concern with this class of 
agents. 13,I4 Because EMD 57033 possesses minor phosphodiesterase-III (PDE-III) inhibitory 
properties",I5 the effect of EMD 57033 was evaluated ill the presence of the fi-adrenoceptor 
antagonist propranolol to minimize tonic and stimulated cAMP production, thereby keeping 
the contribution of PDE-I11 inhibition to the actions of EMD 57033 to a minimum. The 
myocardial responsiveness to added Ca2+ was detemlined using intracoronary infusions to 
prevent that changes in systemic hemodynamics act as confounding factors. Finally, to further 
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minimize the influence of changes in loading cOIlditions, we used, in analogy to the left 
ventricular end-systolic pressure (LVESP)-volumeI6 and LVESP-segment lengthS,17 relations, 
the LVESP~segment area relation to evaluate the contractile response to Ca2+. 
lIIethod, 
Experiments were perfol111ed in accordance with the "Guide for the Care and Use of 
Laboratory Animals" of the Council of the American Physiological Society and under the 
regulations of the Erasmus University Rotterdam. 
Animal preparatioll 
Fifteen with ketamine (20-30 mg.kg-' i.m.) sedated cross-bred Landrace-Yorkshire pigs 
(25-35 kg) were anesthetized with sodium pentobarbital (20 mg.kg·', i.v.), intubated and 
ventilated with oxygen-enriched air. 12,14 Fluid~filled catheters were inserted for intravenous 
administration of sodium pentobarbital (5-10 mglkg.lf') and fluids, and for measurement of 
alierial blood pressure. A micromanometer-tipped catheter (E. Braun Medical) was inserted for 
monitoring left ventricular blood pressure. A balloon catheter was positioned in the inferior 
caval vein to transiently decrease left ventricular preload. After administration of pan cur onium 
bromide (4 mg, Lv.), a mid sternal thoracotomy was performed and an electromagnetic flow 
probe (Skalar) was placed around the ascending aOlia, while a Doppler flow probe (Triton 
Technology) was placed proximally on the left anterior descending coronary .. iery (LADCA). 
Distal to the flow probe, the LADCA was dissected free for placement of an atraumatic clamp 
and cannulated for local infusion of Ca2+. Segment area was measured using sonomicrometly 
(Triton Technology) by placing ultrasonic clystals in the midmyocardiallayer approximately 
10 mm apart in the distribution areas of the LADCA and the left circumflex coronary artery 
(LCXCA). To minimize the influence of malalignment of a single clystal pair with the fiber 
direction, two pairs of crystals were implanted in each region: one pair parallel and another 
pair perpendicular to the myocardial fiber direction. 
Experimelltal protocols 
Propranolol-treated pigs with 1l01l-stwllled myocardium 
To evaluate the effect of EMD 57033 on the responsivcness to intracoronary Ca" of non-
stunned myocardium, 8 pigs received propranolol (0.5 mg.kg·1 + 0.5 mglkg.h-', a dose that 
inhibits the isoproterenol-induced increases in hem1 rate and left ventricular dP/dtmax by more 
than 90% in pigs1S), after which hemodynamic variables were recorded and LVESP-segment 
area relations were constmcted by transiently reducing preload. 12 Then, 3 consecutive 5~min 
infusions of Ca" (CaCi,.2H,o dissolved in saline) were administered into the LADCA at rates 
of 0.25, 0.50 and 0.75 mllmin (con'esponding to 18, 36 and 54 fllllol.miI,-l, respectively). At 
the end of each infusion step measurements were repeated (Figure I). Following Ca'+-washout, 
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the EMD 57033 infhsion (0.1 mglkg.min·', i.v.) was started and after 30 min the Ca'+ infusions 
were repeated. 
Pigs with stullned myocardium 
To evaluate the effect of EMD 57033 on the myocardial responsiveness to intra coronary 
Ca2+ during stunning, seven pigs received the intracoronary Ca2+ infusions before (baseline) 
and 30 min after a 15-min LADCA occlusion (stunning; Figure I). Subsequently, the p-
adrenoceptors were blocked by propranolol and after repeating the Ca2+ infusions (stunning + 
propranolol), the EMD 57033 infusion was st .. ted and 30 min later, the myocardial 
responsiveness to intracoronary Ca2+ was again determined (stunning + propranolol + EMD 
57033). 
Non-stunned 
LADCA 
myocardium 
(n~8) 
Stunned 
LADCA 
myocardium 
(n~7) 
Baseline 
~rIl 
Ca2> 
I5,min Stunning 
LADCA 
occlusion ~rIl ~ 
Ca2> 
Propranolol (0.5 mglkg + 0.5 mglkgmin'!, Lv.) 
n 
EMD 57033 (0.1 mgikgmin'!, i.Y.) 
Baseline EMD 57033 
~rf1 ~tJ 
Propranolol (0.5 mglkg + 0.5 mglkglllin'\ Lv.) 
EMO 57033 (0.1 mgikgmin'!, Ly.) 
Stunning 
Stunning + Propranolol 
+ Propranolol + EMD 57033 
~rIl ~11 
Ca2+ Ca2> 
Figure J Erperimelltal protocols for proprallolol-treated pigs with lIoll-sllllllled myocardi/lm alld pigs with regiol/ally 
stilI/lied lIIyocardiulII. Stul/lling was produced by a 15-11Iill left anterior descelldillg corollary' artelJ' occlusion 
(LADCA) alld 30 mill ofreperfusioll. Three consecutive Cal> illji/siollS illto the LADCA were admillisteredfor 5 mill 
each at rates of 18, 36 alld 54 jbl/ollmill, I'especth'ely. The arroll's indicate the Control (C) measuremellts before the 
start of the Calt illji/siolls (Tables J (11/(/2). 
Data analysis 
All data were digitized and stored for off-line analysis." Segment length data were 
nOlTIlalized to an end~diastolic length of 10 mm at baseline to correct for variability in the 
implantation distance between the various crystal pairs in the different animals. Regional left 
ventricular end~systolic elastance (Ee,) was assessed using L VESPRsegment area relations 
obtained from the relation between left ventricular pressure and the segment area encompassed 
by the two pairs of clystals. The slope of the L VESP-segment area relations (end-systolic 
elastance, Ee,) and the zero pressure-area intercept (Ao) \vere determined via linear regression 
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analysis of the LVESP-segment area data points (Figure 2) which were obtained using an 
iterative method. 19 Data are mean±S.E.M. Statistical significance (P<0.05, two-tailed) of 
changes was detennined using one-way or two-way analysis of variance. Post-hoc testing was 
perfonned using Dunnett's test. 
16 
i" Baseline 
" 
'" 
'" 12 i
0. 
~ 8 
" <) 
'co 
E 
" 4 >
'" " ...J
5 
Segment area 
Stunning 16 
12 
8 
4 
0 
Stunning 
+ Propranolol 
+ HID 57033 
Segment area 
Stunning 
+ Propranolol 
Figure 2 Example ofLVESP-segmellt area re/atiolls durillg Baselille, Stul/nillg. Stulllling + Propranolol alld Stllllllillg 
+ Propranolol + EAlD 57033 ill all illdividual pig ill which the myocardiulI/ was stullned by a J 5-lIIill occlusioll of the 
LADeA. 
Results 
Hemodynamics 
Propranolol-treated pigs with nOIl-stullned myocardium 
In the propranolol-treated pigs there were no changes in any of the hemodynamic 
parameters during the intracoronary Ca2t infusions (not shown), except for a dose-dependent 
increase in left ventricular dP/dtm" up to 17±4% (P<0.05). The infusion ofEMD 57033, which 
was started after recovery from the Ca2+ infusions, increased left ventricular dP/dtm:o.x by 28±8% 
and heart rate by 7±3% (both P<0.05; Table I). The subsequent intracoronary Ca'+ infusions 
had again no hemodynamic effects (not shown), except for the increase in left ventricular 
dP/dtm", by 27±5% (P<0.05). 
Pigs witlt stul1ned myocardium 
When the p-adrenoceptors were stiU unblocked, the intracoronary Ca'+ infusions only 
increased left ventricular dP/dtm" (up to 17±4%, P<0.05). Production of myocardial sturIlling 
after recovel), from the Ca2+ infusions, was accompanied by decreases in mean arterial blood 
pressure (9±3%), cardiac output (13±5%) and left ventricular dP/dtm" (l8±5%), while heart 
rate and systemic vascular resistance remained unchanged (Table 1). Similar to the non-
stunned myocardium, the intracoronary Ca2+ infusions increased left ventricular dP/dtmax dose-
dependently by up to 13±5%, While the other parameters were not affected. In the presence of 
propranolol, infusion of Ca2+ into the stunned myocardium again affected only left ventricular 
dP/dtm" (24±5%). The subsequent infusion of EMD 57033 increased heart rate (4±2%), 
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cardiac output (21±8%) and left ventricular dP/dt,u, (30±10%), while left ventricular end-
diastolic pressure decreased slightly (all P<0.05). In the presence of EMD 57033 the only 
effects of the intracoronalY Ca2+ infusions on hemodynamics were an increase in left 
ventricular dPldtm" (27±3%, P<0.05) and a small decrease (l2±2%, P<0.05) in mean arterial 
pressure. 
Table 1 Effect of ErvlD 57033 on control values of global hemodynamics of propranolol-treated pigs with 11011-
stunned myocardium and of pigs with stunned myocardium 
Propranolol-treated pigs with 110n-
stunned myocardium (n=8) 
Pigs with stullned myocardium (n-7) 
Baseline EMD 57033 Baseline 
fiR (bpnt) 101±7 I07±6" 106±6 
MAP (nlmHg) 86±4 8J±6 94±4 
CO (Umin) 2.7±O.2 2.9±O.J J.3±O.J 
SVR (nunHglLmin) 33±3 31±3 30±J 
LVdP/dt." (mmHg/s) 1360±80 1720±100' 1610±80 
LVEDP (mmHg) 3.J±0.8 2.1±0.8 4.4±1.3 
CBF (mLlmin) 28±4 32±3 22±2 
Stunning 
109±5 
85±4b 
2.8±O.3b 
J2±J 
1320±70b 
6.9±1.4b 
20±J 
Stunning + 
Propranolol 
91±j< 
70±j< 
2.6±O.J 
28±3< 
1010±100' 
7.3±1.5 
20±3 
Stunning + 
Propranolol + 
EMD570J3 
94±4d 
76±4 
3.J±O.3d 
25±2 
1270±90d 
5.0±1.5d 
36±6d 
IlR, heart rate; MAP, mean arterial blood pressure; CO, cardiac output; SVR, systemic vascular resistance; LVdP/dt=. maximal 
rate of rise in left ventricular pressure; LVEOP, left ventricular end diastolic pressure; CBF, coronal)' blood flow. Values are 
mean±S.E.M,,"P<O.05 EMO 57033 vs Baseline; bP<0.05 Stunning vs Baseline; <P<0.05 Stunning + Propranolol vs Stunning; 
dp<O.05 Stunning + Propranolol + EMO 57033 vs Stu1llling + Propranolol. 
Left ventricular end-systolic pressure-segment {[rea relatiolls 
Propranolol-treated pigs with nOIl-stullned myocardium 
Infusion of Ca2+ caused a dose-dependent counter clockwise rotation of the LVESP-
segment area relation of the myocardium perfused by the LADCA (Figure 3A), thereby almost 
doubling Eo; (Figure 4A), without affecting Ao (27±3 and 29±2 mm' during control and during 
the highest Ca2+ infusion rate, respectively). After recovery from the Ca2+ infusions, the 
subsequent infusion of EMD 57033 more than doubled Eo; (Table 2) and enhanced the Ca'+-
induced increments in Eo; (Figures 3A and 4A) without affecting Ao (30±1 and 31±1 mm' 
during control and during the highest Ca2+ infusion rate, respectively). 
The intravenous administration of EMD 57033 also caused a doubling of Be> in the 
myocardium perfused by the LCXCA (Table 2). However, in this segment the Ca2+ jnfusions 
into the LADCA before or during the EMD 57033 infusions altered neither Eo; (P~ 0.28 and 
P~ 0.09; Figure 4B) nor Ao (P~ 0.47 and ~ 0.79, not shown). These results indicate that the 
Ca'+ innlsions into the LADCA did not lead to a spillover of Ca'+ in the distribution area of the 
LCXCA and that the ongoing inntsion of EMD 57033 itself did not nlfther increase 
contractility during the Ca2+ infusions. 
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Non-stunned LADCA myocardium in propranolol-treated pigs 
0; 120 A I C Cal Ca2 Ca3 E 117 .s 80 0 0 b. 'V Propranolol Baseline 0-W • .. '" 'I' Propranolol EMD 57033 W ::; 40 
Stunned LADCA myocardium 
r:'/~ ~ Baseline Stunning 40 
StunnIng + Propranolol 
StunnIng + Propranolol + EMD 57033 
Segment Area (mm2) 
Figure 3. Effect of EUD 57033 (O.imgikgtmli(i i.v.) 011 the respollse to 3 Ca1+ illfusions illlo the LADCA of the 
LVESP-segment area relation ill the dislributioll area of the LADCA ofllOIl-slll1l11ed (pallel A) alld stullned (pal/els B 
al/d C) ill \'h'o porcIne myocardium. The 3 dala points ill each cline were deriwd ji"01ll the lillear LVESP-segmellt 
area relation by computing left \·elliricular elld-systolic press lire at 3 segmel/l areas withill the rallge of aclual 
measurements (lIIillilllllm, maximulII alld (millillllllll + maximum] /2) for each animal. C = COlltrol; Cal< Cal alld CaJ 
refer to tfle 3 Cal. injilsioll rates of 18.36 alld 54101l01/lIIill. respectively. 
Pigs with stullned myocardium 
Infusion of Ca'+ during baseline also caused a counter clockwise rotation of the L VESP-
segment area relation (Figure 3B), thereby more than doubling E" of the myocardium perfused 
by the LADCA (Figure 4C) without affecting Ao (not shown). Myocardial stunning lowered 
E" from6.6±1.2 to 5.3±0.6mmHg mnl' (1'>0.10), and caused a rightward shift of the LVESP-
segment area relation reflected by the increase in AD /i'om 24±4 to 44±2 mm' (P<0.05; Table 
2). The Ca'+ infusions in the stunned myocardium caused a leftward shift of the LVESP-
segment area relation (Figure 3C) reflected by a recovery of AD to 26±4 mm' (P<0.05). E,; was 
not significantly affected in the tested dose range ofCa'+. The response of the LVESP-segment 
area relation of the stunned myocardium to the Ca2f- infusions was not modified by propranolol 
(Figures 3C and 4C). During the subsequent infusion of EMD 57033, E,; returned to baseline 
values, while AD recovered partly (Table 2). Imp0l1antly, the response of E,; to the Ca'+ 
infusions was restored to control levels (Figure 4C). 
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In the adjacent myocardium perfused by the LCXCA, neither E" nor Ao responded to the 
Ca" inft,sions into the LADCA before or after stunning the perfusion tenitOlY of the LADCA 
(Figure 4D), while E" almost doubled during intravenous inft,sion of EMD 57033 (Table 2). 
Non·stunned LADCA myocardium in propranolol·treated pigs 
A LADCA t B LCXCA o Propranolol Baseline 60 60 N 
• Propranolol EMD 57033 E t 
-§, 40 t 40 J: 
E 
t .s t 
• • • ~ 20 20 • W 
* * 
0 0 
C 16 36 54 C 18 36 54 
Stunned LADCA myocardium 
"E <0 C LADCA 40 D LCXCA 0 Baseline 
~ § • Stunning 
I 20 § 20 t " Stunning + Propranolol E 
.s t 
* " " " " 
.. Stunning + Propranolol + EMD 57033 
g 
* C 
" " " W 0 
18 36 54 18 36 54 
Ca2+ LADCA ((Jmollmln) Ca2-LADeA ((Jmol/min) 
Figure 4 E..Oect ofEMD 57033 (O.lmg/kg·milrl i.1'.) 011 the response to 3 Ca l + illfusiolls iI/to the LADCA ofE .. il/ the 
distrlbutioll areas of the LADCA al/d the LCYCA of 1I01l-stl/l/lled (top pallels) alld sWlIl/ed (bottom pal/els) il/ vivo 
pordne myocardiulII. C = COl/lrol; *P<0.05 C'a l + 1'S Conlrol (ollly for Baselille): tp<0.05 EMD 57033 1'S Baseline 
(oll/y for Control) or Stunnillg + Propranolol + EAID 57033 1'S Stunning + Propranolol (on/y for Control); Ip<O.05 
Ca2+-respollse significalltly d(Oerent ji-Olll Ca2+-respollse dl/ring Baseline; §p<0.05 Ca2+-respollse significantly 
d(OerentfimJl C«+-respollsedurillg Stl/lIl/ing + Propranolol. 
Discussion 
111 vivo assessment of myocardial responsiveness to Ca 2+ 
In analogy to the time varying elastance concept,16 we employed the slope Ees of the 
L VESP-segment area relation to obtain a load-insensitive index of regional contractile 
function. A basic assumption for the determination of E .. s is that during the preload reduction 
myocardial contractility (end-systolic stiflhess of the myocardial tissue) does not change. For 
this reason, the preload reductions can only be studied during a period lasting no longer than 6-
7 s17 to avoid hypotension-induced reflex-mediated autonomic nervous system activity 
alterations. Consequently, the range over which the LVESPRsegment area can be determined is 
limited. At a given level of contractility, the LVESP-segment area relation reflects that 
pal1icular contractile state independent of whether the relation is constmcted via alterations in 
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pre- or afterload. In other words, L VESP and end-systolic area are not independent but 
interrelated and are determined by the contractile state of the myocardium. Although 
alterations in diastolic function can modulate the diastolic elastance (and therefore, the left 
ventricular end-diastolic pressure-segment area relation), this should not affect the position of 
the LVESP-segment area relation, provided contractility is unchanged. However, we have 
previously noted that alterations in diastolic function (Le. decrease in end-diastolic segment 
length) can produce trauslations in the L VESP-segment length relation. Thus, atrial pacing 
(which produces a decrease in end-diastolic segment length) also produces a leftward 
translation of the LVESP-segment length relation with no change in Ee-,.20 Similarly, the Ca2t_ 
infusions in the present study also produced a leftward translation of the L VESP-segment area 
relation. These observations are difficult to explain but may be due to methodological 
limitations of the LVESP-regional segment area relations, which do not take into account the 
local left ventricular curvature (and hence, the radius) and wall thickness. For instance, at 
smaller segment areas, the wall thickness increases and radius decreases, which causes a 
decrease in regional wall stress that is larger than the decrease in left ventricular pressure. 
Consequently, it is possible that stress-strain relations would not show such a leftward shift. 
Table 2 Effect ofEMD 57033 on control values ofE .. and Aa of propranolol-treated pigs with lion-stunned 
myocardium and of pigs with stunned myocardium. 
Propranolol-treated pigs with nOIl-
stunned myocardium (n=8) 
Pigs with stunned myocardium (n=7) 
E~ lAOCA (mmHglmm2) 
~.lAncA (1111U2) 
Baseline EMD 
6.9±O.9 
27±3 
57033 
18.3±2.8' 
30±1 
Baseline 
6.6±1.2 
24±4 
Stunning 
5.3±O.6 
44±2b 
Stunning + 
Propranolol 
5.O±O.9 
41±3 
Stunning + 
Propranolol 
+EMD 
57033 
Ec<.lCXCA (mIl1Hglmml) 8,1±1.2 18.0±3.5· 6.5±0.8 7.1±1.2 6.6±1.4 11.8±2.0d 
A{llcxq (nuu2) 30±3 32±2 27±3 28±2 30±2 32±1 
E .. , end·systolic c]astance;~, area intercept at zero pressure of the LVESP-segment area relation. Values are mcan±S.E.M .. ·P<O.05 
EMD 57033 \'s Baseline; bp<O.05 Stunning vs Baseline; ·P<O.05 Stunning + Propranolol vs Stunning; Jp<O.05 Stunning + 
Propranolol + EMD 57033 vs Stunning + Propranolol. 
Intracoronary Ca2+ infusions were employed to evaluate the myocardial responsiveness to 
added Ca2+. As pointed out by Heusch et al.,4 in in vivo experiments, the intracoronary infusion 
rates cannot be directly translated into myocardial intracellular Ca2+ concentrations_ \Ve chose 
to present the response of Ecs as a function of Ca2+ infusion rates rather than added Ca2+ 
concentrations in the blood. Using added blood concentrations would have yielded identical 
conclusions, because firstly, coronary blood flows were very similar under control conditions 
and following stunning, while in the presence of EMD 57033, blood flows were higher. These 
higher blood flows would result in lower Ca'+ concentrations and, hence, the effect of EMD 
57033 on Ca" -responsiveness may have been slightly underestimated. Another potential 
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concem is that intracoronary Ca2+ infusions may recmit different amounts of cytosolic Ca2+ 
(Ca2+-induced Ca2+ release) in non-stunned myocardium under control conditions and in the 
presence of EMD 57033 or in shmned myocardium. However, ill vitro shldies have shown that 
EMD 57033 increases contractile force2l without an effect on Ca2+ transients, indicating that 
the compound does not modulate activator Ca2+, sarcoplasmic reticulum function or Ca2+_ 
induced Ca'+ release. 15•22 Also, several groups of aUlhors have shown Ihal Ihe capacity of Ihe 
sarcoplasmic reticulum for Ca2+ uptake and Ca2+ release is preserved in shumed 
myocardium,2,23+25 and that, consequently, the Ca2+-transients in stunned myocardium are not 
different from those in normal trabeculae. 1,26 Moreover, increases in the [Ca2t]oul produced 
identical increases in peak-systolic [Ca2+]ill in stunned and nonnal myocardial trabeculae,l 
lending further supporl 10 Ihe concepl Ihal Ca'+-induced Ca'+ release and sarcoplasmic 
reticulum function are unperhtrbed in shmned myocardium. Similar to other ill vivo 
studies,4,27,28 maximal Ca2+-activated force could not be detennined, because of the occurrence 
of arrhythmias and conlraclure-like phenomena (evidenced by marked reduclions in end-
diastolic segment length) and post-Ca2+-infusion loss of regional contractile function at higher 
concentrations of intracoronary Ca2+, which we observed in pilot experiments. In the present 
Shldy, we used slightly lower Ca2+ concentrations as compared to previous shldies3,4,27,28 to 
facililale delection of Ihe pulative Ca'+-sensilizing properties ofEMD 57033. Neverlheless, we 
obselved in the nonnal myocardium that the intracoronary Ca2+ -infusions, in the dose-range 
lesled, eliciled relative increases in left venn'icular dP/dlma, (10-20%) and segmenl shortening 
(13%, not presented) that were similar to the 15% increases in wall thickening,3,27 external 
work4 or segment shortening28 and the 10-15% increases in left ventricular dP/dtmax3,4,27,28 
found in earlier shldies. 
RatiolIale for the dose of EMD 57033 
To allow evalualion of Ihe effecl of EMD 57033 on Ihe conlractile response 10 Ihe Ihree 
5 w lllin intracoronmy Ca2+ infusions, a steady state of hemodynamics and contractile function is 
mandalory during infusion of EMD 57033. In a previous sludy,12 we observed Ihal syslolic 
shortening, as well as Ee-s. continued to increase throughout the 60 min infusion period of EMD 
57033 al a rale of 0.2 mg/kg.min·!. Consequently, we selecled a lower dose (0.1 mglkg.min·!) 
and observed in the initial experiments that this dose was still effective as EC$ in the 
myocardium perfilSed by Ihe LCXCA increased from S.I±1.210 lS.0±3.5 mmHg mm" after 30 
min of infusion, but did not further increase during the subsequent Ca2+ infusions into the 
LADCA (Figure 4), while Ihe inlravenous EMD 57033 infusion was continued. The lalter 
obselvation precludes the necessity of a control group} in which Ca2+ infusions are replaced by 
vehicle to exclude the possibility that increases in Ee$ during the intracoronalY Ca2+ infusions 
were caused by a progressive increase in contractility secondary to the continuous infusion of 
EMD 57033. 
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Effect oj EMD 57033 Oil Co"-respollsivelless OJIIOIl-stulllled myocardium 
Calcium-sensitizing agents are a heterogeneous class of dmgs.29-31 Thus, several of these 
agents have been shown to increase Ca2+ -sensitivity of the myofilaments ill vitro by modifying 
the interaction between Ca2+ and Troponin C (e.g. sulmazole, levosimendan, pimobendan, 
MCI-154 and EMD 60263), by modifying the interaction between the various components of 
the thin filaments (e.g pimobendan, and MCI 154) or by altering actin-myosin crossbridge 
kinetics (EMD 57033). In addition to the Ca"-sensitizing propeIiies, most of these agents also 
produce considerable PDE-III inhibitory activity (sulmazole. pimobendan, Icvosimendan and 
MCI-154). The exact mechanism by which EMD 57033 increases the Ca" sensitivity is still 
debated." Solaro et al.33 proposed that EMD 57033 principally acts at the actin-myosin site, 
where the compound reverses the inhibition of actin-myosin interactions by troponin-
tropomyosin and may also promote transition of crossbridges from weak to strong force-
generating states. On the other hand, Pan and 1ohnsol134 observed ill an ill vitro model of pure 
recombinant human cardiac TnC that EMD 57033 binds to the Ca2+JMg2+ sites ofTnC. 
In the present study, 0.1 mg/kg.miIl' EMD 57033 not only increased E" but also 
enhanced the myocardial response to added Ca". Thus, while E" doubled (from 6.9±0.9 to 
13.S±3.S mmHg mnl') during the intracoronmy Ca" infusions in the absence ofEMD 57033, 
E" tripled (from IS.3±2.S to 55.7±10.0 mmHg nllll') during the Ca" i,,/\Isions in the presence 
ofEMD 57033, despite the higher control value during infusion ofEMD 57033. 
Several lines of evidence suggest that in the present ill vivo Shldy, the EMD 57033-
induced systolic actions are principally the result of Ca2+-sensitizatioll, with a negligible 
contribution of PDE-III inhibition. In ill vitro studies, varying dosages of EMD 57033 have 
been used. For instance, Grandis et al.35 found in Langendorffperfused rat hearts that a dose of 
only 2 ~lM could already increase contractility without a significant change in "MV02. 
Flllihermore, Korbmacher et al. lO used 30 fIM EMD 57033 in isolated rabbit hemis and 
showed that at that concentration, EMD 57033 exelis its effect by both Ca"-sensitizing and 
PDE-III inhibitOlY propeIiies. On the other hand, White et al.,15 who used EMD 57033 in a 
dose range of 0.1-20 fIM in isolated ferret cardiac muscle, repOlicd that EMD 57033 acts 
predominantly by increasing myofilament Ca2+ sensitivity_ Taken together, these ill vitro 
shldies suggest that PDE-III inhibition occurs principally at concentrations of EMD 57033 in 
excess of 20 fIM. In our previous study 12 with EMD 57033 (0.2 mg/kg.miIf'), plasma levels 
increased time-dependently to 8, 12, 15 and 17 J..lM at 15, 30, 45 and 60 min infusion, 
respectively, which is below the ill vitro PDE-III inhibiting threshold concentration of20 fIM. 
Since in the present study we infused 0.1 mglkg.miIr', this dose would therefore also not be 
expected to produce PDE-III inhibition. This is supported by the finding that the increases in 
both E" and left ventricular dP/dtm", produced by 0.2 mg/kg.min~' EMD 57033 (maximal 
plasma levels 17 ~lM) in normal myocardium were not altered by propranolol, suggesting 
minimal contribution of PDE-III inhibition to the positive inotropic actions ofEMD 57033. In 
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contrast, we have previously shown that the same dose of propranolol virtually abolished the 
inotropic actions of the phosphodiesterase inhibitor / Ca2+-sensitizer pimobendan.36 Moreover, 
the duration of both global and regional left ventricular systole were not altered by EMD 
57033 in the study by De Zeeuw et al.p independent of the presence propranolol, indicating 
that a positive lusitropic effect of PDE-III inhibition was also unlikely. Taken together, the ill 
vivo observation of an enhancement by EMD 57033 of the Ca2+-induced increase in Ees is 
highly consistent with the ill vitro observation that EMD 57033 increases myocardial 
contractile force via an increase in myofilament Ca2+ responsiveness. 
Effect of EMD 57033 011 Ca" -respollsivelless of stuulled myocardium 
Myocardial stunning was characterized by a trend towards a decrease in Ee~ and a marked 
rightward shift of the L VESP-segment area relation. At first glance, this appears to be a 
surprising finding as most studies (including some from our own laboratory) have reported 
both a decrease in E" and a rightward shift, although some studies have also reported a 
rightward shift as the most prominent feature of stunning,37,38 The reason for the differences is 
unclear, but may be related to the range of pressures over which the LVESP-segment area 
relation was constructed. It is well known that the L VESP-segment length relation may be 
curvilinear and that the curvilinearity increases at higher end-systolic pressures that are 
obtained when increases in aflerload are used.39 For this reason, we used preload reductions to 
yield a pressure range of 40 mmHg over which good linearity was observed. A rightward shift 
of the LVESP-segment area relation is compatible with a decrease of elastic-restoring forces, 
probably induced by alterations in stl1lchlral non-contractile elements, such as the extracellular 
collagen matrix and/or the cytoskeleton. However, as outlined under section "Ill vivo 
assessment of myocardia/responsivelless to Ca}+ ", the use of L VESP-segment area relations, 
rather than of left ventricular end-systolic stress-strain relations, may also have contributed to 
the marked rightward shift. 
It is now generally accepted that the mechanism underlying myocardial stunning does not 
involve a decreased Ca2+ availability,I,2,23,24 but a decreased responsiveness of the 
myofilaments to Ca2+. 1,2 However, experimental supp0I1 for this hypothesis is derived from 
shldies in isolated muscle preparations, whereas evidence obtained in ill vivo experiments is 
lacking. Thus, several groups of investigators have shown that in stunned myocardium, the 
response of systolic wall thickening3, segment shortening,27 or external work4 to intracoronary 
Ca2+ infusions is not impaired. In nyo of these studies, Ca2+ infusions were used that produced 
maximal levels of systolic sh0I1ening27 and external work4 during control conditions, but 
whether these concentrations also resulted in maximum responses in shmned myocardiml1 was 
not determined. Only Ito et aJ.3 used Ca2+ doses that resulted in maximum responses of systolic 
shortening in both normal and stullned myocardium, and demonstrated an unperturbed 
maximum wall thickening in response to Ca2+ following stunning. Consistent with previous 
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studies, we observed a similar Caz+·induced increase in area reduction in normal and stunned 
myocardium. In contrast, however, in the dose·rallge tested, the Caz+-·induced increases in Ees 
were depressed following stunning. These findings can be explained by a rightward shift of the 
[Caz+-].contractile force relations, i.e. a decrease in CaZt sensitivity. A decrease in Caz+-
sensitivity is supported by the study of Hofmann et al.6 who showed a rightward shift of the 
[CaZt]·force relation with a maintained maximum Caz+·activated force. In addition, a decrease 
in maximum Caz+-·activated force may also have contributed to the decreased Ca2+ 
responsiveness. l 
An interesting observation in the present study was that the increase in Ees produced by 
EMD 57033 in stunned myocardium was less than in non·stunned myocardium. In our 
previous study, we also observed that at lower concentrations (12 flM), the effect of EMD 
57033 on Ees was more pronounced in non·stunned than in stunned myocardium,12 While at 
higher concentrations (17 ~lM) the Ees of non·stunned and sh1llned myocardium were no longer 
different. However, interpretation of these observations is difficult, because stunned 
myocardium perfused by the LADCA was compared to non-stunned myocardium perfused by 
the LCXCA, and hence, regional differences in contractile responses cannot be excluded. In 
the present study, we directly compared stulllied myocardium to non·stunned myocardium of 
the same distribution area, which points, indeed, towards a reduced sensitivity of shl1111ed 
myocardium to the actions of EMD 57033. This is also sUPP0l1ed by observations by 
Korbmacher et al:w who found that non-stunned isolated rabbit heat1s were also more sensitive 
to the Ca"-sensitizing effects ofEMD 60263 than stunned hearts. 
Both the response of E" to EMD 57033 as well as the response of E" to the Ca" 
infiLSions in the presence of EMD 57033, were less in stunned than in non-sturmed LADCA 
perfiLSed myocardium. However, infusion of 0.1 mglkg.min·' of EMD 57033 not only 
increased E" of stunned myocardium (from 5.0±0.9 vs 6.9±0.9 mmHg nun"), but also restored 
its response to the Ca2+- infusions to baseline levels. These findings are consistent with a 
decreased myofilament Ca2+ responsiveness of stunned myocardium, and a restoration of 
myofilament Ca" responsiveness by EMD 57033. It is very well possible that the use of a 
higher dose of EMD 57033 in stunned myocardium that would have resulted in an increase in 
E" comparable to the level of E" produced by 0.1 mgikg·mi.r' in non-stunned myocardium 
(i.e. 18.3±2.8 mmHg I11m+2) would also result in comparable responses to intracoronary Ca2+. 
Conclusions 
EMD 57033 enhanced the myocardial responsiveness to intracoronary added Ca2t in nOIl-
stunned and stunned myocardium which supp0l1s the concept, based on ill vitro observations, 
that EMD 57033 increases myocardial contractility via an increase in myofilament Ca2+_ 
responsiveness, and that myofilament Caz+-responsiveness of shllllled myocardium is 
decreased, but can be restored by EMD 57033. 
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New insights into cardioprotection 
by ischemic preconditioning and other forms of stress 
Sandra de Zeeuw, Mirella A vall dell Doel, Dirk J DUllckel', Pieter D Verdouw 
Ischemic preconditioning has not only received wide attention in heart research, but has also 
been a topic of extensive studies involving other organs. In several of these studies, it has been 
shown that in spite of differences in the endpoints used to assess protection, the same 
mediators as in myocardial ischemic preconditioning may be involved. However, several of 
the putative mediators do not require ischemia to become activated. This has guided us and 
others to investigate whether the myocardium can also be protected by brief ischemia in other 
organs and whether other non-pharmacological fonus of stress, which do not produce ischemia 
but are capable of activating these potential mediators, are also cardioprotective. (AIIII NY 
ACfld Sci. 1998;874:178-191) 
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Introduction 
In the past, numerous attempts involving pharmacological agents have been undertaken 
to limit myocardial infarct size after a coronalY artery occlusion. Although several compounds 
showed initially some promise, in the long nm the results have been rather disappointing. In 
1985, Murry mud colleagues I revived interest in cardioprotection when they showed that after 
four days of reperfusion, myocardial infarcts in dogs produced by a 45-min coronary artery 
occlusion were 75% smaller (29% versus 7%) when this 45-min coroUaty occlusion was 
preceded by four sequences of a 5-min coronaty artery occlusion and a 5-min reperfusion. This 
phenomenon of protecting myocardium against irreversible damage during a period of 
sustained ischemia by preceding periods of brief ischemia has been tenlled ischemic 
preconditioning. The smaller infarct size obselved after such an extended period of reperfusion 
was most encouraging as in most of the earlier shldies the infarct size limitation proved only to 
be a delay in the development of infarct size and ultimate infhrct size was not affected. 
Subsequent studies not only confimled the occurrence of ischemic preconditioning in a large 
number of animal species, but also revealed that the time course of protection exhibited (at 
least in some species) a biphasic pattern.2,3 Thus, while in all animal species studied, ischemic 
preconditioning triggered an early phase of cardioprotection lasting up to two hours, it could 
be shown that in some species there was a second window of protection 24 hours later that 
usually lasted a few days. This second window of protection against infarct size has remained 
controversial, however, as several groups of investigators failed to show its existence.4,s 
Reasons may be numerous and could include such factors as the intensity and the duration of 
the preconditioning stimulus, the duration of the infarct-producing coronary artery occlusion, 
the time interval between the preconditioning stimulus and the sustained coronary artery 
occlusion, the area at risk, the surgical preparation and the anesthetic regimen employed. 
When demonstrated, the protection during the second window usually proved to be 
considerably less than during the early phase and this smaller magnitude of protection could 
have contributed to the failure to observe a significant infarct size limitation in some of the 
negative studies. Furthennore, in a recent study Miki and colleagues6 subjected instmmented 
conscious rabbits to a 30-min coronary artery occlusion and determined infarct size by either 
triphenyltetrazolium chloride (TIC) staining afier 3 h of reperfusion or by histology after 72 h 
of repern.sion. Using TIC staining, they found that four cycles of 5·min corOlIalY artery 
occlusion and IO-min reperfusion preceding the 30-min coroUaty atiery occlusion by 24 h 
resulted in smaller infarct sizes (33% of the risk zone compared to 45% in control animals), 
whereas the infarct sizes of the preconditioned animals and the control animals were almost 
identical (57% versus 59%) when they were determined with histology. The authors 
hypothesized that increased levels of myocardial superoxide dislllutase, which have been 
implicated in the mechanism of the second window of protection (not in the early protection), 
may cause necrotic tissue to be seen as viable tissue when TTC staining is performed.6 They 
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therefore conclude that the existence of a second window of protection might be based on the 
failure of TIC staining to measure total infarct size. 
Despite numerous efforts, the mechanisms underlying the protection by both early 
(classical) and delayed (second window) ischemic preconditioning are still incompletely 
understood. Nevertheless a large number of potential mediators, such as adenosine receptors, 
norepinephrine, activation of (isoenzymes of) protein kinase C, which all ultimately lead to 
activation of ATP-sensitive potassium chaImels, have been snggested to be involved in both 
phases of protection.7- 13 
Ischemic preconditioning has not only received wide attention in heart research, but has 
. also been a topic of extensive studies involving other organs such as brainI4-16, kidney17,18, 
skeletal muscle19 and liver.2o In several of these studies, it has been shown that despite 
differences in the endpoint used to assess protection the same mediators as in myocardial 
ischemic preconditioning may be involved. However. several of the putative mediators do not 
require ischemia to become activated. TIllS has guided us and others to investigate whether the 
myocardium can also be protected by brief ischemia in other organs and whether other (not 
phannacological) fonns of stress that do not produce ischemia, but are capable of activating 
these potential mediators are also cardioprotective. 
Cardioprotection by Non-Ischemic Stress 
The first to describe that regional myocardium can become preconditioned without prior 
local ischemia were Przyklenk and colleagues21 when they detennined infarct size in 
anesthetized dogs subjected to a 60-min occlusion of the left anterior descending coronary 
artery (LAD). They observed that when the LAD-occlusion was preceded by four episodes of 
5-min left circumflex coronary artery (LCX) occlusion and 5 min of reperfusion, infarct sizes 
were limited to the same extent as after local ischemic preconditioning. An explanation for this 
finding was not given but the authors suggested that this could involve factors that were 
produced or activated during ischemia and/or reperfusion and transported throughout the heart. 
If true, this could also imply that ischemia in other organs might produce or activate the same 
factors which could then be transported to the heart, and thereby protect the myocardium. 
Conversely, it is also feasible that myocardial ischemia could precondition other organs, an 
option that to our knowledge, has not yet been investigated. In a subsequent study of the same 
group," it was shown that in the same canine model stretch produced by left atrial infusion of 
saline also limited infarct size in dogs subjected to a 60-min coronal), m1ery occlusion. 
Volume loading was chosen such that it caused a 1O~15% increase in end-diastolic segment 
length, which is similar to that observed in the study by Przyklenk and colleagues21 in which 
the LAD distribution area was preconditioned by brief periods of left circumflex coronary 
artery occlusion. Because stretch activates ion channels located in the sarcolenulla,23 which 
appear to be selective for cations but are rather non-selective for K+, Na + or Ca2+, and because 
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these channels can be blocked by gadolinium,24 Ovize and colleagues" investigated whether 
this compound affected the protection by stretch. They proved that pretreatment with 
gadolinium blocked the protection by stretch and attenuated the protection by ischemic 
preconditioning. Unfortunately, the investigators did not study the effect of gadolinium on the 
protection of the remote myocardium observed in the study of Przyklenk and colleagues," as 
this might have led to an insight into the mechanism by which ischemia in the left circumftex 
coronary artery-perfused myocardium protected the adjacent virgin myocardium of the LAD 
distribution territory. III a follow up study, Gysembergh and colleagues2S not only showed that 
volume loading was also as effective as ischemic preconditioning in protecting myocardium in 
anesthetized rabbits, but more importantly, showed that pretreatment with glibenclamide also 
abolished the protection by stretch, thereby suggesting that stretch ultimately protects the 
myocardium through activation of K+ ATP channels. Although these shldies suggest a COllmlOn 
mechanism for the protection by stretch and by early ischemic preconditioning, there have 
been no studies investigating whether there is also a second window of protection by stretch. It 
is equally unknown if the time cOl.lrse of the protection of the remote myocardium in the study 
by Przyklenk and colleagues shows a biphasic pattern.2I 
Adenosine has been repeatedly found to playa major role in the mechanism underlying 
ischemic preconditioning. There are, however, several maneuvers that do not produce 
ischemia, but cause adenosine levels to increase. Thus Saito and colleagues26 observed 
increased myocardial adenosine concentrations during exercise, while Watkinson and 
colleagues27 found that adenosine concentrations in the pericardial fluid increased, with 
increasing workloads during treadmill exercise in dogs and finally Hall and colleagues28 have 
reported that in pigs an increase in workload in the absence of ischemia was accompanied by 
an increase in interstitial adenosine concentrations. Neveliheless, Marber and colleagues29 
failed to show a protective effect of a single 5-min period of rapid atrial pacing against 
myocardial infarction in the rabbit hemi. On the other hand, transient rapid ventricular pacing 
has been reported to protect against the OCCUlTence of ventricular arrhythmias (a still 
controversial endpoint in ischemic preconditioning studies) during a subsequent coronary 
artelY occlusion. However, the authors concluded that based on the ST -segment changes 
occurring during the pacing period, the pacing-induced protection was secondary to 
ischemia.3o We have repOlied that in anesthetized pigs, infarct size after a 60-min coronary 
artelY occlusion was less when the occlusion was preceded by 30-min ventricular pacing at a 
rate of 200 beats Imin.3! Assessment of ventricular perfonnance during and after pacing by a 
number of metabolic, perfusion and functional parameters sllch as myocardial ATP and 
phosphocreatine levels, energy charge, and regional wall fimction data, revealed that pacing at 
this rate did 1101 lead to ischemia. In that study, as with ischemic preconditioning, protection by 
ventricular pacing was abolished after pretreatment with the non-selective ATP-sensitive 
potassium channel blocker glibenclamide. Surprisingly, however, administration of 
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glibenclamide during the intermittent period of normal sinus rhythm between the period of 
ventricular pacing and the 60-min coronmy artery occlusion did not abolish the protection by 
ventricular pacing, In a more recent study, Domenech and colleagues32 reported on a series of 
similar experiments performed in anesthetized dogs. In that study arterial blood pressure was 
controlled at 80-90 mmHg to avoid effects of changes in hemodynamics during the five 
sequences of ventricular tachycardia at 213±12 cycles/min and the subsequent infarct-
producing coronmy artery occlusion. Based on the coronary flow reserve during the pacing 
period, it was also excluded that the period of tachycardia caused myocardial ischemia. 
Ventricular pacing again protected the myocardium, but this protectiou was abolished by 
treatmeut with the non-selective adenosine blocker 8-phenyltheophylline (8PT), independent 
of whether its administration occUlTed before or after the periods of tachycardia, suggesting a 
mechanism that is similar to ischemic preconditioning. Using microdialysis, the authors also 
showed that the tachycardia stimulus indeed increased interstitial adenosine concentrations 
twofold, and that in the preconditioned animals concentrations continued to rise during the 
first 40 min of ischemia, but stat1ed to decline during the last 20 min of ischemia and returned 
to baseline during the first hour of reperfusion. Because dialysis data were not obtained in the 
other series of experiments, it is unknown how treatment with 8PT, either before or after the 
intennittent pacing periods, affected the interstitial adenosine concentrations during and after 
the coronaty artery occlusion. It is also of interest that Domenech and colleagues32 did not 
find any changes in cytosolic or particulate protein kinase C (PKC) activity of translocation of 
the a, fl, E and s-protein kinase C isoenzymes, suggesting that (isoenzyme) protein kinase C 
activity or translocation does not playa role in the tachycardia-induced protection. These data 
on activity and translocation of isoenzymcs of PKC are in agreement with unpublished studies 
from our laboratory. in which we also could not show any changes in the activity or 
translocation of the fJ.- and &-isoenzymcs. 
Although, both studies31•3' suggest that similar mechanisms appear to be underlie the 
cardioprotection by ventricular tachycardia and ischemic preconditioning, the degree of 
protection by ventricular tachycardia was in both studies found to be less than with ischemic 
preconditioning. If only activation of adenosine receptors is involved in the mechanism 
underlying the protection by ischemic preconditioning these observations are difficult to 
explain as the increase in the interstitial adenosine concentrations during ventricular 
tachycardia observed in the study by Domenech and colleagues3' should be sufficient to 
maximally activate adenosine AI receptors.33 
Another difference in the protection by ventricular pacing and ischemic preconditioning 
relates to the time course of protection, as the protection by ventricular pacing appears to be 
more ephemeral than the first window of protection by ischemic preconditioning. Furthermore, 
while a second window of protection against the occurrence of ventricular arrhythmias has 
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been demonstrated after ventricular pacing,34,35 no study has so far addressed whether 
ventricular pacing also produces a second window of protection against infarction. 
The conclusions regarding the magnihlde of protection and the mechanisms by which 
ventricular pacing and ischemic preconditioning protect the myocardium in both ill vivo 
studies31•3' have been challenged by Hearse and colleagues36 employing isolated blood-
perfused paced rat hearts. In this model ischemic preconditioning and rapid pacing produced, 
in contrast with the ill vivo shldies, a similar improvement of postischemic function at 40 min 
of reperfusion after 35-min ischemia as assessed by left ventricular developed pressure. The 
duration of the ischemic period and the time point of the postischemic measurements raise the 
question whether the results may have been the consequence of a mixhue of shnming and 
irreversible damage. Hearse and colleagues36 concluded that the mechanisms of protection are 
different because rapid pacing did not, but ischemic preconditioning did, decrease tissue levels 
of high energy phosphates. This conclusion is premahtre, however, in view of the involvement 
ofK\TP channels in protection by ischemic preconditioning and pacing in our shldies.31 ,37 
Myocardial infarct size limitation by ischemic stress in other organs 
The first to report that brief ischemia in organs other than the heart itself could protect 
the heat1 during a coronary artelY occlusion were McClanahan and colleagues,38 who showed 
that a brief renal artery occlusion followed by reperfusion preceding a 45-min coronary artery 
occlusion limited myocardial infarct size in rabbits. These prelimillaty data led us to 
investigate in detail whether a IS-min occlusion of either renal 3l1ery or the mesenteric artery 
applied 10 minutes before a 60~min coron31Y artelY occlusion also limited myocardial infarct 
size in anesthetized rats.39,40 Since body temperahlre may influence infarct size and 
interventions may be protective only in combination with hypothel111ia, we studied animals 
under normothennic (36.5"C-37.5°C) and mild hypothermic (30°C-31°C) conditions. Table I 
shows that a I5-min mesenteric artery occlusion 10 min before the 60-min coronary artery 
occlusion limited myocardial infarct size in both temperature ranges, while brief renal 
ischemia was only effective in the hypothermic range. Pretreatment with the ganglion blocker 
hexamethonium abolished the protection by the transient mesenteric artery occlusion, but the 
protection by classical ischemic preconditioning was not affected. When the 60-min coronary 
artery occlusion was repeated in the presence of a pennanent mesenteric artery occlusion, 
infarct size was not different from the control group, strongly suggesting that a mediator 
released upon reperfusion of the mesenteric artery may be involved. The reason we failed to 
observe protection by the renal artelY occlusion at normothel1nia is unclear. Other groups of 
investigators have also found positive results with brief renal ischemia in rabbits, and suggest 
the involvement of adenosine in the protection.41 ,42 Preliminary data by Pell and colleagues42 
obtained in rabbits preconditioned with a 10-min renal artery occlusion and 1 O~min 
reperfusion before a 30-min coronary artery occlusion suggest that brief renal ischemia and 
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preconditioning by local myocardial ischemia protect the myocardium by similar mechanisms 
as pretreatment with both the non-selective adenosine blocker 8-(p-sulphophenyl) theophylline 
and the ATP-sensitive K+ channel blocker 5-hydroxydecanoate abolished the protection by 
either mode of protection. 
Table 1 Effect of remote organ ischemia on infarct size produced by 60-min coronary artery occlusion in rats 
AR(%LVJTU,,) INAR(%) 
36.5-37.5'C 30-31°C 36.5-37.5°C 30-31°C 
Protocol I 
(Ganglion intact) 
Shem+60-min CAO 31±4 36±4 68±2 67±3 
(Moll) (N~II) 
15·min CAO + 10 min Rep 47±4 40±5 22±3a,b 
+60minCAO (Mo9) (N=S) 
15-min MAO + 10 min Rep 42±4 41±3 50±3" 44±5~ 
+60minCAO (N~IO) (N~II) 
I5-min RAO + 10 min Rep 35±8 37±2 72±5 
+60minCAO (N~8) (N~9) 
Protocol II 
(After ganglion blockade) 
Shem+60-mill CAO 37±5 35±3 68±3 67±3 
(1F7) (1F7) 
15-min CAO + 10 min Rep 45±3 35±2 54±3" 
+60 min CAO (N~7) (1F7) 
I5-min MAO + 10 min Rep 40±3 37±3 74±2 69±3 
+60minCAO (N~7) (1F7) 
Protocol III 
Permanent MAO + 36±4 34±2 70±3 63±3 
60-minCAO (1F6) (N~8) 
Sham, control group undergoing 60-min CAD without stimulus; CAO, coronary artery occlusion; MAO, mesenteric artery 
occlusion; RAO, renal artery occlusion; Rep, repcrfusion_ Pemlanent MAO started 25 min before the onset of 60-min CAO and was 
maintained until the end of the 3-h reperfusion period. Data are mean±SEM. a p<O.05 versus control. b p<O.05 versus 
corresponding 36.5-37.5 (lC group. (After Gho et a140) 
Since ischemia produced by a pmiial coronary artery occlusion can also precondition the 
myocardimll,43-46 Birnbaum and coUeagues47 investigated whether a 55-65%) reduction in 
femoral aliery blood flow for 30 min and a 30M min stimulation or the gastrocnemius muscle (at 
a rate of one pulse per second for 20 msec with a stimulus of 9V) could also limit infarct size 
produced by a 3D-min coronary artery occlusion. The results revealed that if perfonned alone, 
neither of these two interventions limited myocardial infarct size when compared to the infarct 
size ofa group of control animals (26 ± 3%). However, when both maneuvers were combined, 
infarct size was limited to 9 ± 2%. At variance with abntpt brief renal and mesenteric artery 
occlusion and reperfusion, the combination of flow restriction in the femoral artery and 
stimulation of the gastrocnemius muscle may have a clinical analog in patients with peripheral 
vascular disease. This investigation therefore emphasizes the need for further studies exploring 
the possibilities of holV the myocardium can be preconditioned by transient ischemia outside 
the heart. 
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In this respect the influence of cerebral ischemia on the heart may be of special interest. 
This topic has already been the subject of many studies because donor hearts for 
transplantation are often obtained from patients with brain death. In several of these studies it 
has been noted that brain death leads to severe impainnent in myocardial contractility and even 
to irreversible myocardial damage.48,49 In the experimental animal, cel1 damage is usually 
produced by increasing intracranial pressure (ICP). Shivalkar and colleagues50 have shown 
that rapid, rather than gradual, increases in ICP (producing a I,OOO--foid and a 200--fold 
increase in epinephrine levels, r~spectively) cause ineversible myocardial damage. In recent 
studies, the same group of investigators has shown that sympathetic withdrawal rather than 
myocardial damage, if present at al1, is responsible for the changes in hemodynamic profile 
after brain death in rats. 51 ,52 In contrast to the influence of prolonged cerebral ischemia on 
myocardial function and stmcture, the effect of brief cerebral ischemia on the former has not 
been studied. It is of interest, however, that the brain can be preconditioned by brief cerebral 
ischemia, but in contrast to the hem1, the prote.ction is observed only 2-5 days after the 
preconditioning stimulus, a time interval that resembles that of the second window of 
protection in myocardial ischemic preconditioning. 16 
Hypothermia 
The effect of body temperature on the development of infarction after a coronary artery 
occlusion has been the topic of several investigations in recent years. For instance, Chien and 
colleagues" reported a steep relation between body core temperature in the range of 35°C -
42°C and infarct size after a 30 ll1in~coron81y artery occlusion for rabbits. Thus a decrease in 
temperature of 1°C resulted in 12% less infarction of the area at risk, with no infarction 
occUlTing at a body core temperature of 34.5°C. An even more temperature sensitive relation 
was found by Duncker and colleagues" when they subjected anesthetized pigs to a 45-min 
coronary artery occlusion. Similarly, Schwa11z and colleagues55 also observed that in dog 
hearts the infarct size after a 60-min coronary al1ery occlusion was modulated by epicardial 
temperature. Because we did not observe a difference in infarct size when we subjected 
anesthetized rats to a 60~min coronary 8l1ery occlusion at body temperature of 31°C and 37°C, 
we determined in anesthetized rats infarct size after coronaty artery occlusions of different 
duration. 56 Figure I shows that in rats infarct sizes are smaller at lower body temperatures, 
provided that the coronaty artelY is occluded for less than 60 minutes. For coronaty artery 
occlusions exceeding 60 minutes, infarct size development was complete at both body 
temperatures and no beneficial effect of hypothermia was noticeable. In all the aforementioned 
studies the total body was cooled and cooling was started before the coronaty artery occlusion. 
In order to assess whether regional myocardial hypothennia also affected infarct size and the 
importance of the timing of the onset of regional cooling, Hale and colleagues57,58 studied 
infarct sizes in rabbits in which the entire anterior portion of the heat1 was cooled using a bag 
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containing ice and water. This procedure penuitted a local temperature reduction of 
approximately 6°C within 5 minutes. These studies showed that regional cooling can be 
protective even when stalied 10 min after the onset of ischemia and that changes in 
hemodynamic parameters are not responsible for the protection. As in man inlhrct size 
development is slower than in rabbits, it could very well be that the delay in the onset of 
cooling with respect to the onset of the development of infarction may be longer than 10 
minutes. This approach of regional cooling may therefore have therapeutic value if the 
procedure can be done safely and without surgical intervention in patients developing an 
infarction. 
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Figure 1 Effect of mild hypothenllia and ischemic preconditioning alone and ill combination 011 infarct size (expressed 
as percelltage of area at risk, [AJAR) produced by coronary artery' occlusiolls of different duration. Notice that the 
slopes of tile relation beMeell infarct size (IAlAR) and the duration of the corollary' artery' occlusion (CAD) is less 
steep and linear (over the CAD range tested) ill the preconditioned animals and Ihat combilled hypothermia and 
ischemic preconditioning were also proteclb'e for CAD's of 120 min. O=normothermia (36.5-37.5°C); 
e=hypothermia (30-3JoC); D=precondilionillg at normothermia; • ""'preconditioning at hypothermia; IA=illfarcted 
area; AR=area at risk. Data are mean ± SEM. ·p<O.05 vs 0 at correspolldillg CAD duratioll. = p<0.05 liS 0 at 
correspollding CAD dumtion. (Reproduced with pemlissioll of Cardiovascular Research.) 
To investigate whether the protection by ischemic preconditioning also depends on the 
body temperature, we determined infarct sizes after 3 hours of reperfusion following coronary 
artery occlusions varying from 15 min to 120 min which were preceded by an ischemic 
preconditioning stimulus consisting of a I5-min coronary artery occlusion and 10-min 
reperfusion." Figure I shows that ischemic preconditioning had a protective effect at both 
temperatures. Furthennore, the steep parts of the sigmoid curves describing the relation 
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between infarct size and coronary artery occlusion are less steep for the preconditioned 
animals (at 37°C) than for the hypothennic animals, suggesting a different mechanism of 
action for ischemic preconditioning and lowering of temperature. Figure 1 also shows that the 
hypothermic animals still benefit from ischemic preconditioning and that the duration of the 
coronary artelY occlusion at which there is still infarct limitation can be expanded to 120 
minutes when hypothermia and ischemic preconditioning are combined. 
Hypothemlia and ischemic preconditioning have also been combined in an isolated 
perfused rat heali model by Lu and colleagues.s9 After preconditioning with a single 5-min 
period of ischemia and lO~min reperfusion, hearts were arrested by a 4°C St Thomas Hospital 
cardioplegic solution for 3 hours and then reperfhsed by a 3rC Krebs-Henseleit buffer 
solution for 45 min. The authors observed that creatine kinase activity in the effluent was 
higher when preconditioning was performed at 31°C than at 37°C and therefore concluded that 
hypothermia during preconditioning attenuated the myocardial protection of preconditioning. 
However control groups for either the hypothennic and normothermic preconditioning 
experiments were lacking in this study. Furthennore, the reperfusion period lasted only 45 min 
and it can therefore not be excluded that the lesser recovery in the hypothennic group reflected 
only a delay of recovery. Nevertheless, the data by Lu and colieaguesS9 are of interest as they 
point toward a potential temperature~dependent effect of the ischemic preconditioning 
stimulus. Such an effect is also sUPPolied by the observations of Dote and colieagues60 who 
reported that an ischemic preconditioning stimulus at 25°C was less effective than an ischemic 
preconditioning stimulus at 38°C in protecting against infarction produced by a 45-min 
coronary artery occlusion at 38°C. These findings suggest that in our study56 an ischemic 
preconditioning stimulus at 37°C could have protected the myocardium more during the 60-
min coronary 8I1e1Y occlusion at 31°C than the preconditioning stimulus at 31 °C. 
Can pathological hearts be preconditioned? 
In all ischemic preconditioning studies, but also in all studies employing stimuli which 
do not lead to ischemia, infhrctRsize limitation had been investigated in animals with nOlmal 
healthy hearts, until Speechly-Dick and colleagues61 reported that ischemic preconditioning 
also occurred in hypertrophied rabbit hearts. 
H is also of interest that Ferdinandy and colleagues62 have shown that the protection by 
ventricular pacing could not be demonstrated in rats that had been fed a high cholesterol diet 
for 24 weeks. One should also keep in mind that the authors evaluated their preconditioning 
protocol with rapid ventricular pacing in a setting of a 10-min coronary artery occlusion in an 
isolated rat heart preparation and that evaluation was therefore based on recovery of 
performance rather than infarct size. A major reason for the £1ilure to observe a protective 
effeet in the hypercholesterolemic animals may be that an improved recovelY of the evaluated 
parameters involves myocardial production of nitric oxide.62 Because that same group of 
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investigators also showed that ischemic preconditioning was lost in rabbits fed a high 
cholesterol diet,63 such data strongly suggest that the capability of the myocardium to adapt to 
several forms of stress may be impaired under pathological conditions. 
In contrast to the negative studies,62-64 Iliodromitis and coUeagues65 have recently shown 
that ischemic preconditioning with one cycle of 5-rnin ischemia and 10-min reperfusion was 
equally effective in nOllliocholesterolemic as in hypercholesterolemic (0.2% cholesterol rich 
diet for 8 weeks caused cholesterol increase from 58 ± 9 mg% to 1,402 ± 125 mg%) rabbits in 
limiting infarct size produced by 30-min ischemia. Similarly, Cokkinos and colleagues66 
reported that in isolated hearts obtained from hyperthyroid rats (L-thyroxine administration for 
2 weeks causing an increase in left ventricular mass of 15%) recovery of left ventricular 
developed pressure was similar (38%) in control and hyperthyroid hearts after 20-min 
ischemia and 45-min reperfusion. After preconditioning with two periods of no flow ischemia, 
recovery of fUllction improved in both animals to the same extent (59% and 69%, 
respectively). The currently available data must, however, be interpreted with caution as it can 
not yet be excluded that in the negative studies only the time course of protectiou may be 
shifted or that more intense stress or stress of a longer duration is still capable of eliciting a 
cardioprotective response_ It is, however, equally possible that under certain pathological 
conditions more severe stress or stress of the longer duration preceding a sustained coronary 
artery occlusion may prove to be deleterious rather than protective. 
Conclusions 
The evidence that myocardium can be protected against the development of irreversible 
damage is increasing. Local ischemic myocardial preconditioning is the most potent 
endogenous stimulus, but transient ischemia in remote organs is and non-pharmacological 
stimuli that do not lead to ischemia have also been proven to be cardioprotective. A major 
question remains whether cardioprotection can still be shown in models that mimic more 
closely the pathological conditions in man. Major efforts should therefore be directed to the 
study of ischemic and non-ischemic preconditioning in more pathological models. In earlier 
studies we have shown that partial coronary artelY occlusions are capable of preconditioning 
Honnal myocardium without an intermittent reperfusion period between the partial and 
complete occlusion,45,46 analogous to the two-stage Harris model.67 In these studies we used 
complete reper-fusion after release of the infarct producing 60-min coronary artery occlusion. 
Kapadia and colleagues68 have extended these studies by showing that myocardium can also 
be preconditioned in the presence of a permanent stenosis, which is thus also present during 
the reperfusion period. Shldies in hypercholesterolemic animals, in particular when they have 
moderate to severe coronary artery lesions, and in animals with hypertrophied and failing 
hearts are another step forward in assessing whether ischemic preconditioning or other stimuli 
may be protective in man. A major reason for undertaking such studies is that we believe that 
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the definitive proof of ischemic preconditioning in man cannot be achieved,69.70 because of the 
numerous uncontrolled and confounding factors. If the human myocardium can protect itself 
against the development of irreversible damage, one must also realize that this could be a 
confounding factor when one wants to evaluate the salvaging effects of therapeutic 
interventions such as thrombolysis. 
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Involvement of both Adenosine AI and AJ receptors 
in ischemic preconditioning in rats 
Background The role of adenosine in ischemic preconditioning has been confinned in several 
species such as rabbits, dogs, swine and human. However, in the rat heart its role is not 
clear as several studies show controversial evidence using adensine antagonists. This 
could be explained by the finding that during myocardial ischemia interstitial adenosine 
levels are higher in rats compared to other species. We therefore studied the role of 
adenosine receptors in an ill vivo rat model using both low and high dose of8-SPT. 
Methods and Results Area at risk (AR) and infarcted area (IA) were detennined in 
anesthetized rats after 180 min of reperfusion following a 60-min coronary artery 
occlusion (CAO). In control rats IA/AR was 70±2%. Ischemic preconditioning by a single 
IS-min CAO (PC) decreased IA/AR to 47±4% (p<0.05 vs control). The adenosine 
receptor antagonist 8-SPT had no effect on infarct size by itself (IA/AR ~ 74±1%) and 
blunted the protection by PC at a dose of 10 mglkg Lv. (IA/AR ~ 59±2%, P<0.05 vs PC), 
whereas 50 mg/kg Lv. of 8-SPT abolished the protection (IA/AR ~ 70±1%, P<0.05 vs 
PC). The selective adenosine A, agonist ffi-MECA administered prior to the 60-min CAO 
limited IS (49±4%, P<0.05 vs control) to the same extent as ischemic preconditioning. 
The protection by adenosine A, receptor stimulation, however, was partly blocked by high 
dosage of 8-SPT (62±2%, P<0.05 vs ffi-MECA), but not by low dosage of 8-SPT 
(56±2%, P~O. I 57), suggesting that 8-SPT also blocks adenosine A3 receptors at high dose. 
Conclusions 8-SPT dose-dependently inhibited the cardioprotection by ischemic 
preconditioning indicating that adenosine is involved in ischemic preconditioning in the 
rat heart in vivo via Al receptor stimulation. The higher dose of 8-SPT abolished the 
protection by IP and blunted the cardioprotection by ffi-MECA, suggesting that the A3 
receptor also contributes to ischemic preconditioning. 
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Introduction 
8ince the original obselvation by Downey and coworkersl in an ill vivo rabbit model, that 
the nonselective adenosine receptor blockers 8-SPT and PD115,199 were able to abolish the 
cardioprotection afforded by ischemic preconditioning, the role of adenosine in ischemic 
preconditioning has also been confirmed in other species such as dogs2 and swine,3.4 
The rabbit has been extensively used for studies on the role of adenosine and has shown 
that different adenosine receptor subtypes like AI and A, are involved. Agonists selective for 
adenosine AI (rPIA',6 and CCPA6) or A, (APNEA7,8 and IB-MECA9) receptors showed 
infarct size reduction to the same extent as ,vith ischemic preconditioning in both ill vUro and 
in vivo studies. Moreover, in isolated rabbit myocytes ischemic preconditioning could only be 
partially blocked by the adenosine AI selective antagonist DPCDX, but was completely 
blocked by the combination of DPCPX with either adenosine A/A, antagonist BWAI433 or 
8-SPT, indicating that both adenosine AI and A3 receptors are involved. to 
In the rat heart, however, evidence for the role on adenosine receptors in ischemic 
preconditioning is still incompletely understood. In this species cardioprotection can be 
induced by adenosine or selective AI receptor agonists CCPAII,l2 or rPIA.13 However, Li et 
a1l 4 failed to obselve a blunting of the protective effect of ischemic preconditioning ill vivo by 
the adenosine receptor antagonist 8-SPT at a concentration of 10 mglkg. Other investigators 
also failed to abolish ischemic preconditioning using the non-selective adenosine receptor 
blockers 8-SPTIS or PDI15,199. II It is possible that blockade of adenosine receptors was 
inadequate because not all receptor types, for example adenosine A3 receptors, were blocked. 
Another possible explanation is that the interstitial level of the antagonist is not high enough to 
block all receptors, which is suppOited by the ill Vi/I'O study of Headrick. 16 In that study it was 
shown that during myocardial ischemia interstitial adenosine levels rose 6-fold to ~2 ~tM in 
isolated rabbit hearts, whereas they rose 27-fold to -7 f,M in isolated rat hearts. Using a higher 
concentration of 8-SPT, Headrick was able to block the protective effect of ischemic 
preconditioning. Taken into account the K; value of 8-SPT for AI and A, receptors (K; (AI) ~ 
2600 nM, K; (A,) ~ 10000 nM) it is likely that Headrick, using a higher dose, also blocked the 
A3 receptors in addition to the AI receptors. Thus, suggesting that adenosine A3 receptors may 
also be involved in ischemic preconditioning. 
In view of these considerations, we investigated the role of the adenosine AI and A3 
receptors in ischemic preconditioning in an ill vivo rat model. Taking into account the higher 
interstitial levels of ADO in the rat heart, we used both a low (10 mglkg) and a high 
concentration (50 mglkg) of 8-SPT during ischemic preconditioning. Since high doses of 8-
8PT may also block adenosine A3 receptors, additional experiments were perfonlled using the 
selective adenosine AJ agonist IB-MECA with and without 8-SPT. 
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Methods 
Atl experiments were perfonued in accordance with the Guiding Principles in the Care 
and Use of Laboratory Animals, as approved by the American Physiological Society and with 
prior approval ofthe Animal Care Committee of the Erasmus University Rotterdam. 
Surgical and experimental procedures 
Male Wistar rats weighing approximately 300 g, fed ad libitum, were anesthetized with 
pentobarbital (60 mglkg) and intubated for positive pressure ventilation (Harvard rodent 
ventilator, Hilliston, Mass, USA) with room air. Through the carotid artelY a PE-50 catheter 
was positioned in the thoracic aorta for measurement of arterial blood pressure and heart rate. 
In the inferior caval vein a PE-50 catheter was placed for infusion of Haemaccel 
(Behringwerke AG, Marburg, Germany) to compensate for blood loss during surgery. After 
thoracotomy via the left third intercostal space and opening of the pericardium, a silk 6-0 
suture was looped under the coronary al1ery for later production of coronalY artelY occlusion. 
Following laparotomy, a catheter was positioned in the abdominal cavity to allow 
intraperitoneal infusion of pentobarbital for maintenance of anesthesia. 
Rectal temperature was continuously measured with an electronic thenllometer 
(Electromedics Inc.) and was maintained at 36.5-37.5 'C by either heating pads or ice-filled 
packages. Except during production of coronary art elY occlusion and reperfusioll, the 
thoracotomy site was covered with aluminum foil to prevent heat loss from the thoracic cavity. 
In an earlier shldyl7 we verified the adequacy of this procedure in five rats in which 
simultaneous measurements of rectal and intrathoracic temperature showed no differences at 
baseline and at the end of a 60-min coronaty miery occlusion. 
Rats that fibrillated during occlusion or reperfusion were allowed to complete the 
protocol when conversion to nonnal sinus rhythm OCCUlTed spontaneously within I min, or 
when resuscitation by gently thumping on the thorax or defibrillation with a modified baUelY 
of 9V was succesful within 2 min after onset of fibrillation. Occlusion and reperfusion were 
visually verified by appearance and disappearance of myocardial cyanosis. 
E.'perimental protocols 
All protocols were performed at a body temperature of 36.5-37.5 'C. In all animals the 
hearts were subjected to a 60-min coronmy m1ery occlusion (CAO) followed by 180 min of 
reperfusion (Rep) (Fig I). In the control groups, animals received either no pretreatment or 
pretreatment with the HI antagonist mepyramine (MEP) or the non-selective adenosine 
antagonist 8-(p-Sulfophenyl)theophylline (8-SPT) to exclude an effect of these agents on 
infarct size. In groups 4,5 and 6, ischemic preconditioning was produced by a 15-lllin CAO 
followed by 10 min of Rep before the 60-min CAO. To investigate the contribution of 
adenosine receptors in ischemic preconditioning groups 5 and 6 were pretreated with a low (10 
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mglkg) and high (50 mglkg) dose of the non-selective adenosine antagonist 8-SPT, 
respectively. In groups 7 and 8, the effect of A3 receptor stimulation on infarct size was studied 
using the selective A, agonist N'-(3-iodobenzyl)adenosine-5'-N-methyluronamide (lB-MECA, 
I 00 ~glkg). Since infusion of IB-MECA induced a marked decrease in arterial blood pressure, 
which has been ascribed to release of histamine from :mast cells,I8 the animals in group 8 were 
pretreated with the HI-antagonist mepyramine (5 mglkg). In groups 9 and 10 the selectivity of 
8-SPT was tested by infusion of 10 or 50 mglkg of 8-SPT before administration of IB-MECA. 
60-min CAO 
Group 1 Control w,wm lBO-min Rep n=10 
Group 2 Control+MEP a I'W$@ n=6 
Group 3 Control+SPT I. w,wm n=5 
Group 4 PC t:l3.Iw,wm n=8 
Group 5 PC+10SPT aw,wm n=7 
Group 6 PC+50SPT aw,wm n=7 
Group 7 IB-MECA Dw,wm n=6 
Group 8 IB-MECA+MEP ~D w,wm n=6 
Group 9IB-MECA+MEP+10SPT ,Mw,wm n=8 
Group 10 IB-MECA+MEP+50SPT ,M w,wm n=7 
preCAO end CAO eod 
i t t t 
·55 0 60 240 
Time (min) 
Figure 1 Diagram showillg the 10 experimental groups. Ischemic preconditioning (PC, hatched bars) was produced 
by 15 mill of total COrollal}' artel)' occlusion (CAO) followed by 10 mill ofreperfllsioll (Rep). IB-MECA (lOOllgikg, 
open bars), loll' (/0 mgikg) aI/(/ high (50 mg/kg) dose of 8-SPT (black bars) alld mepyramille (5 mgikg, horizontal 
striped bars) lI'ere gi~'ell illtrm'wol/sly. Illfarct size was detel'milled at the end of the 180 mill ofreperflfsioll ill all 
groups. 
Measurement of infarct size 
At the end of each experiment the coronary artery was reoccluded and the area at risk 
lVas demarcated by infusion of 10 ml Trypan Blue (0.4%, Sigma Chemical Co.) to stain the 
nonnally perfused myocardium dark blue and delineate the nonstained area at risk (AR). The 
heart was then quickly excised, cooled in ice-cold saline and cut into slices of 1 nun from apex 
to base. From each slice, the right ventricle was removed and the left ventricle was divided 
into the AR and the remaining Jeft ventricle, using microsurgical scissors. The AR was then 
incubated for 10 min in 37°C Nitro-Blue-Tetrazolium (Sigma Chemical Co., 1 mg per I ml 
Sorensen buffer, pH 7.4), which stains vital tissue purple but leaves infarcted tissue unstained. 
After the infarcted area (IA) was isolated from the noninfarcted area, the different areas of the 
- 135 -
Brief Ischemia: a double-edged sword 
L Y were dried and weighed separately. Infarct size was expressed as a percentage of the AR. 
Animals in which AR was below 15% of left ventricular weight were excluded. 
Data analysis and presentation 
Infarct size (WAR, in percent) was analyzed by one-way ANOYA followed by 
Dunnett's test. Hemodynamic variables were compared by two-way ANOYA for repeated 
measures followed by the paired or unpaired I test. Statistical significance was accepted when 
p<O.OS. Data are presented as mean±SEM. 
Resnlts 
Mortality 
Of the 100 rats that had entered the study 19 animals were excluded because of technical 
failure and three because of sustained ventricular fibrillation during the 60-min CAO (Group I 
Control, Group 2 Control + MEP and Group 4 PC). In S animals the area at risk was less than 
15% of total left ventricular mass and therefore also excluded. 
Hemodynamics 
Table 1 shows that at baseline there were no significant differences in mean arterial 
pressure (MAP) among the 10 groups. Heart rate (HR) was significant only between group I 
(control) and group S (IB-MECA+MEP), but similar just before the sustained occlusion. 
Fifteen minutes of ischemia (group 4) resulted in a slight decrease in both HR and MAP, 
which was not significant. Infusion of 8-SPT also had 110 effect on heart rate, but increased 
MAP by 15-35%. Stimulation of the adenosine A3 receptors by infusion of IB-MECA (group 
7), however, resulted in severe hypotension as MAP decreased from 116±S mmHg to 59±7 
mmHg, most likely via A3 receptor-mediated histamine release. A bolus of MEP, which partly 
attenuated the hypotensive response to lB-MECA (group S), also had a negative effect on HR, 
as in the control group (group 2) HR decreased from 410±13 bpm to 371±1l bpm and in the 
lB-MECA treated group from 419±6 bpm to 369±12 bpm. Despite infusion of both MEP and 
S-SPT in groups 9 and 10, lB-MECA stil decreased MAP, but to a lesser extent. 
The 60-min coronary artery occlusion followed by ISO min of reperfusion resulted in a 
decrease in both HR and MAP in the control groups (groups I, 2 and 3). In preconditioned 
animals HR and MAP were maintained, while the increase in MAP produced by both doses of 
S-SPT was lost during the 60-min CAO and ISO-min Rep. After infusion oflB-MECA the 60-
min coronary at1ery occlusion did not further decrease MAP with or without MEP or S-SPT. 
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BL Pre Stimulus PreCAO EndCAO EndR!:E 
Control 
Group I 60MminCAO 
HR{bpm) 363±I3 360±12 362H2 363±14 
MAP (nunHg) lO5±6 I02±5 93±6'" 85±6",t 
Group 2 MEP+60·min CAO 
HR{bpm) 410±!3 365±1l'" 371±11 '" 366±8'" 360±14* 
MAP (nunHg) 115±6 112±5 I08±6 I02±5 85±7*t 
Group 3 SPT +60~min CAO 
HR{bpm) 381±16 382±22 382±18 345±I3*t 326±8",t 
MAP (nunHg) 98±4 137±7'" I33±5'" 86±S' 71±9*t 
PC 
Group 4 I5-min CAOt-lO min Rep+60Mmin CAO 
HR{bpm) 391±IO 391±9 377±11 380±8 377±S 
MAP(nunHg) I09±6 I08±6 92±3'" 93±5 89±6' 
Group 5 1 OSPT+ 15Mmin CAOt-lO min Rep+60Mmin CAO 
HR{bpm) 367±6 366±8 356±8 340±11 '" 323±9",t 
MAP (nunHg) 99±5 129±4* I02±IO 83±8t 74±4*t 
Group 6 SOSPT+ IS-min CAO+ 1 0 min Rcp+60Mmin CAO 
HR{bpm) 369±IO 362±8 360±lO 345±10* 348±IO 
MAP (nunHg) 119±6 I37±9 111±6 96±4t 86±5",t 
IB·MECA 
Group 7 IB-MECA+60-min CAO 
HR{bpm) 386±17 379±17 363±16 337±21'" 311±16* 
MAP (nunHg) 1l6±8 I08±IO 59±7'" 63±10'" 66±8'" 
Group 8 :MEP+IB-MECA+60Mmin CAO 
HR{bpm) 419±6 352±14'" 369±12'" 368±10* 351±8'" 
MAP (nunHg) 120±5 98±1l'" 76±IO'" 76±7'" 73±7'" 
Group 9 MEP+IOSPT+JB.-MECA+60-min CAO 
HR{bpm) 403±IO 363±11* 366±14'" 34O±1I'" 336±19'" 
MAP (nunHg) 110±5 133±7* 67±5'" 72±7'" 72±7* 
Group 10 MEP+50SPT+IBM1{ECA+60-min CAO 
HR{bpm) 390±9 369±!3 367±14 341±16'" 316±lO*t 
MAP (nunHg) I05±S 135±5'" 86±4 72±7'" 65±6",t 
AR area at risk as percentage of left ventricular total mass; WAR infarct size as percentage of area at risk CAO, coronary artery occlusion; Rep, coronary reperfusion; 
MEP, Mepyr.unine (5 mg!kg); IOSPT, 8-(p·Sulfophenyl)tbeophylline (IOmg!kg); 50SPT, 8·(p-Sulfophenyl)tbeophylline (50mg!kg); IB·MECA (!OO~g!kg); PC, 
preconditioning. Data are mean±SEM. "'P<O.05 vs BL; tP<O.05 vs pre CAO. 
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hI/arc! size 
There were no significant differences in AR among the experimental groups (Table 2). In 
the control rats, 60-min CAO resulted in an IN AR of 70±2%. Pretreatment with MEP or 8-
SPT had no effect on infarct size (71±1% and 74±1%, respectively). Ischemic preconditioning 
by a single IS-min CAO (PC) decreased WAR to 47±4% (P<O.OS vs control). This protection 
was blunted by 10 mglkg 8-SPT (S9±2%, P<O.OS) and abolished by SO mglkg 8-SPT (70±1%, 
P<O.OS). Pharmacological stimulation of the adenosine A, receptors by IB-MECA also 
decreased IN AR during the 60-min CAO (49±4%, P<O.OS vs control) to a similar extent as 
ischemic preconditioning. MEP had no effect on this protection (S1±2%, P<O.OS vs control). 
The protection by adenosine A) receptor stimulation, however, was partly blocked by high 
dosage of 8-SPT (62±2%, P<O.OS vs IB-MECA), but not by low dosage of 8-SPT (S6±2%, 
i"=0.16), suggesting that 8-SPT at high doses blocks adenosine A, receptors in addition to AI 
receptors. 
Table 2 Myocardial infarct size 
Control 
Group I 60-miu CAO 
Group 2 MEP+60-lllin CAO 
Group 3 SPT+60-lllin CAO 
PC 
Group 4 IS-Illin CAO+IO-Illin Rep+60-lllinCAO 
Group S IOSPT+IS-lllin CAO+IO-lllin Rep+60-lllin CAO 
Group 6 SOSPT+IS-Illin CAO+ 1O-lllin Rep+60-lllinCAO 
ID-MECA 
AR,%LV 
mass 
39±3 
36±2 
3S±S 
38±4 
36±4 
34±2 
INAR,% 
70±2 
71±1 
74±l 
47±4* 
S9±2*t 
70±lt 
Group 7 IB-MECA+60-lllin CAO 33±S 49±4* 
Group 8 MEP+IB-MECA+60-lllin CAO 33±1 51±2* 
Group 9 MEP+IOSPT+lB-MECA+60-lllin CAO 32±3 56±2* 
Group 10 MEP+50SPT+lB-MECA+60-lllin CAO 34±3 62±2'! 
AR, area at risk as percentage oflefi ventricular total mass; WAR, infarct size as percentage ofan~·a at risk; Sham indicates control 
group undergoing 60-nlin CAO without pretreatment; CAO, coronary artery occlusion; Rep, coronary reperfusion; MEP, 
l'.Iepyramine (5 mglkg); JOSPT, 8-(p-Sulfophenyl)theophylline (IOmglkg); 50SPT, 8-(p-Sulfophenyl)theophylline (50mglkg); lB-
MECA (100~lglkg); PC, preconditioning. Data arc mean±SEM. ·P<O.05 YS control; tP<O.05 \'s PC; tP<O.05 \'s IB-MECA. 
Discussion 
The major findings of the present study are that (i) 8-SPT, at a dose which had no effect 
on the cardioprotection by the selective A, agonist lB-MECA, attenuated the protection by 
ischemic preconditioning in the rat heali ill vivo, indicating the involvement of AI receptors in 
ischemic preconditioning. (ii) A higher dose of 8-SPT abolished the cardioprotection produced 
by ischemic preconditioning, but also blunted the protection by IB-MECA, suggesting that 
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both AI and AJ receptors are involved in the cardioprotection afforded by ischemic 
preconditioning in the rat heart ill vivo. 
Both ill vitro and in vivo studies on the role of adenosine in ischemic preconditioning in 
rats have shown controversial results. In Langendorff perfused rat hearts cardioprotection, 
defined as increased recovery of function, could be induced by activation of the adenosine 
receptors by either adenosine13,I9 or the adenosine AI agonist rPIA.13 On the other hand, using 
comparable concentrations of agonists in the same model Cave et aFo and Asimakis et aPI 
were unable to induce cardioprotection. Similar controversies were found using non-selective 
adenosine antagonists 8-SPT and BWAI433 before ischemic preconditioning, which did not 
block ischemic preconditioning at low dose of 10 IIMI3"O,,!, but at high dose (50 11M) 
cardioprotection was completely abolished. 16,22 Moreover, in ill vivo studies adenosine 
infusion decreased infarct size, II but ischemic preconditioning could not be abolished by the 
adenosine antagonists 8-SPTI4 or PD-155199,1I These results can be explained by the very 
high interstitsial adenosine levels found in rat heart and as a result, to competitively overcome 
the elevated levels of adenosine, high concentrations of potent antagonists must be delivered to 
the rat heat1 receptor site. 16 Thus, conclusive evidence on the role of adenosine in ischemic 
preconditioning in the rat heal1 is still lacking. 
In the present study, cardioprotection by ischemic preconditioning was dose dependently 
inhibited by the non-selective adenosine receptor antagonist 8-SPT indicating that adenosine is 
involved in ischemic preconditioning in the r~t heart in vivo. Although Li et aP4 also used a 
dose of 10 mglkg 8-SPT ill vivo, blockade of ischemic preconditioning could not be exhibited, 
An explanation for this discrepancy could be attributed to the use of different anesthesia in that 
study, a combination of ketamine/xylazine, which can interfere with the process of ischemic 
preconditioning23, or to the use of female rats in that study as estrogen has been shown to be 
cardioprotective,24 even at physiological levels.25 Still, the dose dependent inhibition by 8-
SPT in this study is consistent with the hypothesis of Headrickl6 that in preceding studies in 
the rat the 8-SPT dose was insufficient to block adenosine receptors as interstitial adenosine 
levels increased more in rat hearts compared to rabbit hearts. That study was the first to 
measure interstitial adenosine in the rat heart during ischemia and have put forward an 
explanation for the negative findings on the role of adenosine in ischemic preconditioning, as 
in these studies13,20,21 adenosine receptors were not completely blocked. 
Based on the higher interstitial adenosine levels during myocardial ischemia, Headrick 16 
used a dose of 50 11M 8-SPT instead of a dose of 10 11M 8-SPT, but did not make a distinguish 
between AI or AJ adenosine receptors. Taken into account the Kj value of 8-SPT for AI and A3 
receptors (K, (AI) = 2600 nM, K, (AJ) = 10000 nM) it is likely that a higher dose also blocked 
the AJ receptors in addition to the AI receptors, This is supported by oUl' finding that low dose 
of8-SPT (10 mglkg) is unable to block cardioprotection afforded by the adenosine AJ receptor 
agonist IB-MECA, and thus only blocks adenosine AI receptors, The cardioprotection by IB-
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MECA was, however, partly blocked by a dose which is five times higher (50 mglkg), whereas 
the K; value for A, receptors is only 4 times higher, suggesting that 50 mglkg 8-SPT also 
blocks the adenosine A3 receptors. In conclusion, the complete abolishment of ischemic 
preconditioning in this study by the high dose of 8-SPT, suggests a role for both adenosine A, 
and A3 receptors in ischemic preconditioning in rats in vivo. 
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Time course and mechanism of myocardial catecholamine release 
during transient ischemia ill vivo 
Thomas W Lameris, Sandra de Zeeuw, Gooitzell Alberts, Frans Boomsma, Dirk J DUI/cker, 
Pieter D VerdoulV, Arie J Mall ill 't Veld, Alltoll H vall dell Meiracker 
Background Elevated concentrations of norepinephrine (NE) have been obselved in ischemic 
myocardium. We investigated the magnitude and mechanism of catecholamine release in 
the myocardial interstitial fluid (MTF) during ischemia and reperfusion ill vivo through the 
use of microdialysis. 
l\fethods and Results In 9 anesthetized pigs, interstitial catecholamine concentrations were 
measured in the perfusion areas of the left anterior descending coronary artery (LAD) and 
the left circumflex coronmy mtery. After stabilization, the LAD was occluded for 60 
minutes and reperfused for 150 minutes. During the final 30 minutes, tyramine (154 mnol· 
kg-I. min-I) was infused into the LAD. During LAD occlusion, MIF NE concentrations in 
the ischemic region increased progressively from 1.0±0.1 to 524± 125 nmollL. MIF 
concentrations of dopamine and epinephrine rose from 0.4±0.1 to 43.9±9.5 nmollL and 
from <0.2 (detection limit) to 4.7±0.7 nmollL, respectively. Local uptake-l blockade 
attenuated release of all 3 catecholamines by >50%. During reperfusion, MIF 
catecholamine concentrations rehmled to baseline within 120 minutes. At that time, the 
tyramine-induced NE release was similar to that seen in nonischemic control animals 
despite massive in£'lfction. Arterial and MIF catecholamine concentrations in the left 
circumflex coronary artel), region remained unchanged. 
Conclusions Myocardial ischemia is associated with a pronounced increase of MIF 
catecholamines, which is at least in part mediated by a reversed neuronal reuptake 
mechanism. The increase of MIF epinephrine implies a (probably neuronal) cardiac 
source, whereas the preselved catecholamine response to tyramine in postischemic 
necrotic myocardium indicates functional integrity of sympathetic nerve tenllinals. 
(Circulatioll.2000;101:2645-2650.) 
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Intl'oduction 
Myocardial ischemia is associated with a marked accumulationof norepinephrine (NE) in 
ischemic tissue. l -4 In vitro shldies suggest that this is caused by nonexocytotic release of NE 
from cardiac sympathetic nerves.5-7 In contrast to the nonnally occurring exocytotic NE 
release, this non-exocytotic NE release is (1) calcium independent, (2) not under influence of 
local or central sympathetic stimulation, and (3) not affected by presynaptic inhibition.' 
Interestingly, these ill vitro studies in the sympathetically dominant rat heart also suggest that 
the ischemia-induced nonexocytotic NE release can be attenuated by neuronal uptake-I (U I) 
blockade, indicating that under ischemic conditions, the U I mechanism is reversed and can 
operate as a carrier for outward instead of inward NE transport. 5,6 However, this has not been 
investigated in parasympathetically dominant human and porcine hearts ill vivo. Furthenllore, 
little is known about the myocardial release of epinephrine (E) and dopamine (DA) in the 
ischemic heart in vivo; this is of particular interest because cardiac E release has been reported 
in ill vitro studies and in healthy elderly men and patients with severe congestive heart failure 
at rest and during exercise.8- 11 
Microdialysis allows the measurement of catecholamine concentrations in the myocardial 
interstitial fluid (MIF) ill vivo and the investigation of the mechanisms that underlie their local 
release and clearance. 12 Using an ill vivo porcine model, we investigated the time course and 
magnitude of changes in MIF concentrations of catecholamines during severe myocardial 
ischemia and reperfusion. To determine the contribution of reversal of the VI mechanism to 
ischemia-induced NE release, 1 of the microdialysis probes in the ischemic myocardium was 
copernlsed with the UI inhibitor desipramine (DMI).I2·13 
We also detenuined whether sympathetic nelve endings are functionally impaired during 
reperfusion after severe myocardial ischemia, as has been suggested for the isolated rat hearts.2 
For this purpose, local NE response to an intracoronmy infusion of tyramine in the 
postischemic myocardium was compared with the response obselved in the nonischemic 
porcine myocardium of control animals previously shldied under similar experimental 
conditions. 12 Tyramine is taken lip via U I into the sympathetic nerve endings, where it releases 
NE. Tyramine thus provides information on the NE content as well as on the U 1 function of 
sympathetic nerve endings. 12 
Methods 
Animal Care 
All experiments were perfonued in accordance with the Guiding Principles for Research 
Involvillg Animals and Human Beings as approved by the Council of the American 
Physiological Society and under the regulations of the Animal Care Committee afEraslllus 
University Rotterdam. 
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Surgical Procedure 
After an overnight f.1st, crossbred Landrace xYorkshire pigs of either sex (weight 30 to 
35 kg, n~59) were sedated with ketamine (20 to 25 mglkg IM), anesthetized with sodium 
pentobarbital (20 mglkg IV), intubated, and connected to a respirator for internlittent positive 
pressure ventilation with a mixture of oxygen and nitrogen. RespiratOIY rate and tidal volume 
were set to keep arterial blood gases within the nomlal range. 12,14 Catheters were positioned in 
the superior caval vein for the continuous administration of sodium pentobarbital (10 to 15 mg 
. kg·' ·If') and saline to replace blood withdrawn during sampling. In the descending amia, a 
fluid-filled catheter was placed to monitor aortic blood pressure and blood sampling. Through 
a carotid artelY, a micromanometer-tipped catheter (B. Braun Medical BV) was inserted into 
the left ventricle (LV) for the measurement of LV pressure and its first derivative, LVdP/dt. 
AileI' the administration of pancuronium bromide (4 mg), a midstemal thoracotomy was per-
formed, and the heart was suspended in a pericardial cradle. An electromagnetic flow probe 
(Skalar) was then placed around the ascending aorta for the measurement of cardiac output. 
After a Doppler flow probe was placed on a proximal segment of the left anterior descending 
coronary artelY (LAD), a calUlUia (outer diameter=1.3 mm) was inserted distal to this site into 
the LAD for the administration of tyramine. 
Microdialysis probes \vere implanted in the LV myocardium through the use of a steel 
guiding needle and split plastic tubing: I probe in the region perfused by the left circumflex 
coronary ariery (LCx) and 2 probes in the area perfused by the LAD. To achieve local VI 
inhibition, I of the LAD probes was coperfused with DMI (100 mmoIlL).13 In addition, a 
microdialysis probe was placed in the interventricular corot131Y vein that drains the LAD 
region. IS 
Dialysis Methodology 
The polycarbonate dialysis membrane of the microdialysis probes (CMN20; Carnegie 
Medicine AB) has a cutoff value of 20 kDa, a length of 10 nUll, and a diameter of 0.5 mm. 
Probes were perfused with an isotonic Ringer's solution at a rate of2 gL/min with a CMAlIOO 
microinjection pump. Dialysate volumes of 20 mL (sampling time 10 minutes) were collected 
in microvials containing 20 flL of a solution of 2% (wt/vol) EDT A and 30 nmollL l-erythro-a-
methyl-NE (AMN) as internal standard in 0.08 N acetic acid. Sampling started immediately 
after insertion of the probes. Plasma samples were drawn into chilled heparin~containing tubes 
containing 12 mg glutathione. Microdialysis and plasma samples were stored at -80°C until 
analysis within the next 5 days.12,16 
III vivo probe recovery of NE (5261%) has been detennilled through retrodialysis with 
AMN as a calibrator and direct comparison of hemomicrodialysis and plasma samples. ".17 III 
vivo probe recovery for E (68±3%) was detennined through a comparison of E concentrations 
in arterial plasma with E concentrations in the dialysate obtained from the carotid artery probe. 
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The ill vivo probe recovery for DA was not determined directly but was assumed to be similar 
to the probe recovery of NE because of the similarities of NE and DA in size and charge 
distribution. 
Experimental Protocol 
After a 120-minute stabilization period,12 baseline measurements were obtained during a 
30-minute period before the LAD was occluded distal to the first diagonal branch for 60 
minutes, with an atraumatic clip, and then reperfused for 150 minutes. During the final 30 
minutes of reperfusion, tyramine (154 mnol . kg-I -min-I) was infused directly into the LAD. 
At the end of the experiment, the perfusion area of the LAD was determined with an intraatrial 
infusion of 30 mL of a 5% C\vt!\vt) solution of fluorescein sodium during reocclusion of the 
LAD. During occlusion, ventricular arrhythmias were counted and distinguished as premature 
ventricular contractions, ventricular tachycardia, or ventricular fibrillation. 18 After the 
induction of ventricular fibrillation with a 9-V battery, the heat1 was excised and infarct size 
was determined with the use of para-nitro blue tetrazoliul11_ 14 
Analytical Procedures 
Plasma catecholamines were detel111ined through HPLC with fluorometricdetection after 
liquid-liquid extraction and derivatization with the fluorogenic agent 1,2-diphenyl-
ethylenediamine. 19 For microdialysis samples, the catecholamines are not extracted before 
fluorometric detection with HPLC but instead were directly derivatized according to the 
procedure described by Alberts et al,l7 This method suppresses the interference of sulfhydryl 
compounds on derivatization, thus improving sensitivity. 
Reagents and Pharmaceuticals 
Ketamine and sodium pentobarbital were obtained from Apharmo BV. Pancuronium 
bromide was obtained from Organon Teknica BV. Ringer's solution was purchased from 
Baxter. Tyramine was obtained fro111 the Department of Pharmacy, University Hospital 
Rotterdam. Fluorescein sodium, para-nitro blue tetrazolium, DMI, NE, E, DA, and AMN 
were purchased from Sigma Chemical Co. EDT A was purchased from Merck. L-Glutathione 
was obtained from Fluka. Acetic acid was obtained from Baker. 1,2-Diphenyl-ethylenediamine 
was prepared as rep0l1ed previously.19 
Statistical Analysis 
Five of the 9 animals experienced ventricular fibrillation during LAD occlusion (between 
10 and 30 minutes of ischemia) but were successfully defibrillated within I minute with the 
use of 20- to 30-W countel~hocks and therefore were included in the analysis. Because there 
were no differences in the hemodynamic and catecholamine responses between animals that 
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fibrillated and the animals that maintained sinus rhythm, the data for all 9 animals were 
pooled. Catecholamine concentrations obtained with microdialysis were corrected for probe 
recovery. Lower limits of detection for catecholamines measured with microdialysis and those 
measured in arterial plasma were 0.2 and 0.02 nmollL, respectively. Baseline values were 
determined by averaging the 3 measurements during the 30~minute period before occlusion.12 
Results are expressed as mean±SEM. For statistical analysis, 2-way ANOV A, I-way ANOV A 
for repeated measures with Dunnett's multiple comparison test as post hoc test, and StudenCs t 
tests were used as appropriate. 
Results 
Systemic ]femodYJlamics During Ischemia and ReperJusion 
Baseline hemodynamic data and the changes produced with 60-minute LAD occlusion 
and 120 minutes of reperfusion (Table I) are in accordance with previously published data 
from our laboratory.14 
Table 1 Cardiac and Systemic Hemodynamics at Baseline, at 60 Min of Ischemia, and at 120 Min of Reperfhsion 
Baseline Ischemia Rcperfusion 
Mean Aortic Pressure, mmlIg 
Cardiac Output, Llmin 
Heart Rate, bpm 
Systemic Vascular Resistance, mmHg.min.L·! 
Stroke Volume, mL 
LVdP/dtnu" mmHgls 
Left Ventricular End Diastolic Pressure, nUHlIg 
LADCA Flow, mLlmin 
Da!a arc pr;;sented as mean±SEM, n=9; ·P<O.05 YS Baseline. 
b!(a/,ct Size 
97±2 
2.4±{).2 
114±4 
42±4 
22±2 
1680±IOO 
6.6±O.8 
34±3 
60 min 120 min 
82±2* 79±5 
2.1±O.l 1.8±0.1* 
118±7 137±11* 
4I±4 43±5 
18±1* 
1460±1IO 
9.3±1.4* 
o 
15±2* 
1380±150 
IO.0±1.9' 
46±8 
The LAD occlusion resulted in an ischemic area (area at risk) that composed 29±2% of 
the LV mass. Infarct size detelmined at the end of reperfusion was 84±4% of the area at risk. 
Catecholamine Concentrations During Ischemia alld Repeljusioll 
At baseline, NE concentrations in MIF (NE~nF) in the LAD and Lex regions were similar 
to concentrations in the coronary vein (NEcv) but were 3 times the concentrations in arterial 
plasma (NE",}(P<0.05; Table 2). DA concentrations followed a similar pattern, whereas E was 
detectable only in arterial plasma. Under UI blockade, NEMIF increased 5-fold, whereas DAMlF 
did not change and EM IF remained undetectable. 
During the first 10 minutes of ischemia, NEMIF in theLAD region tripled and continued to 
rise progressively, so NEMIF increased 500-fold by the end of ischemia (Table 2, Figure I). In 
the presence of U I blockade, the rate of rise of NEMIF was attenuated so that after 20 minutes 
of ischemia NEMIF under U I blockade was similar to, and at 60 minutes was less than half of 
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NEMIF in the absence of UI blockade. NEev increased progressively to 100-fold its baseline 
value. On reperursion, NEMIF under U I blockade and NEev declined rapidly, with the early 
rate of decline being most pronounced for NEMIF in the absence of U I blockade (Figure I). 
Withill120 minutes ofreperfusion, catecholamine concentrations in MIF and coronary vein 
had rehlrned to baseline values. NE:-'HF in the Lex perfused area and NEart remained unchanged 
during the course of the experiment. 
In the LAD region, EMIF and DAMIF in the absence and presence of U I blockade and Ecv 
and DAcv followed qualitatively similar patterns as NE, but absolute increments during 
ischemia were substantially less pronounced (Table 2, Figure I). Again, E,",DA,", and DAMIF 
in the Lex region did not change over the course of the experiment, whereas EMIF in the Lex 
region remained undetectable. 
Table 2 Plasma and MIF catecholamine concentrations al Baseline during Ischemia and Reperfusion 
Arterial Plasma Coronary MIF LADCA MIF LADCA + MIF LCXCA 
nmoUL Vein IlnloUL DMI ll1110UL 
Norepillephrille 
Baseline 
60 min Ischemia 
120 min ReperfusioJl 
Epinephrine 
Baseline 
60 min Ischemia 
120 min Reperfusion 
Dopamille 
O.30±O.08 
0.32±Q.07 
0.54±Q.23 
O.04±Q.Ol 
O.03±Q.Ol 
O.07±O.02 
nmoUL 
O.86±Q.22t 
90±36't 
O.62±O.30 
<0.20 
2.55±I.07't 
<0.20 
O.97±Q.llt 
524±125'ti 
O.54±O.l1 
<0.20 
4.74±O.71'U 
<0.20 
nmoVL 
5.76±Q.77tl§ O.96±Q.13t 
198±46'tl§ O.79±O.27tt§ 
1.99±Q.28'tH O.62±O.16 
<0.20 <0,20 
2.09±Q.43't§ < O.201§ 
<0.20 <0.20 
Baseline O.06±O.OI O.71±Q.45t 0.40±0.l2t O.57±O.l6t O.59±Q.27t 
60 min Ischemia 0.06±0.Ot 11.6±4.3*t 43.9±9.5*ft 16.5±5.6*t§ 0,47±O.04tt§ 
120 min Reperfusion 0.15±0.07 O.27±O.l1 O.30±0.IOf 0.34±O.13t 0.2I±O.03 
MIF; myocardial interstitial fluid; LADCA; left anterior descending coronary artery; LCXCA; left circumflex coronary artery; 
DMI; desipramine, UI inhibitor. Data are presented as mean±SEM, n=9, ·P<O.05 vs Baseline; tP<O.05 vs Arterial Plasma; 
tP<O.05 I\nF LADCA vs Coronary Vein; § P<O.05 vs MIF LADCA. 
Ventricular Arrhythmias During Ischemia 
Most of the ventricular arrhythmias occurred within the first 30 minutes of ischemia. The 
incidence of premature ventricular contractions was paIticularly high between 20 to 30 
minutes of ischemia (a total of 661 and a mean of 73±19 per animal). Five animals 
experienced ventricular fibrillation but were defibrillated successfully within I minute. There 
was no con-elation between NEMIF concentrations and the occurrence of ventricular 
arrhythmias in general or ventricular fibrillation in pal1icular. 
Postischemic Catecholamine Release Wilh Tyramine 
Figure 2 shows that the inulsion of tyramine directly into the LAD after 120 minutes of 
reperfusion caused an increase in NEMIF in the postischemic myocardium from O.6±O.1 to 
11.5±1.9 nmoVL (P<0.05). This increment was not different from the increase of from 0.9±0.2 
to 13.4±3.2 nmollL in the LAD region of the normal (nonischemic) swine heart.12 
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FUlihennore, compared with the increment seen in the absence of VI blockade, the increase in 
the presence ofUl blockade was minimal. 
I 
f 
time (mIn) tlma (mIn) tlma (mIn) 
Figure 1 Time course of changes ill catecholamille COl/centrations during ischemia alld reperfilsion. Data are shOll'lI 
for MIF ill LAD regioll ill absel/ce (.) and presence (0) ofU] blockade, M]F ill Lef regioll ill absence ofU] blockade 
(3), alld cOllcelltrations in arterial plasma (hate/led bars) and ill corollary Veill (J.). Data are gil'ell as meall±SEM 
(1l~9). 
Discussion 
The results of the present study demonstrate that myocardial ischemia is associated with 
a rapid and massive increase in the concentration of all 3 endogenous catecholamines (NE, E, 
and DA) in the myocardial interstitial fluid as measured with the microdialysis technique ill 
vivo. As suggested for NE in ill vitro studies,s,6 the reversed VI mechanism plays an impor-
tant role in the release of all 3 catecholamines during ischemia ill vivo. Furthennore, our study 
shows that after 60 minutes of ischemia, which results in massive infarction of the jeopardized 
myocardium, the functional integrity of sympathetic Helve terminals remains intact. Finally, 
our results suggest that cardiac interstitial E has a neuronal origin. 
·DMt +DMI 
Figure 2 Tyramine-indllced NE release ill perfusion area of LAD with alld witho/lt U] illhibition. Data are shown for 
postischemic myocardium (11"'4, hatched bars) andfor historic lIollischemic control animals (11=4, solid bars). 11 Data 
are gil'ell as meall±SEM (1/=4), *P<O.05, 
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Interstitial Catecholamine Concentrations Dllring Basal Conditions 
The present study confhms that at baseline, NEwF is ~3 times the NE,rt and increases .6-
fold in response to U I blockade,I,12,20 whereas EMIF was below the detection limit regardless of 
the presence ofUI inhibition. DA'IIP did not rise under UI blockade, suggesting that UI does 
not playa predominant role in the clearance of DA from the interstitial compartment under 
baseline conditions in the heart. Little is known about the affinity of DA for UI and the 
relevance of VI to DA clearance in the heart. Because the main purpose of the VI mechanism 
is to modulate synaptic transmission, it is hard to envisage a substantial role for U 1 in the 
clearance of DA in the absence of any cardiac dopaminergic synaptic transmission. 
Furthennore, in tissues with known dopaminergic transmission, like brain and kidney, DA is 
taken up by a specific DA neuronal uptake mechanism that does not take up NE and is poorly 
inhibited by DMI.21.22 
Interstitial Catecholamine COllcentrations During Ischemia and Repelfusioll 
In in vitro experiments in isolated rat hearts, 3 phases of ischemia-induced release ofNE, 
each with a different mechanism, have been recognized?,5,6,23 During the early phase of 
ischemia (0 to 10 minutes), the release of NE, if present, is exocytotic and depends on the 
activation of efferent sympathetic neurons. Accumulation of catecholamines in the extra-
cellular space during this early phase is prevented by the highly efficient UI mechanism and 
by presynaptic inhibition by adenosine, which accumulates in cardiac tissue during this phase 
of ischemia. The latter has been shown to be of particular importance in the rat, because 
adenosine concentrations are considerably higher than those in other species.24 During the 
second phase of ischemia {l0 to 40 minutes), the release ofNE becomes nonexocytotic and is 
thought to involve the U 1 mechanism in the carrier-mediated efflux of NE in reverse of its 
nom!al transport direction.'" During the third phase (>40 minutes ischemia), the release ofNE 
is no longer attenuated by UI inhibitors, which is explained by the occurrence of stmctural 
changes in the neuronal membrane of the myocardial neurons.2 
In the present study, a rapid and pronounced increase in :MIF concentrations of all 3 
catecholamines was observed shortly after occlusion of the LAD. Because released NE is 
avidly taken up by the cardiac VI mechanism, we expected a larger rise in NEMIF in the 
presence of the UI inhibitor DMI than without UI inhibition. However, during this first 10 
minutes of ischemia, the increment of NEMIF with UI blockade (5.8 to 8.5 nmol/L) was 
similar to the increment without UI blockade (0.9 to 2.7 nmoIlL). Possibly, in the parasym-
pathetically dominant porcine heart, UI carrieHnediated nonexocytotic NE efflux already 
occurred within the initial 10 minutes of ischemia, so in the presence of DMI, any decrease in 
UI-mediated clearance was compensated for by a decrease in the ischemia-induced UI 
carrier-mediated NE efflux. As mentioned, myocardial release of NE in first 10 minutes of 
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ischemia is not an invariable finding. For example, stimulation-evoked NE release has shown 
to be suppressed in rat hearts and human atrial tissue but to be facilitated in guinea pig hemis." 
Throughout the ischemic period, MIF catecholamine concentrations rose progressively in 
the ischemic area. Concentrations of catecholamines did not change in either the nonischemic 
LCx area or the systemic circulation. The reversal of the U I mechanism continued to 
contribute to the catecholamine release during the entire period of ischemia. Thus, U 1 
blockade attenuated the release of all catecholamines by .50%, indicating that despite 
infarction of 83% of the area at risk, U 1 was operative after 60 minutes of ischemia. Our 
findings vmy from those obtained in the ischemic myocardium of the isolated rat heart, where 
the reversed UI mechanism no longer conh'ibutes to the release of catecholamines 40 minutes 
after the induction of ischemia. This difference may be explained by the differences in 
experimental conditions (eg, in vivo versus ill vitro studies) and the species investigated.2 
On reperfitsioll, MIF catecholamine concentrations rapidly declined in the postischemic 
myocardium. Washout probably was the predominant factor ill the clearance of catechol-
amines in this early phase of reperfusioll. However, the decline in the first 10 minutes of 
reperfusion was substantially greater without inhibition of the U 1 mechanism, indicating that 
the UI mechanism also contributed significantly to the clearance of NE during early 
reperfusion. Although it should be noted that in contrast to techniques used in ill vitro 
shldies/,25 the time resolution of the MD te?hnique as presently used does not allow 
conclusions to be made regarding minute-toM minute changes in catecholamine concentrations. 
Compatible with previous findings that E and DA are less avidly taken up by UI than NE,'6 
the decline in E'"F and DAMIF during reperfusion was not affected by U I blockade. 
Origill of Myocardial Illterstitial E 
An interesting finding was the ischemia-induced increase in Er-.UF, albeit small compared 
with the increase in NEr-.UF. Because the concentrations ofEart and Er-.nF in the nonischemic LCx 
region did not change during ischemia, this increase must have originated from the heart. It is 
currently unclear whether this source is neuronal or extraneuronal. Evidence favoring 
extra neuronal synthesis and release of E is the presence of the enzyme phenylethanolamine N-
methyltransferase in extraneuronal myocardial tissue. IO,27 Furthelmore, an intrinsic cardiac 
adrenergic cell type outside the sympathetic nervous system, capable of releasing E and NE, 
has been identified in the human hem1. 10 Finally, enhanced cardiac E spillover into the 
coronary circulation of patients with heart failure during sympathetic stimulation was 
disproportionate to the spillover of NE, suggesting that E may in part be derived from sources 
other than chromaffin cells or sympathetic nerves."" On the other hand, it is known that 
sympathetic neurons can take up E from the circulation and release it upon stimuiation.28 In the 
present study, the pattern of release and clearance of E during ischemia and reperfusion was 
similar to that of NE and DA. Furthermore, inhibition of the neuronal VI mechanism 
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attenuated the ischemia-induced release of all catecholamines to a similar degree, suggesting a 
common source, thus favoring a neuronal origin. 
Flilictiollai Integrity of Sympathetic Nelw Elldings 
The effects of U 1 blockade on the NE}'IIF responses to ischemia and reperfusion 
suggested that UI mechanism of the sympathetic nerves was still functioning during and after 
the 60-minute LAD occlusion. This is further substantiated by the NEMIF response to tyramine 
at the end ofreperfilsion. Similar to NE, tyramine is taken up by neurons through UI, where it 
displaces NE from the nerve tenninals because of its higher affinity for the neuronal storage 
proteins. Consequently, the tyramine-induced NE release reflects both neuronal NE content 
and the efficacy of Ul. 12,29 The increase in NE~lIF in the postischemic LAD region was very 
similar to that in the nonischemic control hearts (Figure 2).12 These findings are in line with 
those reported by Shindo et al,4 who studied the tyramine-induced NE release in nonischemic 
and post ischemic areas in feline hearts after 40 minutes of reperfusion after 40 minutes of 
ischemia. In addition, in the present study, the attenuation of the tyramine-induced NE release 
by U I inhibition in both postischemic and non ischemic groups also was similar (Figure 2). 
Although the present experimental setup does not allow for any predictions concerning the 
long-tenn survival of sympathetic nelves, the present findings indicate that sympathetic nerve 
temlinals remained functionally intact at least during the first few hours after reperfusion. 
However, functional alterations of the somata of the sympathetic nerves cannot be entirely 
excluded. Thus, in a canine model of tachycardia-induced heart £'lilure, impainnent of the 
myocardial contractile response to electrical or chemical stimulation of sympathetic somata 
was observed at a time when the contractile response to tyramine was completely preserved.30 
Implications 
Although the pathophysiological significance of the massive accumulation of 
catecholamines in the ischemic myocardial issue was not investigated in the present study. 
there is evidence from experimental as well as clinical studies that high catecholamine 
concentrations are deleterious to the heart.3H4 Several studies have demonstrated NE-
dependent antiarrhythmic effects of UI inhibition during ischemia with either tricyclic 
antidepressant agents like desipramine and imipramine or stmcturally unrelated U I inhibitors 
like cocaine and nisoxetineY' This study provides a possible explanation for this beneficial 
effect by demonstrating that the reversed UI mechanism contributes substantially to the 
release of catecholamines during ischemia. 
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Cardioprotection in pigs 
by exogenous norepinephrine 
but not by cerebral ischemia-induced 
release of endogenous norepinephrine 
Brief Ischemia: a double-edged sword 
Cardioprotection in Pigs by Exogenons Norepinephrine, but not by Cerebral 
Ischemia-Induced Release of Endogenous Norepinephrine 
Sandra de Zeeuw, Thomas TV Lameris, Dirk J Dunckel', Djo Hasan, 
Frans Boomsma, Anton H van delllvleiracker, Pieter D VerdolHv 
Background Endogenous norepinephrine release induced by cerebral ischemia may lead to 
small areas of necrosis in Honnai hemis. Conversely, norepinephrine may be one of the 
mediators that limit myocardial infarct size (IS) by ischemic preconditioning. Because 
brief ischemia in kidneys, gut or skeletal muscle limits IS produced by a coronary artery 
occlusion, we investigated whether cardiac norepinephrine release during transient 
cerebral ischemia is also capable of eliciting remote myocardial preconditioning. 
I\1ethods and Results In 10 anesthetized control pigs, IS after a 60-min coronary occlusion 
and 120 min of rcperfusion was 84±3% (mean±SEM) of the area at risk. Intracoronary 
infusion of 0.03 nmollkg·miIf' norepinephrine for 10 min before coronary occlusion did 
not affect IS (80±3%, IF6), whereas infusion of 0.12 nmollkg·min·1 limited IS (65±2%, 
n~7, P<0.05). Neither a 10-min (n~5) nor a 30-min (IF6) period of cerebral ischemia 
produced by elevation of intracranial pressure before coronary occlusion affected IS 
(83±4% and 82±3%, respectively). Myocardial interstitial norepinephrine levels tripled 
during cerebral ischemia and during low dose norepinephrine, but increased ten-fold 
during high dose norepinephrine. Norepinephrine levels increased progressively up to 
500-fold in the area at risk during the 60-min coronary occlusion, independent of the 
pretreatment, while norepinephrine levels remained unchanged in adjacent non-ischemic 
myocardium and arterial plasma. 
Conclusions Cerebral ischemia preceding a coronary occlusion did not modify IS, which is 
likely related to the modest increase in myocardial norepinephrine levels during cerebral 
ischemia. The IS limitation by high dose exogenous norepinephrine is not associated with 
blunting of the ischemia-induced increase in myocardial interstitial norepinephrine levels. 
(Stroke, revisioll submitted) 
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Introduction 
Ischemic preconditioning, originally described for the myocardium I is not organ specific 
as it also occurs in kidneY,2,3 skeletal ml1scle,4,S IUllg6 and brain.7,8 Przyklenk et al.9 have 
shown that brief regional myocardial ischemia protects not only the jeopardized myocardium 
from infarction during a subsequent coronary artery occlusion, but also the adjacent "virgin" 
myocardium. Several groups of investigators have extended this obselvation and have shown 
that brief ischemia in remote organs sllch as kidney,IO.12 small intestines lO and skeletal 
muscle,13 is capable of limiting myocardial infarct size produced by a prolonged coronary 
artery occlusion. Norepinephrine is one of the mediators involved in the signaling pathway 
leading to ischemic preconditioning,14.16 and because cerebral ischemia has been reported to 
cause a profound release of norepinephrine from sympathetic nerve endings in nonnal 
myocardium,17 this raises the question whether transient cerebral ischemia prior to a coronary 
artery occlusion may also be cardioprotective. In addition, exogenous administration of 
norepinephrine before a coronat)' artel)' occlusion has been shown to elicit cardioprotection in 
rabbits!S and rats. 19 The aim of the present study was therefore to study the effect of cerebral 
ischemia on myocardial infarct size produced by a'coronary artery occlusion in pigs. Because 
the cardioprotective effect of norepinephrine has not been established in pigs, we first shldied 
whether intracorol1at)' infusions of norepinephrine are capable of limiting myocardial infarct 
size, A fmiher aim was, using the microdialysis technique,I7,20 to quantitate the increase in 
myocardial norepinephrine concentrations during cerebral ischemia and exogenous 
norepinephrine infusions, and to determine whether limitation of inL1rct size by these 
interventions is mediated by attenuation of myocardial interstitial norepinephrine levels during 
the infarct~producing coronal), artery occlusion.21 
Methods 
The present experiments conformed with the "Guide for Care alld Use of LaboratOlJ' 
Allimals" published by the US National Institutes of Health (NIH publication No. 85-23, 
revised 1996) and under the regulations of the Erasmus University Rotterdam. 
Etperimelllal Groups 
Fourty one crossbred Landrace x Yorkshire pigs of either sex (34±l kg) were assigned to 
one of 7 experimental groups of which in 6 groups myocardial infhrct size was determined at 
the end of the protocol (Figure I). Ten of these animals (Control) underwent only a 60-min 
occlusion of the left anterior descending coronary artery (LAD) followed by 120 min of 
reperfusioll, while in 13 animals the 60·min LAD occlusiOlH'eperfusion protocol was preceded 
by a IO-min infusion of norepinephrine into the LAD at a rate of either 0.03 nmoVkg-min'! 
(NEww, n~6) or 0.12 lllilollkg-min'! (NEHlGH , n~7). In 3 additional animals, the effects of a 10-
min infusion of the high dose of norepinephrine (NEH'GH SHA\a on regional myocardial function 
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and metabolism was evaluated in order to assess whether this dose produced myocardial 
ischemia and asynchrony of contraction. In£1rct size was not detennined in these animals. In 5 
animals a lO-min period of global cerebral ischemia (CliO) preceded the 60-min LAD-
occlusion by 20 min, while in 6 animals the LAD-occlusion was preceded by a 30-min period 
of cerebral ischemia (CI30) and 30 min of reperfusion. Finally, in 4 animals, we studied 
whether 30 min of global cerebral ischemia per se (CI30 SHA.") produced damage of nonnal 
myocardium. Cerebral ischemia was achieved by rapid infusion of artificial cerebrospinal 
fluid,22 such that intracranial pressure increased to approximately 250 nmilig, which was 
invariably above the systolic arterial pressure. In all groups, a 120-min stabilization period 
followed the surgical procedures, after which baseline measurements of cardiovascular 
performance were made. Microdialysis was perfonned in the Control, NEww, NEII!Gu, and CI30 
groups. Dialysate samples were collected over 10-min periods for detennination of myocardial 
interstitial norepinephrine concentrations stmiing 90 min into the stabilization period, a time at 
which norepinephrine concentrations have reached stable levels.20,21 During the subsequent 30 
min baseline dialysate samples were collected. Plasma samples were obtained halfway through 
each 10-min dialysate collection period Animals which encountered ventricular fibrillation 
during the LAD-occlusion or upon reperfusion, but in which sinus rhythm was successfully 
restored by DC-countershock within 2 min, were allowed to complete the experimental 
protocol. 
Swgel)1 
Overnight fasted pigs were sedated with ketamine (20-25 mglkg i.m., Apharmo BY, 
Arnhem, The Netherlands), anesthetized with sodium pentobarbital (20 mglkg i.v., Aphanno), 
intubated, and connected to a respirator for intermittent positive pressure ventilation with 30% 
oxygenated room air. Respiratory rate and tidal volume were set to keep arterial blood gases 
within the Honnai range. Catheters were inserted into the superior caval vein for infusion of 
sodium pentobarbital (10-15 mg/kg·lf') to maintain a constant depth of anesthesia and saline 
for replacement of blood withdrawn during sampling. A fluid-filled catheter was placed in the 
descending aorta for the measurement of a0l1ic blood pressure and collection of arterial blood 
samples, while a micromanometer-tipped catheter was inserted into the left carotid artery and 
advanced into the left ventricle for the measurement of left ventricular pressure (L VP) and its 
first derivative (LYdP/dt). After administration of pancuronium bromide (4 mg, Organon 
Teknika BY, Boxtel, The Netherlands), a midsternal thoracotomy was perfonned, and the 
heart was suspended in a pericardial cradle. An electromagnetic flow probe (Skalar, Delft, The 
Netherlands) was placed around the ascending aOlia for the measurement of cardiac output, 
while the segment of the LAD between the first and the second diagonal branch was dissected 
free for placement of a Doppler flow probe (Triton Teclmology Inc., San Diego, CA, U.S.A.) 
and a microvascular clamp. In the 16 animals which received intracoronalY infusions of 
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norepinephrine (NELOWI NEIlIGIh and NEHlGH SHM\), a small cannula was inserted into the LAD 
distal to the flow probe. 
LAD-occlusion Reperfusion 
Control n=10 
NELQW n=6 
NEHIGH n=7 
NE 
NEHIGHSHAM ml n=3 
ICP t 
CI10 n=5 
CI30 n=6 
CI30SHAM n=4 
I I I I 
I I 
/I I 
-60 -30 0 60 Time (min) 180 
Figure 1 Diagram sholVing the 7 experimental groups. Norepinephrine (NE) was ill/used at a rate 0/ either 
0.03 (NELO~) 01' 0.12 1I11101Ikg'mill-1 (NEmGII and NEwGHSJWJ into the left arterial descending coronmy artel)' 
(LAD). Global cerebral ischemia (CI) produced by elevating illlracrallial pressure (ICP) to 250 mmHg, 
was maintailled/or either 10 mill (ClIo) 01' 30 mill (Cho and CI)olilloJ. In/arct size was determined al the 
end 0/120 mill o/repel/usio1l ill all groups e.'(cept in NEHIGHIiH,m. 
Microdialysis probes were implanted in the left ventricular myocardium using a steel 
guiding needle and split plastic tubing: one in the area perfused by the LAD and one in the 
area perfused by the left circumflex coronary artery (LCX). Finally, in the CIJO group a third 
microdialysis probe was placed in the cortex of the brain. Perfusion of the probes started 
immediately after insertion.20,21 
In the CI30 SHAM and NEHIGII SHAM groups ultrasound crystals were implanted to assess the 
effect on regional myocardial wall function using sonomicrometry (Triton Technology Inc., 
San Diego, CAl. Each pair of crystals was implanted in the midmyocardial layer 
approximately 10 mm apart and parallel to the fiber direction. In these animals also the great 
cardiac vein accompanying the LAD was cannulated for collection of coronary venous blood 
samples. Finally, in the NEHlGII SltA\l group, also the left atrium was cannulated for injection of 
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radioactive microspheres (' J3Sn or I4ICe, 15±1 (SD) ~Ill) to determine the distribution of 
myocardial blood flow at baseline and at the end of the norepinephrine infusion. I 
In order to produce cerebral ischemia, two catheters were inserted into the left and right 
cerebral lateral ventricles through bore holes.23 A fluid-filled catheter was used for infusion of 
the artificial cerebrospinal fluid to elevate intracranial pressure, which was monitored with a 
micromanometer-tipped catheter. 
Microdialysis Methodology 
The polycarbonate dialysis membrane of the microdialysis probes (CMAf20, Camegie 
Medicine AB, Sweden) has a cut-off value of20 kD, a length of 10 mm and a diameter of 0.5 
mIll. Cardiac probes were perfused with an isotonic Ringer's solution and the cerebral probe 
with the artificial cerebrospinal fluid, at a rate of 2 Ill/min using a CMAfIOO microinjection 
pump. Dialysate volumes of 20 III (sampling time IO min) were collected in microvials 
containing 20 ~I of a solution of 2% ("I,) EDTA and 30 nM I-elythro-alpha-methyl-
norepinephrine (AMN) as internal standard in 0.08 N acetic acid. Plasma samples were drawn 
into chilled heparinized tubes containing 12 mg glutathione. All samples were stored at -80'C, 
until analysis within the next five days.20,21,24 
III vivo probe recovery of norepinephrine (52±1%) has previously been determined by 
retrodialysis, using AMN as a calibrator and by direct comparison of hemo-microdialysis and 
plasma samples.20,21,25 
Infarct Size Determination 
At the end of the 120-min reperfusion period, the LAD was reoccluded and the area at 
risk was determined by intra-atrial infusion of 20 ml of 5% C'/w) fluorescein sodium.26 
Ventricular fibrillation was then induced using a 9V battery and the heart was excised. 
Subsequently, the left ventricle was isolated and cut parallel to the atrioventricular groove into 
five slices of equal thickness. After the area at risk was demarcated on an acetate sheet under 
ultraviolet light, slices were incubated in 0.125 g para-nitrobluetetrazolium (Sigma Chemicals 
Co., St Louis, U.S.A.) per liter of phosphate buffer (PH 7.4) at 37'C for 30 min, after which the 
non-stained pale infarcted area was also traced onto the sheet. The area at risk and the infarct 
area were detennined by summation of the areas at risk and infarct areas of the individual 
rings. Myocardial infarct size was defined as th~ ratio of the infarct area and area at risk. 
Regiollal Myocardial Flillclioll alld Pel/usioll 
From the segment length tracings percent systolic shortening (SS) was calculated as the 
difference in segment length at end-diastole and the minimal segment length during systole 
divided by the segment length at end-diastole. The development of asynchrony during local 
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infusion of norepinephrine was assessed by detennining the time interval between the 
occurrence of minimal segment length (Ln.;.) in the areas perfused by the LAD and LeX. 
Myocardial 02-extraction (%) was calculated as the ratio of the arterio - coronary venous 
O,.content difference and the arterial O,-content. At the end of the experiment, the heart was 
excised, the LAD and LeX perfused areas were separated and divided into three layers of 
equal thickness. The subendocardial (inner layer) and subepicardial (outer layer) blood flows 
and their ratios were detemlined using standard techniques. 1 
Statistical Analysis 
All data have been expressed as mean±SEM. Statistical significance (P<0.05) for the 
changes in hemodynamics mid norepinephrine concentrations was detennined by two-way 
ANOYA and one-way ANOYA for repeated measures, followed by Dunnett's multiple 
comparison test. Statistical significance (P<O.05) for differences in infarct size was determined 
using one-way ANOY A without replication followed by Student's t test. 
Results 
Hemodynamics 
Norepinephrine infusions. Intracoronary norepinephrine infusion in the NELOW group 
produced an increase in LVdP/dtmax, reflecting an increase in regional contractility as the other 
cardiovascular variables remained unaffected (Table I). During the 10-min washout period 
LVdP/dtmax retumed to baseline. During norepinephrine infusion in the NElilGII + NE IIIGII SHAM 
animals, mean arterial pressure decreased rapidly from 91±2 to 74±6 mmHg at 5 min followed 
by a gradual recovelY (Table I). The decrease in cardiac output was responsible for the fall in 
at1erial blood pressure as systemic vascular resistance remained unchanged. Cardiac output 
decreased, because the increase in heart rate was insufficient to compensate for the decrease in 
stroke volume. The latter occurred despite the increase in LV dP/dtmax• and was likely due to 
asynchrony of contraction (see below). At the end of the I O-minllorepinephrine infusion mean 
arterial pressure was still slightly depressed (10%), while heart rate (10%) and LYdP/dtm", 
(65%) remained elevated. All parameters recovered during the 10-min washout period that 
preceded the 60-mill LAD-occlusion. 
After 2 min of norepinephrine infusion jn the NEwGII SHAM group SS in the LAD perfused 
myocardium increased from 27±2% at baseline to 34±4%, while SS jn the LeX area decreased 
from IS±!% to 13±I% (both P<0.05). SS in either area did not change further during the 
remainder ~f the infusion period. These changes were accompanied by asynchrony of 
contraction between the LAD and LCX areas. Thus, whereas under baseline conditions Lmin of 
both areas occurred at the end of global left ventricular systole, during norepinephrine the 
occurrence of Lm;, in the LAD area preceded Lm;. in the Lex area by 119±2 ms (P<0.05). The 
latter was due to Lmin in the LAD area occurring 56±15 illS before and Lmin in the LCX area 
- 163-
Table 1 Cardiovascular HemodVnamics During NoreEineEhrine Infusion or Cerebral Ischemia 
Treatment Baseline !:::. abs from Baseline 
2 min 5 min to min 30 min Recove!y 
NE~w 93±3 O±3 2±2 3±3 -1±2 
MAP,mmHg NE.,IGH + NEHIGH$HA.M 91±2 ~15±6'" ~17±5'" ~8±4 -2±2 ClIO 92±5 80±10'" 53±13'" -1l±5 -16±12 
CI30 + CI30 SfIAM 90±4 83±6'" 67±8'" ~19±4'" ~17±5'" ~20±4'" 
NE~w 2.9±0.2 O.O±O.1 O.O±O.1 O.O±O.1 -O.I±O.1 
CO,I'min-) NE.,IGli + NEIIlGHSHAM 2.5±O.2 ~OA±O.2'" ~O.5±O.2'" -O.2±O.1 -O.I±O.1 
Clio 3.8±0.5 O.7±O.2* 2.1±OA'" O.7±O.3 -O.3±O.6 
CI30 + Cho SHA-\\ 3.1±O.2 O.7±O.2'" 2.2:!:0.3'" OA±O.1 '" 0.9±O.2'" -O.2±OA 
NE~ow 33±3 O.2±O.8 OA±O.7 l.l±O.7 1.l±1.l 
SVR, mmHgll'min-1 N"E,IIGH + ~IGH SlIAM 37±3 -O.6±1.4 O.7±O.9 O.6±l.O 1.2±O.9 
ClIO 26±3 lS.9±4.6'" 1.4±4.4 ~7.4±1.9'" -3.6±l.O'" 
Cho + CI 30 Sl{AM 30±2 18.8±4.2'" 1.8±3.2 -8.8±1.3'" -ll.O±l.S'" -9.00.1 '" 
NE~w 107±7 1±1 1±2 1±2 1±3 
HR...bpm NEIMH + NEHlaHSl1M! 117±6 13M'" lS±5'" 12±5* 2±2 ClIO 112±5 37±8'" 68±12'" 19±13 17±IO 
CI30 + CI30sfIAM 101±3 46±5'" 79±6'" 22±4'" 2±3 9±7 
NE~ 27±4 l.l±l.S 1.5±1.4 1.2±1.2 O.5±l.l 
SV,ml NEHIGH + NEmGHSHAM 22±2 -S.4±1.9* -6.4±1.6* -3.8±1.7 -l.l±O.7 ClIO 33±3 -2.6±2.2 0.2±3.8 1.4±3.0 -S.8±3.0 
Cho + CI30511AM 30±2 -4.4±1.8'" -O.8±1.5 -1.8±1.2 8.0±1.6* -4.2±3.2 
NEeow 1560±110 760±IOO'" 790±90>l< 8S0±60>l< -60±70 
LVdP/dtmax. mmHg's-) NEmGH + NEmGIl SHAM 2030±200 86Q±210'" 890±160'" 1270±120* -150±70 
CliO 1790±170 2810±660'" 46S0±910'" -310±410 410±560 
CI30 + CI30 ~'IAM. 1640±120 2570±440* 5010±340'" 160±230 -90±170 SOO20 
NEww 8±2 1.2±O.5 l.3±O.6 1.9±O.8 l.l±O.6 
LVEDP.mmHg N"E,IIGH + ~ilClII SI{AM 8±1 -1.7±O.8 ~2.0±0.8>1< -1.4±O.6 O.7±O.6 ClIO 9±1 8.S±1.7'" l.S±1.2 O.2±2A -2.S±1.8 
CI30 + C13O :>l1M! 7±1 10.6±2.5* O.9±1.7 -1.2±1.2 1.8±1.5 O.0±0.9 
NEtow l.7±O.2 O.3±O.2 O.3±O.2 O.3±O.1 O.0±0.2 
CBF. rnl/ming-1 NEIiIClII + NEHIOH SlIM! 1.0±0.1 O.O±O.1 O.I±O.1 O.3±O.1 O.O±O.1 ClIO 1.0±0.2 J.O±O.2'" 0.7±O.1'" O.O±O.1 -O.I±O.1 
CI~ + CI'2<Ii~M l.3±O.l 1.3±O.2'" 1.4±O.3'" -O.I±O.1 O.2±O.2 -O.I±O.1 
MAP. mean arterial blood pressure: CO. cardiac output; SVR. systemic vascular resist::lnce; HR. heart rate; SV. stroke volume: L VdPJdtmax. maximal mte of rise in left ventricular pressure; L VEDP. 
left ventricular end-diastolic pressure; CBF.coronary blood flow. NElow and NErugh refer to the infusion rates of nor epinephrine (0.03 and 0.12 nmoIlkg'min"l, respectively); ClIO and CI;1O refer to the 
durations of cerebral ischemia (CI) (10 and 30 min, respectively); The NEHIGH$HA.M and CI)o SlIM! animals did not undergo the 60~min LAD~occ1usion and 120-min reperfusion protocol L VdPJdt:..-. 
maximal rate of rise ofleft ventricular pressure. Datrl. are mean±SEM; n=6 (NE~ow). n=10 (NEIllGH + NEHICHSIVl"J. n=S (el lO). n=lO (CIJO + CI3O $HA.M); "'P<0.05 vs Baseline. 
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occurring 63± 7 ms after closure of the aOliic valves (both P<0.05 vs their respective baseline 
values). During washout all wall function parameters retumed to baseline values. 
In the LAD area of the NEWGHSHAM group, Orextraction decreased slightly from 64±7% at 
baseline to 54±7% during norepinephrine infusion, indicating that Or delivery increased 
slightly in excess of the increase in myocardial Ordemand. In agreement with this finding, 
myocardial proton release was not increased, as reflected by the maintained arterio - coronary 
venous pH difference (O.OG±O.O 1 at baseline and O.06±O.O I at the end of infusion). Moreover, 
the subendocardial to subepicardial blood flow ratio remained unchanged in both the LAD 
area (I.l4±O.25 at baseline and 1.30±O.17 at the end of infusion) and the LCX area (1.21±0.07 
and 1.24±0.05, respectively). Finally, SS in the LAD and LCX areas retumed to baseline 
values immediately during the recovClY period (24±3% and 17±1 %, respectively), indicating 
that the infusion of norepinephrine did not produce myocardial ischemia and stunning. 
Cerebral ischemia. The elevation of intracranial pressure from 12±2 mmHg at baseline 
to 250 mmHg produced an immediate increase in mean aOliic pressure in both the ClIO and 
CI30 + CI30 SHAM animals, which was initially the consequence of increases in both cardiac 
output and systemic vascular resistance (Table I). However, after 5 min the tachycardia-
mediated increase in cardiac output was exclusively responsible for the elevated arterial blood 
pressure. Despite the dramatic increase in afterload, stroke volume was maintained most likely 
due to enhanced myocardial contractility as LV dP/dtmax increased lip to four times its baseline 
value. The increase in coronary blood flow paralleled the increase in myocardial oxygen 
demand, reflected by the 150% increase in double product (heart rate . systolic arterial 
pressure). 
Similar to earlier observations in dogs27 and pigs,17 the transient hyperdynamic phase 
was followed by a fall in mean arterial pressure below baseline levels at 10 min of cerebral 
ischemia, which was the result of a decrease in systemic vascular resistance. Except heart rate, 
which remained slightly elevated, all other variables had recovered at 10 min. In the CIJO + 
CI30 SHAM animals, mean arterial pressure, cardiac output and systemic vascular resistance did 
not change filliher during the remainder of the 30 min period. Although cardiac output did not 
change, heali rate returned to baseline levels, and stroke volume increased. During the 
recovery period, intracranial pressure returned to baseline values (12±2 mmHg), and except for 
mean arterial pressure and systemic vascular resistance, all other variables had also recovered 
(Table I). 
The elevation of the intracranial pressure produced a small decrease in myocardial O2-
extraction from 64±5% at baseline to 58±6% at 5 min and no change in myocardial proton 
release (i.e. no widening of the arterio - coronary venous pH difference: 0.04±0.0 1 both at 
baseline and at 5 min), indicating the absence of myocardial ischemia. The elevation of the 
illtracranial pressure decreased SS from 24±1% to 16±2% at 2 min, but at 5 min SS had 
already recovered to 23±1% and to 2G±I% at 10 min, with no evidence of depressed regional 
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Table 2 Cardiovascular IIemod~namics During Coronary: Occlusion and Reperfilsion 
Treatment Pre-occlusion End-occlusion End-reperfusion 
Control 90±2 75±2* 76±6* 
NEw'll 93±4 72±6* 70±5* 
MAP,mmHg NEHJ<JfI 87±4 77±S 77±4 
ClIO 7S±9 74±5 65±5 
CI30 65±4 61±S 66±4 
Control 2.6±0.2 2.1±O.l* 2,1±O,2* 
NEw,. 2.8±O.2 2,3±O,2* 1.9±Q,1* 
CO,I'min,1 NE1UGU 2.2±O.2 1.9±O.2* 1.8±Q,2* 
ClIO 3.5±O.4 2.9±O.3 2.S±0.4 
CI30 2.9±0.3 2.2±O.2* 2.0±0.1* 
Control 38±3 37±3 38±4 
NEw,,' 34±4 32±3 38±4 
SVR,lluuHgll'min'[ NEHJG!! 41±4 43±4 45±S 
ClIO 22±3 27±4 28±4*' 
CI30 24±2 28±2* 33±2* 
Control 115±4 123±7 139±8* 
NElOW lO8±9 112±9 119±13 
HR,bpm NE)f:<;" I 24±6 133±11 136±11 
CliO 129±7 119±9 120±7 
CI)o 112±6 112±S IIS±6 
Control 22±2 18±1* 16±l* 
NElOW 27±4 22±3 17±2 
SV,ml NE~G!! 18±2 14±2*" 13±1* 
ClIO 28±4 25±4 21±3 
CI30 25±2 20±2* 18±1* 
Control 1610±100 1480±100 I 640±260 
NEw,,· ISOO±11O 13SO±IIO 12SO±l00 
LVdP/dtm.m mmHg·s·1 NElllGH 1980±280 2060±3S0 20S0±340 
ClIO 2200±410 1630±140 13SO±l40 
CI30 1710±320 12SO±l60 1170±100 
Control 7±1 9±1 1O±!* 
NElO'~' 9±2 10±1 10±1 
LVEDP,mmHg NEH,,,,. 8±2 1O±2 12±1 
ClIO 7±3 13±3 13±! 
CI30 6±1 9±2* 12±1* 
MAP, me8fi arterial blood pressure; CO, cardiac output; SVR, systemic vascular resistance; HR, heart mte; SV, stroke volume; 
LVdP/dt;n", maximal rate of rise in left ventricular pressure; LVEDP, left ventricular end·diastolic pressure. Pre·occlusion values 
of the Norepinephrine and Cerebral Ischemia groups correspond to the recovery valnes in Table I; NE low and NE high refer to the 
infusion rates of norepinephrine (0.03 and 0.12 nmol!kg·min·1, respectiyely); CliO and CIJO refer to the durations of cerebral 
ischemia (el) (IO and 30 min, respecth'ely); L VdP/dtrr:au maximal rate of rise of left ventricular pressure. 
Data are mean±SEM; n=tO (Control), n",6 (NEw.,,), 11"'7 (NE)ljG!!), n=5 (ClIO), n=6 (Cho); *P<0.05 vs Pre·occlusion. 
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wall function during the remainder of the 30 min period (27±1 %) or the subsequent recovery 
phase (23±3%). 
LAD-occlusion and repeljilsioll. Mean arterial pressure in the control group decreased 
secondaty to the decrease in cardiac output during the 60-min LAD-occlusion and did not 
change fmiher during reperfusion (Table 2). Hemirate increased slightly, but insufficiently to 
compensate for the decrease in stroke volume. 
Pretreatment with norepinephrine had no effect on the hemodynamic responses during 
the subsequent LAD-occlusion and reperfusion, in either the NEww or NEwGII group. In the 
animals subjected to cerebral ischemia prior to the LAD-occlusion, mean aortic pressure did 
not further decrease during the LAD-occlusion most likely because systemic vascular 
resistance, which was still below baseline levels at the onset of the LAD-occlusion, recovered. 
Area at Risk Infarct Size 
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Figure 2 Area at risk alld illfarct size for the 5 e.\perimental groups in which the LAD was occludedfor 60 
mill and reperfused for 120' mill. Global cerebral ischemia alone did 1101 cause irreversible myocardial 
damage (not showlI). *P<O, 05 liS COlllrol, Forfllrtherdetails see Figure /, 
Myocardial Infarct Size 
The area at risk of the Control group and of the groups pretreated with norepinephrine or 
cerebral ischemia prior to the 60-min LAD-occlusion were identical (Figure 2). Infarct size 
was 84±3%, in the Control group and 80±3% in the NELOw gl'OUp, but was only 65±2% in the 
NEIIIGH group (P<0.05). Cerebral ischemia had no effect on infarct size development during the 
60-min LAD occlusion as in the ClIO and CI" groups infarct size was 83±4% and 82±3%, 
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respectively. Cerebral ischemia per se did not cause irreversible damage as in none of the CI30 
SHAM animals infarct tissue was detected. 
20 
S 
o 
E 15 
-S 
'" c: 
:§ 10 
Q. 
'" c: 
'6.. 5 ~ 
o 
Z 
NE 
+-> 
* 
NE LOW 
o 30 60 
Time (min) 
20 
15 
10 
NE 
+-> 
* 
o 30 60 
Time (min) 
20 
15 
10 
5 
o 
* 
CI30 
ICP 
* 
* 
o 30 60 
Time (min) 
Figllre 3 Norepillephrine levels ill plasma (hatched bars) and ill the interstitium of left ventricular 
myocardium perfitsed by the LAD (full circles) and Lex (opell circles) during the 1O-l1Iill norepinephrille 
ill/us ions alld during 30 mill 0/ cerebral ischemia. *P<O.05 \'s Baselille. Forfurther details see Figure 1. 
A1yoca1'dial Illterstitial Norepinephrine COllcentratiolls 
The myocardial interstitial norepinephrine levels in the LAD perfused area increased 
from 0.S±0.2 nmoUI to 2.2±0.5 nmol/l during norepinephrine infusion in the group NEww, and 
to 12.2±5.9 nmol/I in the NE""" group (both P<0.05, Figure 3). Despite the intracoronary 
route of administration, there was some spillover in the NE IIIGH animals as evidenced by small 
transient increments of norepinephrine in plasma from 0.2±0.1 to 1.0±0.2 nmoUl and in the 
interstitium of the LCX-perfused myocardium from 1.J±0.3 to 2.4±1.2 nmoUI (both P<0.05, 
Figure 3). 
In the ClJO group, cerebral interstitial norepinephrine levels increased from 0.9±OA 
nmol/l at baseline to 6. 1±1.9 nmol/I at 10 min of intracranial pressure elevation and increased 
gradually up to S.3±I.S nmoUI at 30 min (not shown in Figure 3). Upon cerebral reperfusion, 
interstitial levels initially increased further to 12.3±2.3 nmoUI but retumed to baseline during 
the 30-min recovery period. Cerebral ischemia resulted in a transient tripling of interstitial 
norepinephrine levels in both the LAD- and LCX-perfused myocardium, and a 20-fold 
increase in plasma norepinephrine levels (Figure 3). 
In the Control, NELOW, NEH1GH• and CI30 groups, norepinephrine levels increased 
progressively during the LAD-occlusion by up to approximately 500-fold, and decreased to 
baseline levels during reperfusion, independent of the preceding intervention (Figure 4). There 
was no correlation (r = 0.03) between the maximum interstitial norepinephrine levels during 
the LAD-occlusion and myocardial infarct size. 
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Figure 4 Norepinephrille levels ill plasma (hatched bars) and ill the tilters/ilium oj left ve1lfricular 
myocardium perfused by the LAD ({Illl circles) alld LCX (open circles) during 60-1IIin LAD occlusioll alld 
J 20 mill of reperJlIsioll, Notice that the levels in the LAD-peljilsed myocardium increased 50010ld during 
LAD-occlusion indepelldent of the precedillg illfervelltioll, while the levels ill the LCX-perJused 
myocardium ami plasma remained unchanged. 
Discussion 
The major findings of the present study in swine are: (i) global cerebral ischemia, 
produced by either a IO-min or a 30-min elevation of intracranial pressure, which by itself 
produced no in'eversible myocardial damage, had no effect on myocardial infarct size 
produced by a 60-min coronary artery occlusion; (ii) intracoronary inlhsion of 0.03 
nmollkg'min-1 norepinephrine produced similar increases in myocardial interstitial levels as 
cerebral ischemia, and did also not limit myocardial infarct size; (iii) conversely, intracoronary 
infusion of 0.12 nmollkg'min-' of norepinephrine Ihat resulted in five times higher myocardial 
interstitial norepinephrine levels than cerebral ischemia and low dose norepinephrine was 
capable of limiting myocardial infarct size; (iv) the cardioprotection by exogenous 
norepinephrine was not caused by ischemic preconditioning and (v) this protection was not 
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associated with a blunting of the progressive increase in myocardial interstitial norepinephrine 
levels during the coronary atiery occlusion. 
Catecholamines and myocardial il1jll1Y 
The relation between catecholamilles and myocardial injmy was first established by 
Rona and co-workers,2S-30 who showed some 40 years ago that administration of high systemic 
doses of isoproterenol produced focal necrotic lesions in nOlTIml rat hemis.29 
Elevation of intracranial pressure is well recognized as a cause for myocardial 
dysfullction and injury. Brain death caused by increased intracranial pressure has been shown 
to produce echocardiographic alterations, hemodynamic instability, and contraction band 
necrosis, all of which have been suggested to be the result of massive neuronal depolarization 
and release of catecholamines.31 -35 These clinical observations initiated a large number of 
experimental investigations in which deleterious effects of brain death on fUl~ction and 
integrity of nonnai myocardium were found, but generally 110 or only minimal focal 
myocardial necrosis could be demonstrated,36-40 
In view of the massive release of norepinephrine in the myocardium during coronary 
artery occlusion,2lAI it could be hypothesized that catecholamines may contribute to the 
development of in"eversible injUlY during a coronalY artcIY occlusion. Several,42-4S though 
certainly not all,46-48 studies have reported that p-adrenoceptor blockade slows the 
development of myocardial infarction produced by a coronalY aliery ligation. In contrast, 
depletion of cardiac norcpinephrine stores by reserpination, did not limit myocardial inh1rct 
size in rabbits14 and dogs,16 suggesting that endogenous catecholamines do not contribute to 
irreversible damage. 
In contrast to the potentially deleterious effects of norepinephrine on normal and 
ischemic myocardium, this catecholamine has also been implicated in mediating 
cardioprotection by ischemic preconditioning. Thus, Toombs et al. 14 have shmvn that in 
rabbits the protection by ischemic preconditioning was abolished when catecholamine stores in 
sympathetic nerve endings were depleted by prior administration of reselpine. Furthennore, 
Thomton et al. 18 demonstrated in the same species that tyramine-induced norepinephrine 
release 10 min before a 30-min coronary artely occlusion also protected the myocardium. This 
cardioprotcctive action of catecholamines has been confinned in other species such as the rat19 
and the dog. ls,16 We now show that a high dose ofnorepincphrine can also protect the porcine 
myocardium against a sustained ischemic epidose. 
Our data on wall function, (distribution of) myocardial blood flow, 02-extraction and 
proton release indicate that the high dose of norepinephrine did not produce myocardial 
ischemia and did therefore not protect the myocardium by ischemic preconditioning. In 
supp0!1 of this observation, the degree of protection afforded by norepinephrine was less than 
what we previously rep0!1ed for ischemic preconditioning, but similar to that produced by 
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other nonRischemic stimuli, like ventricular pacing49 and pharmacological agents such as the 
K\TP channel openers bimakalim50 and aprikalim.5J Since all these stimuli have in common 
that they ultimately activate K+ ATP channels, it is tempting to speculate that norepinephrine 
also protected via u\RadrenoceptorRmediated protein kinase C activation and subsequent 
opening of (mitochondrial) K\TP channels.52 Another mechanism by which norepinephrine 
might protecfthe myocardium is via a blunted release in catecholamines during the sustained 
ischemic episode as has been suggested for ischemic preconditioning.53 However, 
pretreatment with norepinephrine did not modify the release of cardiac norepinephrine during 
sustained myocardial ischemia, in the present study, implying that the norepinephrine-
mediated cardioprotection is not related to a blunting of the ischemiaRinduced increase in 
norepinephrine levels. 
Finally, the present study clarifies another issue on the role of norepinephrine in 
cardioprotection. Przyklenk et al.9 demonstrated that myocardial ischemia could also elicit 
cardioprotection in adjacent virgin myocardium and speculated that this cardioprotective effect 
might have been triggered by a substantial release of catecholamines in that adjacent region. 
However. the present study shows that norepinephrine levels in the n0l1llal (LeX-perfused) 
myocardium remained unaltered during and after the 60Rmin LADRocclusion (Figure 4), even 
though the interstitial norepinephrine levels in the LAD-per/\lsed myocardium were lOa-fold 
higher than the value observed after 10 min of ischemia, corresponding to the period used by 
Przyklenk et a1.9 to produce preconditioning of the adjacent virgin myocardium. 
Cerebral ischemia as a stimulus/or cardioprotectioll 
It is well documented that transient ischemia in small intestines, kidneys and skeletal 
muscle prior to a coronal), artel)' occlusion can be cardioprotective. IO•13 \Ve therefore 
hypothesized that cerebral ischemia might similarly protect the myocardium, especially 
because cerebral ischemia is associated with substantial norepinephrine release, one of the 
mediators involved in cardioprotection by ischemic preconditioning. However, in the present 
study transient cerebral ischemia did not reduce myocardial infarct size. The explanation for 
the lack of protection might be two-fold. Firstly. 30 min of cerebral ischemia did not produce 
myocardial ischemia and could not protect the myocardium via ischemic preconditioning. 
Secondly. although myocardial norepinephrine levels increased during 30 min of cerebral 
ischemia the failure to elicit cardioprotection appears to be related to the magnitude of the rise 
in myocardial interstitial norepinephrine levels, as the high dose of norepinephrine, which 
yielded 5 times higher interstitial concentrations than cerebral ischemia elicited 
cardioprotection. This is further c011'Oboratcd by the findings with the low dose of 
norepinephrine. which produced similar interstitial myocardial norepinephrine levels as 
cerebral ischemia, and was also ineffective in protecting the heart. 
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It could be argued that even the 30-min global cerebral ischemia (CI30) was too short to 
elicit cardioprotection. However, there is ample evidence that the intensity of the 
preconditioning stimulus is more impOliant than its duration.54,55 Moreover, because the 
elevation of myocardial interstitial norepinephrine levels occUlTed exclusively during the first 
10 min of cerebral ischemia, it is unlikely that extending the period of cerebral ischemia would 
produce cardioprotection. On the contrary, it might be argued that the duration of the 
intracranial pressure elevation and recovery phase lasted too long as the maximum myocardial 
interstitial norepinephrine levels reached their peak during the first 10 min, so that a potential 
effect of that stimulus was lost by the time (50 min later) the LAD was occluded for 60 min. 
This is supported by observations that the memOIY for cardioprotection is shorter when stimuli 
are used that do not cause myocardial ischemia.49,56,57 However, when cerebral ischemia was 
maintained for only 10 min, and the cerebral reperfusion was shortened to 20 min (ClIO), 
infarct size after the 60-min coronary artelY occlusion was also not different from control. 
Finally, it can be excluded that a protective effect of transient global cerebral ischemia 
exerted during the coronalY artery occlusion was masked by ilTeversible myocardial damage 
produced by transient global cerebral ischemia prior to the coronary 3liery occlusion, as in the 
animals which were subjected to only the 30 min of cerebral ischemia (CIJO SHAl>')' ineversible 
damage could not be detected. This observation is in agreement with most experimental 
shldies that have generally reported minimal or no focal myocardial necrosis following 
cerebral ischemia.36-38,58 
Conclusions 
In conclusion, global cerebral ischemia preceding a coronary artery occlusion did not 
modify myocardial infarct size, which is likely related to the modest increase in myocardial 
norepinephrine levels during cerebral ischemia. The infarct size limitation by the high dose of 
norepinephrine is not associated with a blunting of the increase in myocardial interstitial 
norepinephrine levels during the coronaty occlusion. 
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Chapter 10 Discllssion alld Sllmmat)' 
Myocardial ischemia 
Coronmy artery disease, one of the most prominent health problems in modem society, 
may lead to myocardial ischemia (i.e. the energy demand cannot be met by the energy supply). 
The resultant damage of myocardial ischemia is dependent on the duration and severity of the 
myocardial ischemia and diverges from no damage, reversible damage (contractile 
dysfunction), to irreversible damage (myocardial infarction). During the last 25 years both 
experimental and clinical observations have led to the recognition of three ischemic 
syndromes: (I) Myocardial stllllning, the delayed recovery of regional myocardial contractile 
function upon reperfusion of myocardial ischemia, despite the absence of ilTeversible dam agel , 
(2) lschem;c preconditioning, the cardioprotective effect of Sh0l1 periods of ischemia 
preceding a period of prolonged ischemia2, and (3) Hibe1'1lation, the chronic left ventricular 
dysfunction in the absence of ongoing metabolic evidence of ischemia by a self-protecting 
downregulation in myocardial function and metabolism to abort evolution toward cell death 
despite chronic hypoperfilsion3 (chapter I). 
The general aim of this thesis was to study some remaining questions on the effects of 
brief periods of myocardial ischemia on the hemi muscle, focusing on stunning and ischemic 
preconditioning. For these studies, an in vivo porcine model was used because of the extensive 
possibilities to determine regional contractile function. The size of the heart allows 
implantation of ultrasonic crystals in stunned and nonnal myocardium, for detennination of 
segment shortening and pressurewsegment length/area loops, but also implantation of 
microdialysis probes, for continuous measurement of interstitial levels of norepinephrine. In 
addition, both atierial and coronmy venous samples can be taken at several time points 
throughout the whole experiment, for detennination of myocardial oxygen consumption. In the 
ischemic preconditioning studies in which infarct size is the most impOliant parameter and 
regional myocardial function measurements were not mandatory, the rat was used as 
experimental animal. In these studies it is impOliant that translll.ural flow is not influenced by 
the presence of coronary collaterals. Both pigs and rats have the advantage that they possess a 
negligible amount of collaterals, which provide less variability in the severity of myocardial 
ischemia, and thus less variability in the degree of stunning and myocardial jnt'uct size (see 
chapter 2). 
l\lyocardial stunning 
Established myocardial stunning can be treated with administration of positive inotropic 
agents. Ca2+ sensitizers may pose an advantage over classic positive inotropic agents, because 
the fomler can increase force production with no (or negligible) increments in energy costs.4.6 
However, a seriolls concem of increased Ca2+ sensitivity is that it can prolong the duration of 
contraction and delay the onset of relaxation, thereby impairing diastolic function,1·8 
Therefore, we studied in chapter 3 the effects of the Ca" sensitizer EMD 60263 on diastolic 
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ftmction. The results show that a low dose could fully restore systolic ftmction without any 
adverse effect on diastolic ftmction. However, diastolic ftmction was slightly impaired when 
the dose of EMD 60263 was doubled. Because EMD 60263 is not a pure Ca2+ sensitizer, but 
also possesses inward rectifier K+ CUlTent properties, we also used the enantiomer EMD 
60264, which only possesses inward rectifier K+ current properties. The study with the 
enantiomer showed that the diastolic impairment at high dose of EMD 60263 was not caused 
by the inward rectifier K+ cutTent propel1ies, but by the Ca2+ sensitizing propel1ies, as EMD 
60264 did not produce such a delay in onset of relaxation. 
In view of the narrow therapeutic window of Ca2+ sensitizers, as is the case with EMD 
60263, Ca2+ sensitizers with additional phosphodieasterase III (PDE-III) properties may be 
advantageous over pure Ca2+ sensitizers. In chapler 4 we therefore used EMD 57033, which 
has no effect on the delayed imvard rectifier K+ ClitTent, but exerts in addition to its Ca2+ 
sensitizing properties also minor PDE-III inhibitory actions.s This Ca2+ sensitizer is different 
from pimobendan and levosimendan, which have already been used in clinic trials,9,10 as the 
latter mainly exe11 their cardiovascular actions by PDE-III inhibition and a relatively minor 
Ca2+ sensitization. The results showed that in an in vivo porcine model of regionally stunned 
myocardium EMD 57033 had no adverse effect on global and regional diastolic function in a 
dose that increased regional systolic function far beyond baseline levels. To assess the 
contribution of PDE-I11 inhibition to the effects of EMD 57033, the actions of the PDE-III 
inhibition were minimized by adrenergic blockade. This blockade, however, did not influence 
the effect of EMD 57033 on stunned or non-stunned myocardium, and consequently at the 
dose used in this study the positive inotropic actions of EMD 57033 cannot be ascribed to 
PDE-Ill inhibition. 
In an earlier study by our laboratOlY, II it has been suggested that the inotropic response 
to Ca2+ sensitizers may differ between stmmed and normal myocardium. For instance, it has 
been shown that after inftlsion of EMD 60263 the increase in regional systolic segment 
sh0I1ening in stunned myocardium of anesthetized pigs was much more pronounced than that 
in nonnal myocardium. In accordance with this finding, in chaplers 3 and 4 we observed that 
the Ca2+ sensitizers fully restored segment shortening in the stunned region, but only slightly 
increased segment shortening in the control area. Regional systolic segment shortening is, 
however, a load-dependent parameter for regional contractile function. Therefore, we also used 
the left ventricular end systolic pressure-segment leugth relation, in analogy to the time-
varying elastance coucep!. This parameter showed that infusion of EMD 57033 induced 
similar increases in end-systolic elastance in both snllllled and normal myocardium. The same 
observations are made when dobutamine is used, which suggests that the difference in 
response of the stunned and nonnal myocardium using load-dependent or load-independent 
parameters results predominantly from a greater sensitivity of regions with a lower end-
systolic elastance for positive inotropic interventions. 
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Several investigators have questioned, despite ill vitro evidence, whether Ca2+ sensitizers 
exert their cardiovascular effects in vivo by Ca2+ sensitization. Thus, although infusion of Ca2+ 
in in vivo experiments can increase myocardial contractility reflected by LVdP/dtmax,12.15 
segment sh0I1ening,12 wall thickening13•14 and extemal work,15 it has not been adressed in any 
Shidy whether the responsiveness to Ca2+ was enhanced when Ca2+ sensitizers were 
administered. Moreover, in vivo evidence for a decreased Ca2+ responsiveness in stunned 
myocardium is lacking. In chapter 5 we therefore studied the effect of EMD 57033 on the 
responsiveness of normal and stunned myocardium to intracoronmy Ca2+ infusions in vivo. 
Intracoronmy infusion of Ca2+ increased global and regional contractility of normal 
myocardium and this effect was markedly enhanced by EMD 57033. Conversely, stunned 
myocardium was characterized by a loss of the inotropic response to Ca2+ and this response 
was restored after infusion of EMD 57033. These ill vivo findings supp0l1 the concept, based 
on ill vitro observations, that EMD 57033 increases myocardial contractility via an increase in 
myofilament Ca2+.responsiveness, and that the myofilament Ca2+·responsiveness of shmned 
myocardium is decreased. 
Ischemic preconditioning 
Brief periods of myocardial ischemia preceding a prolonged period of ischemia limit 
myocardial infarct size (ischemic preconditioning).2 In addition, several studies have now 
shown that brief ischemia in the adjacent myocardiumI6 or in other organs, like the kidney l7 or 
smalJ intestines,17 can also induce cardioprotection (remote preconditioning, chapter 6). 
Another group of stimuli, which do not lead to myocardial ischemia, such as ventricular 
pacing,18 myocardial stretch 19 or pharmacological preconditioning20-22 can also limit infarct 
size. The cardioprotection by remote preconditioning and nonMischemic stimuli is, however, 
less than the cardioprotection induced by ischemic preconditioning. 
Adenosine as a mediator of cardioprotectioll 
During myocardial ischemia, several substances such as adenosine and norepinephrine 
are released and accumulate in the interstitium. Adenosine is the breakdown product of A TP 
and is transp0l1ed into the interstitium via the nucleoside transporter and activates adenosine 
AI and A3 receptors on the cardiomyocytes and adenosine A2 receptors in the vasculahue. The 
role of adenosine in the pathway leading to ischemic preconditioning, has been confinned in 
several species, although the subtypes of adenosine receptor that contribute to ischemic 
preconditioning remain to be elucidated. In the rat, the role of adenosine in ischemic 
preconditioning is controversial, as several studies failed to block ischemic preconditioning 
with adenosine receptor blockade.23,24 However, because interstitial adenosine levels are much 
higher in rats than in other species,25 blockade of adenosine receptors in these studies could 
have been inadequate. These considerations led us to study the role of adenosine receptors in 
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ischemic preconditioning in the in vivo rat heart. The results in chapter 7 show that the non-
selective adenosine blocker 8-sulphophenyl-theophylline (8-SPT) dose dependently inhibited 
ischemic preconditioning, with a complete abolition of protection after a high dose, 
demonstrating the importance of adenosine in ischemic preconditioning in the rat heart. As 
cardioprotection induced by the adenosine A, receptor agonist IB-MECA was not affected by 
the low dose of 8-SPT, but was blunted by the high dose of 8-SPT, these results suggest that 
both adenosine AI and A3 receptor subtypes are involved in ischemic preconditioning in the rat 
heart. 
Norepinephrine as a mediator of cardioprotectioll 
Norepinephrine, released by the cardiac sympathetic nelve endings during myocardial 
ischemia, is another mediator involved in the signaling pathway leading to ischemic 
preconditioning. Using the microdialysis technique, we first studied in chapter 8 the 
mechanism by which norepinephrine is released during ischemia and the effects of ischemia 
on the functional integrity of nerve endings. The role of the uptake I mechanism was studied 
using the uptake I blocker desipramine and the results showed that during the first 10 min of 
ischemia norepinephrine was released by local exocytotic release, selectively in the ischemic 
area. However, in contrast to previous studies in rats,26-29 nonexocytotic uptake via the uptake 
1 mechanism was not enhanced. After 10 min the release involved non-exocytotic release via 
reversal of the carrier-mediated uptake 1 mechanism. Upon reperfusion the uptake 1 
mechanism contributed to the clearance of norepinephrine. This observation together with the 
finding that tyramine could induce release of norepinephrine after 60 min myocardial ischemia 
suggests that the functional integrity of the nerve endings is still intact, at a time when massive 
cardiomyocyte necrosis has occurred (84% ofthe area at risk infracted). 
The effect of norepinephrine, released during ischemia, on cardiomyocytes is still under 
debate. It has been shown that norepinephrine can be cardiotoxic and cause focal myocardial 
necrosis,30 but norepinephrine is also known as one of the mediators in ischemic 
preconditioning.3l -33 Cerebral ischemia has been reported to cause an excessive release of 
norepinephrine from sympathetic nerve endings in nonnalmyocardium.34 Therefore in chapter 
9 we tested the hypothesis whether cerebral ischemia-induced norepinephrine release could 
protect the heart during sustained myocardial ischemia via remote preconditioning. Glohal 
cerebral ischemia, induced by increasing the intracranial pressure above systolic blood 
pressure, caused a tripling of the interstitial norepinephrine levels. Cerebral ischemia by itself 
did not cause myocardial necrosis, but also did not protect the heart against a prolonged period 
of myocardial ischemia. Exogenous infusion of a low dose of norepinephrine, which produced 
similar increases in interstitial norepinephrine levels as cerebral ischemia, was also unable to 
induce cardioprotection. On the other hand, a high dose of norepinephrine, which resulted in a 
IO-fold increase in interstitial norepinephrine levels decreased infarct size after prolonged 
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myocardial ischemia. The cardioprotection by exogenous norepinephrine was not caused by 
ischemic preconditioning or associated with blunting of norepinephrine release during 
sustained ischemia. These findings suggest that the lack of cardioprotection by cerebral 
ischemia could be related to the modest rise in myocardial interstitial norepinephrine levels. 
Future studies 
One of the most interesting remaining questions regarding myocardial stunning is the 
molecular mechanism underlying the decrease in Ca2+ -responsiveness of the myofilaments. It 
has been proposed, based on ill vitro studies, that troponin I proteolysis by pmteases such as 
catpains, and the consequent alteration in Ca2+ -troponin C interaction, contribute to the loss of 
Ca2+ -responsiveness. Future studies, using inhibitors of calpai'us are required to establish 
whether this mechanism contributes to myocardial stunning in vivo. 
Treatment of contractile dysfunction with positive intropic agents such as p-agonists and 
pure phosphodiesterase inhibitors has been limited by the increased mortality as a result of 
increased incidence of arrhythmias, which can be ascribed to the effects of an increase in 
cAMP. Experimental studies in genetically modified mice suggest that a positive inotropic 
intervention that does not modify cAMP and sarcolemmal function can improve left 
ventricular contractile function without a concommittant increase in mortality (Rockman and 
Chien unpublished data). Positive inotropic intelvention that acts via the sarcomplasmic 
reticulum (up-regulation of Ca'+ ATPase or down-regulation of phospholamban) or the 
myofilaments (increasing the Ca'+ sensitivity) might become usefill in the therapy of 
contractile dysfunction of the human heart. Gene therapy (Le. phospholamban knock-out or 
SERCA overexpression) is certainly of interest, but still in an early experimental phase, and 
further study in transgenic animals is required. 
For the treatment of contractile dysfunction, Ca2+ sensitizers appear promising, due to 
their favorable cardiac energetic effects compared to traditional positive inotropic agents, such 
as l3-agonists and PDE-inhibitors. However, a concern has been their potentially detrimental 
effects on diastolic function. The Ca2+ sensitizer EMD 57033 exerted minimal effects on 
diastolic function and promising results in animal models of heart failure warrant further 
studies in patients with heart failure. 
In this thesis the role of adenosine A3 receptor in rats was studied using the non-selective 
blocker 8-SPT. Our data that are suggestive, but not definitive prove of a role for A, receptors 
in ischemic preconditioning. The use of novel selective adenosine A3 receptor antagonists, 
such as MRS 1191, is mandatory to proof the role of adenosine A3 receptors in ischemic 
preconditioning. In addition, the use of microdialysis will enable us to determine the role of 
exaggerated increases in interstitial adenosine levels during myocardial ischemia ill vivo, in 
overcoming the nonwselective adenosine receptor blockade as was proposed by Headrick.25 
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The experiments on the effect of cerebral ischemia on the development of myocardial 
ischemia, showed that global ischemia could not induce cardioprotection. These experiments 
were done in pigs anesthetized with pentobarbital, of which is known to decrease cerebral 
blood flow to one-third of cerebral blood flow measured in conscious pigs. To exclude the 
influence of the anesthesia on the lack of induction of cardioprotection, these experiments 
should be repeated with an anesthetic regoment that has less influence on cerebral blood flow. 
The model of global cerebral ischemia used in our study resembles that of brain death. It is 
possible that regional cerebral ischemia could induce cardioprotection. For example, 
subarachnoidal hemorrhage, of which it is known that it causes myocardial stunning in 
patients, could be an interesting regional cerebral model,35,36 
Similar to stunning, the exact mechanism of ischemic preconditioning is also not yet 
known, and fuhue studies should be directed at unraveling this mechanism. Although there is 
consensus that K\11' channels (ire the end-effector of cardioprotection, there is still some 
debate whether this concems the mitochondrial or also the sarcolemmal K+-ATP channels. This 
can now be further studied using mitochondrial and sarcomlenunal selective K\11' chamlel 
openers and blockers. 
Another issue that is often raised with respect to ischemic preconditioning is its clinical 
relevance. In recent years, the clinical relevance of ischemic preconditioning, which was 
originally a laboratory observation, has become accepted. Clinical application of the 
cardioprotective strategies could include the use of K+-ATP channel openers, such as nicorandil, 
in patients with unstable angina pectoris. A question that needs to be addressed is whether 
tolerance to its cardioprotective actions occurs. However, many patients do not experience 
unstable angina pectoris prior to a myocardial infarction and treatment can only be given as 
part of reperfusiOJHherapy. Thus, treatment should also be focused on reperfusion injury, with 
for example Na+/H+ exchange inhibitors, because they can decrease Ca2+ overload at the onset 
of reperfusion. In a recent clinical trial it has been demonstrated that the Na+/H+- exchange 
inhibitor HOE 642 attenuates reperfusion injmy and thereby improve the recovery from left 
ventricular dysfunction after myocardial infarction)7 In addition, the combination of 
percutaneous trans luminal angioplasty (PTCA) and a cardioprotective agent, such as 
adenosine, has already been successfully applied to primalY PTCA.38 
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Myocal'd ischemia 
Coronair vaatlijden, een van de meest voorkomende gezondheidsproblemen van deze 
tijd, kan uiteindelijk leiden tot myocard ischemie, wanneer de energie voorziening via het 
bloed niet voldoet aan de energie behoefte van de hartspier. De uiteindelijke schade als gevoig 
van myocard ischemie is afhankeJijk van de duur en de ernst van de ischemie en varieert van 
geen schade, reversibele schade (contractiele dysfunctie), tot ilTeversibele schade (hartinfarct). 
Gedurende de afgelopen 25 jaar hebben zowel experimentele als klinische studies geleid tot 
onderscheid van 3 ischemische syndromen: (I) Myocardiale slllllning, het vertraagde herstel 
van regionale contractiele hartfunctie na volledig herstel van perfusie van het ischemische 
hartweefseI, ondanks de afwezigheid van irreversibele schade, (2) [schemische 
precollditiolleJ'ing, het cardioprotectieve effect van k0l1e perioden van ischemie voorafgaand 
aan een lange periode van ischemie, en (3) Hibernation, de chronische linker ventrikel 
dysfunctie in de afwezigheid van metabole aanwijzingen voor ischemie door een 
zelfbeschermende down·regulatie van de hartspierfunctie en metabolisme om ontwikkeling tot 
celdood te voorkomen ondanks chronische hypoperfusie (hooidslllk I). 
Het doel van dit proefschrift was het bestuderen van een aantal openstaande vragen 
betreffende stunning en ischemische preconditionering. In deze shldies werd cen in vivo 
varkensmodel gebmikt vanwege de uitgebreide mogelijkheden om de regionale 
hartspierfunctie te meten. Door de grootte van het hart is het mogelijk om ultrasone kristallen 
in geshmned en normaal hartweefsel te plaatsen voor de bepaling van segment lengte 
verkorting en dl1lk-segment Iengteioppervlakte relatie. Ook is het mogelijk microdialyse 
probes te implanteren voor de continue meting van noradrenaline concentraties tussen de 
cellen (interstitiele concentraties). Naast deze metingen kUllnen ook arteriele en coronair 
veneuze bloedmonsters worden genomen op verschillende tijdstippen gedurende het gehele 
experiment. Voor shldies naar ischemische preconditionering waarbij vooral de bepaling van 
de infarctgrootte belangrijk is en die van de hm1spierfunctie niet vereist is, zijn ratten gebruikt. 
In shldies naar de effecten van ischemie van de hm1spier is het belangrijk dat de transmurale 
doorbloeding van het hart niet belnvloed wordt door de aanwezigheid van collateralen. Zowel 
in varkens als in ratten zijn nauwelijks collateralen aanwezig. Hierdoor is er bij een coronair 
afsluiting minder variabiliteit in de ernst van ischemic en dus oak minder variabiliteit in de 
mate van stunning en infarct ontwikkeling (hoofsluk 2). 
Myocardiale stunning 
Stunning van de hartspier kan worden behandeld door toediening van positief inotrope 
stoffen. Calcium sensitizers zouden voordeliger kunnen zijn dan klassieke positief inotrope 
stoffen, omdat zij de contractiekracht l<Ulillen verbeteren zonder of met venv.arloosbare 
toename in energieverblllik. Echter, een probleem van een toename in de calcium gevoeligheid 
kan zijn dat de duur van de cOlltractie wordt verlengd Dit kan lei den tot een vertraging van de 
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start van de relaxatie van de ventrikel, betgeen de vulling van het hart ongunstig kan 
beinvloeden. Daarom is inltoofdslllk 3 het effect van de calcium sensitizer EMD 60263 op de 
relaxatie bestudeerd. De resultaten laten zien dat een lage dosis van deze calcium sensitizer de 
contractiele filllctie volledig kan herstellen zonder nadelige effecten op de relaxatie. Echter, de 
relaxatie was wei gedeeltelijk venninderd wanneer de dosis werd verdubbeld. Omdat EMD 
60263 geen zuivere calcium sensitizer is, maar ook invloed heeft op de kalium kana len in de 
celmembraan hebben we ook de effecten van de enantiomeer EMD 60264 bestudeerd. Deze 
enantiomeer die geen calcium gevoeligheid-verhogende eigenschappen heeft, maar aileen een 
effect heeft op de kalium kanalen, liet zien dat de relaxatie vermindering bij de hoge dosering 
van EMD 60263 veroorzaakt werd door de calcium gevoeligheid-verhogende eigenschappen, 
maar niet door de effecten op de kalium kanalen. 
Om problemen met de relaxatie te voorkomen, kan het voordelig zijn een calcium 
sensitizer te hebben die zowel calcium gevoeligheid-verhogende als fosfodiesterase-lII 
remmende eigenschappen heeft. In ltoofdsfllk 4 hebben we daarom de effecten van EMD 
57033 bestudeerd, een stof die geen effect heeft op de kalium kanalen in de celmembraan, 
maar naast calcium gevoeligheid-verhogende eigenschappen ook enige fosfodiesterase-III 
remmende eigenschappen bezit. EMD 57033 is verschillend van pimobendan en 
levosimelldan, die beide al gebnlikt zijn in klillische studies, in dat de laatstgenoemden meer 
uitgesproken fosfodiesterase-lII remmende eigenschappen hebben dan calcium gevoeligheid-
verhogende eigellschappen. De resultatell laten zien, dat in een ill vivo varkensmodel van 
regional gestunned hartweefsel EMD 57033 geennegatief effect heeft op globale en regionale 
relaxatie zelfs in een dosis die de regiollale contractiele functie herstelde tot ver boven 
uitgangswaarden. Om de bijdrage van de fosfodiesterase-III renllnende eigenschappen van 
EMD 57033 te bepalen, werden de fosfodiesterase-lII remmende effecten geminimalizeerd 
door de adrenerge receptoren te blokkeren. Deze blokkade had echter geen invloed op de 
effecten van EMD 57033 op geshmned en nOl1uaal hartweefsel en dus kunnen de positief 
contractiele effecten van EMD 57033 in de dosis gebruikt in deze studie niet worden 
toegeschreven aan fosfodiesterase-III remming. 
In een eerdere studie door ons Iaboratorium uitgevoerd, werd gesuggereerd dat de 
positief inotrope respons op calcium 'sensitizers in gestullned en nOll11aal hartweefsel 
verschillend zou zijn. Deze studie liet zien dat na infusie van EMD 60263 in genarcotiseerde 
varkens de toename in systolische segment lengte verkorting groter was in geshmned dan in 
n0l111aai hartweefsel. In overeenstemming met deze bevinding hebben we in hoofdstuk 3 en 4 
gevonden dat de calcium sensitizers de segment lengte verkorting volledig herstelde in 
geshuUled hartweefsel en maar een kleine toename liet zien in nonnaal hartweefsel. Regiollale 
segment lengle verkorting is echter een load-afhankelijke parameter voor regionale 
contractiele filllctie. We hebben daarom ook gebl1lik gemaakt van de linker ventrikel eind-
systolische dmk-segment lengte relatie, analoog aan het concept van de tijdsafhankelijke 
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variatie in elastantie. Deze parameter liet zien dat infllsie van EMD 57033 dezelfde toename in 
eind-systolische elastantie induceerde in zowel gestunned als normaal hartweefseI. Dezelfde 
resultaten worden gevonden \vanneer dobutamine wordt gebmikt. Deze shldies suggereren dat 
parameters die niet gecorrigeerd zijn voor load-afllankelijkheid ongeschikt zijn voor de 
bepaling van regionaie contractiiiteit. 
Ondanks de aanwijzingen ill vitro twijfelen verschillende onderzoekers of calcium 
sensitizers hun cardiovasculaire effect in vivo ook uitoefenen door verhoging van de calcium 
gevoeligheid. III vivo experimenten hebbell laten zien dat infusie van calcium de contractiliteit 
kan verhogen, weergegeven door een toename in de LVdP/dtmax, segment verkortillg, 
wandverdikking en exteme arbeid. Er zijn echter geen studies die hebben aangetoond dat de 
calcium respons is toegenomen na toediening van een calcium sensitizer. Bovendien is het ill 
vivo bewijs voor een afgenomen calcium gevoeligheid in gestullllcd hartweefsel nog niet 
geleverd. In Iwolds/uk 5 hebben we daarom de effecten van EMD 57033 op de respolls van 
nonnaal en geshmned hartweefsel op intracoronaire calcium infllsics ill vivo bestudeerd. 
Intracoronair calcium verhoogde zowel de globale als de regionale contractiele functie van 
nonnaal hartweefsel en de respons op calcium was duidelijk toegenomen na toediening van 
EMD 57033. Anderzijds was er ill geshlllllCd myocard een verlies van de inotrope respons op 
calcium, die echter was hersteld na toediening van EMD 57033. Deze ill vivo bevindingen 
ondersteunen het concept, gebaseerd op ill vitro shldies, dat EMD 57033 de contractiele 
functie doet verhogen via een toename in de calcium rcspons van de myofilamenten, en dat de 
calcium respons van de myofilamenten in gestunned hartweefsel is velminderd. 
Ischemischc preconditioncring 
Korte perioden van ischemie voorafgaand aan een langdurige periode van ischemie kan 
de infarct ontwikkeling vertragen (ischemische preconditionering). Tevens latcn verschillende 
studies zien dat een korte peri ode van ischemie in het naastgelegen hartweefsel of in andere 
organen, zoals de nieren en de dannen, ook het halt kUlll1en beschennen Cremate' 
preconditionering, ollewel beschenning op afstand}. Prikkels die niet tot ischemie leiden, zoals 
ventrikel pacen, myocardiale stretch of activatie van (bijvoorbeeld adenosine) receptoren 
mogeJijk betrokken bij ischemische preconditionering kUllIlen ook de illfarctontwikkeling 
vertragen. De beschenning van de hartspier door preconditionering op afstand en niet-
ischemische prikkcls is echter mindel' dan de beschenlling via ischemische preconditionering 
(hoolds/llk 6). 
Adenosine als eell mediator van ;sclzem;sc!ze precollditiollering 
Tijdens ischemie van de hartspier, worden verschillende stoffen, zoals adenosine en 
noradrenaline, uitgescheiden en hopen op tussen de cellen (interstitium). Adenosine is cen 
afbraakprodukt van ATP en wordt via de nucleoside transporter in het interstitium 
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uitgescheidell, waar het de adenosine Al en A3 receptoren op de halispiercellen en adenosine 
A2 receptoren in de vaten activeelt. De rol van adenosine in het mechanisme dat leidt tot 
ischemische preconditionering is in verschillende diersoorten bevestigd, maar in de rat is de rol 
van adenosine controversieel omdat in verschillende studies ischemische preconditionering 
niet kon worden geblokkeerd met adenosine receptor blokkers. In de rat zijn interstitiele 
adenosine concentraties tijdens ischemie echter veel hoger dan in andere diersoorten en dus 
kan blokkade van de adenosine receptoren in de hiervoorgenoemde shldies niet voldoende zijn 
gewees!. Deze hypothese heeft eltoe geleid dat we in "ooids/uk 7 de ral van de adenosine 
receptoren in ischemische preconditionering in ratten in vivo hebben beshldeerd. De resultaten 
laten zien dat de non-selectieve adenosine receptor blocker 8-sulphophenyl theophylline (8-
SPT) ischemische preconditionering dosis afhankelijk kon rem men, met een complete 
blokkade van de beschemling na de hoge dosering (50mglkg). Omdat cardioprotectie 
opgewekt door de adenosine A3 agonist JB-MECA niet werd belnvloed door de lage dosering 
8-SPT, maar gedeeltelijk vellllinderd was door de hoge dosering 8-SPT, lijkt het dat zowel 
adenosine Al als A3 receptoren betrokken zijn bij ischemische preconditionering in de rat. 
Noradrenaline als mediator voor isclzemisclze precollditionerillg 
Noradrenaline, tijdens ischemie van de hartspier uitgescheiden door de sympatische 
zenuwuitcinden in het hart, is ook bctrokken bij het mechanisme van ischemische 
preconditionering. Gebruik makend van microdialyse, hebben we in hoo/dstuk 8 eerst 
bestudeerd wat het uitscheidingsmechanisme van noradrenaline is tijdens ischemie van de 
hartspier en wat de effecten van ischemie op de functionele integriteit van de zenuwuiteillden 
zijn. De rol van het presynaptische opname kanaal (Uptake I) werd bestudeerd door de Uptake 
I blokker desipraminc te gebmiken. De studie laat zien dat tijdens de eerste 10 minuten van 
ischemic noradrenaline sclectief wordt uitgescheiden in het ischemische gebied via lokale 
exocytose. In tegenstel1ing tot bevindingen in eerdere studies in ratten, was de opname van 
noradrenaline via het uptake 1 mechanisme niet verhoogd. Na 10 minutcn ischemie werd 
noradrenaline ook uitgescheiden via omkering van het presynaptische uptake 1 mechanisme. 
Tijdens reperfusie is de uptake I weer hersteld en zorgt mede voor de klaring van 
noradrenaline. Deze resultatell en de bevindingen dat tyramine de uitstoot van noradrenaline 
na 60 minuten ischemie kon stimuleren Iaat zien dat de functionele integriteit van de 
zenuwuiteinden nog intact is, op cen tijdstip dat een groot deel van de hartspier cellen reeds 
irreversible beschadigd is (84% van het risicogebied is afgestorven). 
Het effect van noradrenaline uitgescheiden tijdens ischemie op hartspiercellen is nog 
steeds een punt van discussie. Hoewel studies hebben aangetoond dat noradrenaline is 
betrokken bij ischelllische preconditionering zijn er oak studies die hebben uitgewezen dat 
noradrenaline toxisch kan zijn voor het hart en kleine infarcten kan veroorzakcn. Van hersen 
ischemie is bekend dat het enonne uitstoot van noradrenaline induceert in nonnaal 
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hartweefsel. Daarom hebben we in hoofilslllk 9 de hypothese getest dat uitscheiding van 
noradrenaline in het hart als gevolg van hersen ischemie het hart kan beschennen via remote 
preconditionering. Globale hersen ischemie, geinduceerd door de intracraniele dl1lk te 
verhogen boven de systolische bloeddruk, veroorzaakte een verdrievoudiging van de 
interstitiele noradrenaline concentraties. Hersen ischemie zelfveroorzaakte geen necrose in het 
normale hartweefsel, maar kon ook het halt uiet beschemlCn tijdens een daaropvolgende lange 
peri ode van ischemie van de hartspier. Exogene toediening van eell lage dosis noradrenaline, 
die een vergelijkbare toename in de interstitiele noradrenaline spiegels induceerde als hersen 
ischemie, gaf ook geen cardioprotectie. Echter, na toediening van een hoge dosis 
noradrenaline, die de interstitiele noradrenaline spiegels vertieuvoudigde, was de infarct 
grootte na 60 minuten ischemie van de hartspier wei kleiner. Aanvullende experimenten 
toonden aan dat de cardioprotectie via exogene noradrenaline uiet werd veroorzaakt door 
ischemische preconditionering. Hoewel het hartinfarct kleiner was in de experimenten waarin 
noradrenaline exogeen werd toegediend was er geen vennindering van de uitstoot van 
noradrenaline tijdens de daaropvolgende 60 miuuten ischemie. Deze studie suggereert dat 
hersen ischemie geen cardioprotectie kon op\vekken omdat de interstitiele noradrenaline 
spiegels in het hart niet hoog genoeg kwamen. 
ToekoIllstige studies 
Een van de meest interessante vragen die nog open staat betreffende stunning is het 
moleculaire mechanisme dat ten grondslag ligt aan de afhame in calcium respolls van de 
myofilamenten. Er is verondersteld, gebaseerd op ill vitro studies, dat troponin I proteolyse 
door proteasen zoals calpaine, en de daaropvolgende veranderingen in calcium-troponin C 
interactie bijdragen aan het verlies van calcium respons. Studies die gebmik maken van 
calcpaine l'emmers kunnen uitwijzen of dit mechanisme inderdaad bijdraagt aan myocardia Ie 
stunning in vivo. 
Behandeling van contractiele dysfunctie met positief inotrope stoffen zoals p-agonisten 
en pure fosfodiesterase-III remmers, is gecontraindiceerd door de verhoogde kans op plotse 
dODd ten gevolge van een toename van het aantal ventriculaire aritmieen, toegeschreven aan de 
verhoogde concentratie cAMP. Studies in genetisch gemodificeerde muizen hebben laten zien 
dat een positief inotrope interventie die geen invloed heeft op de cAMP concentratie of op de 
functie van het celmembraan, contractlele functie van de linker ventrikel kan verbeteren 
zonder een toename in sterfie. Positief inotrope interventie die via het sarcoplasrnatische 
reticulum (up-regulatie van Ca'+ ATPase of down-regulatie van phospholamban) of de 
myofilamenten (toename van de calcium gevoeligheid) werkt, kan belangrijk zijn in de 
behandeling van contractiele dysfunctie van het humane hart. Gentherapie (bijv. 
phospholamban knock-out of SERCA overexpressie) is zeker interessant, maar nog steeds in 
de experimentele fase. 
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Voor de behandeling van contractiele dysfunctie lijken calcium sensitizers een 
veelbelovende groep positief inotropic a, vanwege het gunstige energie verbmik van het hart in 
vergelijking met traditionele positief inotrope stoffen, zoals p-agonisten en fosfodiesterase-III 
remmers. Een belangrijk probleem kan echter het effect op de linker ventrikel relaxatie zijn. 
EMD 57033 heeft minimale effecten op de relaxatie en de veelbelovende resultaten in 
diermodellen van hat1falen (ventrikel pacen en hartinfarct) kUllilen aanleiding zijn tot het 
uitvoeren van studies in patienten met hartfalen. 
In dit proefschrift is de rol van adenosine AI en A3 in ischemische preconditionering in 
de rat bestudeerd door gebruik van de non-selectieve adenosine receptor blokker 8-SPT. Onze 
data zijn echter suggestief omdat we door gebmik te maken van non~selectieve blockers geen 
direct bewijs hebben geleverd. Het gebruik van nieuwe selectieve adenosine A, receptor 
blokkers, zoals MRS 1191, is nodig om de ral van adenosine A3 receptor in ischemische 
preconditionering aan te tonen. Daarnaast zal het gebmik van micradialyse het mogeJijk 
maken 0111 de rol te bepalen van de enonne toename in interstitiele adenosine cOllcentraties 
tijdens myocard ischemie die de non-selectieve adenosine blokkade doorbreken, zoals in 
eerdere shldies. 
De shldies naar de effecten van hersen ischemie op de ontwikkeling van het hartinfarct in 
dit proefschrift liet zien dat globale ischemie geen cardioprotectie opwekte. Deze 
experimenten zijn uitgevoerd in varkens genarcotiseerd met pentobarbital, waardoor de 
bloeddoorstroming van de hersenen maar 30% was vergeleken met wakkere varkens. Om de 
invloed van het narcose middel op het onvennogen om cardioprotectie op te wekken uit te 
siuiten, zouden deze experimenten herhaald moeten worden in varkens met een narcose middel 
dat minder effect l10eft op de bloeddoorstroming van de hersenen. Het in onze studie gebmik1e 
model van globale hersen ischemie, komt overeen met een model voor hersendood. Het is 
echter heel goed mogelijk dat een model van regionale hersen ischemie weI cardioprotectie 
zon opwekken. Een voorbeeld van regionale hersen ischemie zon een model met 
subarachnoidale bloedingen kunnen zijll. Van subarachnoidale bloedingen is bekend dat het 
sh1l1J1ing in patienten kan veroorzaken en dus misschien ook weI cardioprotectie. 
Evenals bij stunning is ook het exacte mechanisme van ischemische preconditionering 
nog niet bekend en in de toekomst zouden shldies zich moeten richten op het ontrafelen van dit 
mechanisme. Hoewel het algemeen geaccepteerd is dat ATP gevoelige kalium kanalen de 
eind~effector zijn van ischemische preconditionering, is er nog steeds de vraag of dit de 
mitochondriale dan weI de sarcolemmale kalium kanalen betreft. Dit zon nu verder onderzocht 
kunnen worden met behulp van selectieve openers en blokkers van mitochondriale en 
sarcolemll1ale kalium kana len. 
Een ander belangrijk punt dat vaak naar voren wordt gebracht met betrekking tot 
ischemische preconditionering is de klinische relevantie. In de afgelopen jaren is de klinische 
relevantie van ischemische preconditionering} dat oorspronkelijk een laboratorium bevinding 
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was, aigemeell geaccepteerd. Klinische toepassing van cardioprotectieve strategieen zouden 
het geb11lik van ATP gevoelige kalium kanaal openers, zoals nicorandil, in patienten met 
instabiele angina pectoris kunnen inhouden. Een vraag die dan opkomt is of patienten 
tolerantie tegen de cardioprotectieve effecten van deze stoffen zonden ontwikkelen. Echter 
veel patienten hebben last van instabiele angina pectoris voordat het hartinfarct olltstaat en 
behandeling kan aileen gegeven worden als onderdeel van de reperfusie therapie. Dus 
behandeling zou oak gericht moeten zijn op beperking van de reperfusie schade, zoals door 
natrium-waterstof exchange remmers die de calcium overload venninderen bij aanvang van de 
reperfusie. Een recente klinische studie heeft laten zien dat de natrium-waterstof exchange 
remmer HOE 642 de reperfusie schade vermindert en daarmee het hers tel van de linker 
ventrikel dysfunctie na een hartinfarct verbetert. De combinatie van percutane transluminale 
angioplastie (PTCA, "dotteren") en een cardioprotectieve stof zoals adenosine wordt inmiddels 
succesvol toegepast bij primaire PTCA. 
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DOllkwoord 
Promoveren kun je niet aileen. Daar Iteb je veel mensen voor nodig. Daarom maak ik ook 
dankbaar gebmik van de lege mimte achterin dit proefschrift am iedereen (ik hoop dat ik 
niemand vergeet) nog eens te bedanken. 
Allereerst mijn promotor Professor Verdouw: Piet, bedankt dat ik op de afdeling 
Experimentele Cardiologie onderzoek mocht doen. AI tijdens mijn stage wist ik dat ik hier 
weer temg wilde komen. De besprekingen waren altijd zeer gevarieerd. En ik heb dan oak veel 
geleerd over: baseball (The Phillies), politiek en niet te vergeten de wetenschap en het 
schrijven van artikelen. Het heeft toch uiteindelijk geleid tot een 'revised submission' naar 
Stroke. 
Mijn co-promotor Dirk Duncker: Dirk, bedankt voor alles wat je mij geleerd hebt over 
experimenteren, theoretische achtergronden en het schrijven van artikelen. We hebben leuke 
discussies gehad. Over het 'I love you'-vims (dit ga ik niet voorlezen!) tot welke 
vervolgstudics er gedaan moesten worden (lage of hoge concentratie noradrenaline of tach een 
ander anesthesiemiddel). 
Professor Schelling: thank you for revie\ving my manuscript and your suggestions. 
Professor Lamers and Dr Boomsma: bedankt voor het lezen en beoordelen van mijn 
proefschrift en de lluttige suggesties. 
Professor Koudstaal, Professor van del' Laarse en Dr Krams: bedankt Vaal' UW bereidheid 
plaats te nemen in de commissie. 
Voor aile hulp bij het analyseren van de dmk-segment lengte relaties wil ik Rob Krams en 
Serge Trines bedanken. 
Rob bedankt voor je uitleg en discussies over loops en elastantie. 
Serge, onze 'Matlab'en SPSS specialist. Dankzij jou programmeertalent in Matlab heb ik al 
die jaren hMMel veeeelloops kunnen analyseren. 
Voor aile microdialyse wit ik graag de afdeling Illwendige Geneeskunde bedanken: Tall van 
den Meiracker, Frans Boomsma, Thomas Lameris, Gooitzen Alberts en Richard Zuiderent. 
Ton en Frans, bedankt voor jullie enthousiasme en discussies over aile experimenten. 
Thomas, bedankt voor aile tijd die je in de microdialyse hebt gestoken. Het was altijd erg 
gezellig op het lab. Vooral in het verzinnen van lange protocollen benje erg goed. Veel sllcces 
met je eigen promotie! 
Gooitze en Richard: bedankt voor het analyseren van al die cllpjes (ongeveer 163.582 cllpjes) 
en het aannemen van de telefoon. 
Djo Hasan wiI ik bedanken vaal' zijn enthousiasme, zijn kennis over de neurologie en hulp bij 
de experimenten. Je weet altijd een heleboel dingen even te regelen (zoals hersencatheters). 
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Dal/f...>~'oord 
Voor de experimentele en technische ondersteuning wil ik graag Rob van Bremen (Rob, ik 
krijg geen signaal op mijn scherml), Jan van Meegen (de meest 'coole' man van het lab 
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